This is the CodeSystem that contains all the codes in Nomenclature Unifiée des Vaccins (https://smt.esante.gouv.fr/terminologie-nuva) and Nomenclature Unifiée des Vaccins (https://smt.esante.gouv.fr/terminologie-nuva). E.g. what you have to deal with if you get resources containing codes in either of them
Generated Narrative: CodeSystem 11ef1f82-7104-4d22-a114-4816a2cca1e3-791
Properties
This code system defines the following properties for its concepts
Name | Code | URI | Type | Description |
type | type | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | code | |
created | created | http://purl.org/dc/terms/created | dateTime | |
modified | modified | http://purl.org/dc/terms/modified | dateTime | |
containedInVaccine | containedInVaccine | http://data.esante.gouv.fr/NUVA/nuvs#containedInVaccine | code | |
prevents | prevents | http://data.esante.gouv.fr/NUVA/nuvs#prevents | code | |
comment | comment | http://www.w3.org/2000/01/rdf-schema#comment | string | |
containsValence | containsValence | http://data.esante.gouv.fr/NUVA/nuvs#containsValence | code | |
isAbstract | isAbstract | http://data.esante.gouv.fr/NUVA/nuvs#isAbstract | boolean | |
hiddenLabel | hiddenLabel | http://www.w3.org/2004/02/skos/core#hiddenLabel | string | |
Parent | parent | http://hl7.org/fhir/concept-properties#parent | code | Codes des parents du concept courant |
Child | child | http://hl7.org/fhir/concept-properties#child | code | Codes des enfants du concept courant |
imported | imported | boolean | Indicates if the concept is imported from another code system. | |
root | root | boolean | Indicates if this concept is a root concept (i.e. Thing is equivalent or a direct parent). | |
type | type | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | code | |
created | created | http://purl.org/dc/terms/created | dateTime | |
modified | modified | http://purl.org/dc/terms/modified | dateTime | |
containedInVaccine | containedInVaccine | http://data.esante.gouv.fr/NUVA/nuvs#containedInVaccine | code | |
prevents | prevents | http://data.esante.gouv.fr/NUVA/nuvs#prevents | code | |
comment | comment | http://www.w3.org/2000/01/rdf-schema#comment | string | |
containsValence | containsValence | http://data.esante.gouv.fr/NUVA/nuvs#containsValence | code | |
isAbstract | isAbstract | http://data.esante.gouv.fr/NUVA/nuvs#isAbstract | boolean | |
hiddenLabel | hiddenLabel | http://www.w3.org/2004/02/skos/core#hiddenLabel | string | |
Parent | parent | http://hl7.org/fhir/concept-properties#parent | code | Codes des parents du concept courant |
Child | child | http://hl7.org/fhir/concept-properties#child | code | Codes des enfants du concept courant |
imported | imported | boolean | Indicates if the concept is imported from another code system. | |
root | root | boolean | Indicates if this concept is a root concept (i.e. Thing is equivalent or a direct parent). |
Filters
Code | Description | Op | Value |
root | = | True or false. | |
deprecated | = | True or false. | |
imported | = | True or false |
Concepts
This code system http://hl7.org/fhir/comparison/CodeSystem/11ef1f82-7104-4d22-a114-4816a2cca1e3-791
defines codes, but no codes are represented here
Code | Display | Parent | Child | Parent | Child |
VAL152 | Valence grippe, inactivée, entière, sans précision | VAL365, VAL365 | VAL365, VAL365 | ||
VAL370 | Valence pneumocoque, polyosidique conjuguée, sérotype 15C | VAL184, VAL184 | VAL184, VAL184 | ||
VAC1062 | Immunoglobulines CMV, sans précision | ||||
DIS078 | Lèpre | ||||
VAC1280 | Vaccin Pneumocoque conjugué 21-valent, sans précision | ||||
VAC0878 | TRITANRIX | ||||
VAC0527 | VACCIN DIPHTERIQUE ET TETANIQUE ADSORBE | ||||
VAC0745 | MF59 ADJUVANTED SARS-CoV-2 SCLAMP VACCINE | ||||
VAC1195 | Vaccin Covid 19 à vecteur viral non réplicatif, adénovirus 26 codant la protéine de pointe du SARS-CoV-2, en essai clinique, sans précision | ||||
VAC0830 | Vaccin Zona sous-unitaire, sans précision | ||||
VAL067 | Valence tétanos, anatoxine | ||||
VAC0612 | DTP-vax FINLAY | ||||
VAL285 | Valence grippe, trivalente, inactivée, obtenue sur culture cellulaire, fractionnée ou sous-unité, dose normale | VAL360, VAL360 | VAL360, VAL360 | ||
VAC0963 | ANATOXAL DI TE PER | ||||
VAC0082 | MENBVAC | ||||
VAL020 | Valence zona, vivant atténué | VAL160, VAL160 | VAL160, VAL160 | ||
VAL371 | Valence pneumocoque, polyosidique conjuguée, sérotype 16F | VAL184, VAL184 | VAL184, VAL184 | ||
DIS077 | Entérovirus | ||||
VAC1281 | PENTABIO | ||||
VAC0529 | IMOVAX TETANO | ||||
VAC0528 | MOSQUIRIX | ||||
VAC0613 | BORYUNG DTap VACCINE | ||||
VAC0879 | ACELLUVAX | ||||
VAC1063 | Vaccin Hépatite C, sans précision | ||||
DIS076 | Infection urinaire | ||||
VAC1196 | Vaccin Encéphalite japonaise, entier inactivé préparé sur tissu cérébral murin, sans précision | ||||
VAL068 | Valence hépatite B, sans précision | VAL090, VAL291, VAL158 | VAL090, VAL291, VAL158 | ||
VAC0964 | ANATOXAL DI | ||||
VAL153 | Valence Haemophilus influenzae type b, polyoside de PRP conjugué à l'anatoxine diphtérique | VAL103, VAL103 | VAL103, VAL103 | ||
VAC0831 | Vaccin Ebola, sans précision | ||||
VAL286 | Valence hépatite A, vivant atténué, sans précision | VAL288, VAL288 | VAL288, VAL288 | ||
VAC0083 | SYNFLORIX | ||||
VAL283 | Valence hépatite A, inactivée, entière, dose pédiatrique, sans précision | VAL125, VAL125 | VAL142, VAL143 | VAL125, VAL125 | VAL142, VAL143 |
VAL150 | Valence dengue, sans précision | VAL087, VAL065 | VAL087, VAL065 | ||
VAC1193 | Vaccin Encéphalite japonaise, vivant recombinant atténué, sans précision | ||||
VAC0307 | MORUBEL | ||||
VAC1060 | SPIKEVAX XBB.1.5 50 µg MODERNA | ||||
DIS075 | Fièvre de la vallée du Rift | ||||
VAC0525 | INFANRIX PENTA | ||||
VAC0658 | COMIRNATY 30 µg BIONTECH-PFIZER | ||||
VAC0743 | BBV154 | ||||
VAC0961 | ANATOXAL TE N | ||||
VAL198 | Valence pneumocoque, polyosidique conjuguée, sérotype 14 | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0876 | CINQUERIX | ||||
VAC0610 | Vaccin dTca - Diphtérie-Tétanos-Coqueluche, dose réduite, sans précision | ||||
VAL065 | Valence dengue, vivante atténuée, tétravalente, chimérique recombinante | VAL150, VAL150 | VAL150, VAL150 | ||
VAC0080 | BCG PASTEUR | ||||
VAL284 | Valence hépatite A, inactivée, entière, dose adulte, sans précision | VAL125, VAL125 | VAL144, VAL145 | VAL125, VAL125 | VAL144, VAL145 |
VAL151 | Valence tularémie, sans précision | ||||
VAC1061 | PENBRAYA | ||||
VAC1194 | Vaccin Tétanos, Typhoïde et Paratyphoïde A et B, sans précision | ||||
VAC0308 | MORUMAN BERNA PRODUCTS | ||||
VAC0309 | MORUPAR | ||||
VAC0659 | ZIFIVAX ANHUI COVID-19 VACCINE | ||||
VAC0877 | INFANRIX HEPB | ||||
DIS074 | Streptococcus pyogenes | ||||
VAC0526 | HECOLIN | ||||
VAC0611 | SHAN-5 | ||||
VAC0962 | ANATOXAL DI TE N ADULT | ||||
VAL199 | Valence pneumocoque, polyosidique conjuguée, sérotype 15B | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0744 | COVID-19 INACTIVATED VACCINE | ||||
VAL066 | Valence covid 19, vecteur viral réplicatif, virus influenza codant la protéine de pointe du SARS-CoV-2 | VAL398, VAL398 | VAL398, VAL398 | ||
VAC0086 | TETAVAX | ||||
DIS073 | Mélanome | ||||
VAC1066 | Vaccin Mélanome, sans précision | ||||
VAL289 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 10 microgrammes | VAL303, VAL303 | VAL303, VAL303 | ||
VAC0701 | BACTRL-SPIKE | ||||
VAC1151 | Vaccin quadrivalent DTCeP - Diphtérie-Tétanos-Coqueluche-Polio, sans précision | ||||
VAC0967 | HEPASOMA | ||||
VAC1284 | NUSAGARD | ||||
VAL156 | Valence Haemophilus influenzae type b, polyoside de PRP conjugué à l’anatoxine tétanique | VAL103, VAL103 | VAL103, VAL103 | ||
VAL023 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, voie intradermique, sans précision | VAL024, VAL024 | VAL024, VAL024 | ||
VAL241 | Valence papillomavirus, VLP, type 18 | VAL236, VAL236 | VAL236, VAL236 | ||
VAC1199 | Vaccin Ebola à vecteur viral réplicatif de la stomatite vésiculaire recombinant (rVSV) - glycoprotéine GP d'EBOV, sans précision | ||||
VAL374 | Valence pneumocoque, polyosidique conjuguée, sérotype 23B | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0171 | PREPANDEMIC INFLUENZA VACCINE (H5N1) NOVARTIS | ||||
VAC0172 | DIFTAVAX | ||||
VAC0087 | VAXICOQ | ||||
VAC0969 | LYSSAVAC N BERNA | ||||
VAC1370 | JENVAC | ||||
VAC1285 | NOPV2 BIO FARMA | ||||
VAC0968 | INFLEXAL V | ||||
VAC0835 | FIOCRUZ COVID-19 VACCINE | ||||
VAL157 | Valence covid 19, sans précision | VAL164, VAL165 | VAL164, VAL165 | ||
VAC0702 | RRBD PRODUCED IN CHO-CELL CHEMICALLY CONJUGATE TO TETANUS TOXOID | ||||
VAC1152 | Vaccin Méningocoque B contenant la fHbp des sous-familles A et B, sans précision | ||||
VAL024 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, sans précision | VAL058, VAL058 | VAL023, VAL231 | VAL058, VAL058 | VAL023, VAL231 |
VAL375 | Valence pneumocoque, polyosidique conjuguée, sérotype 24F | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0920 | Vaccin dT - Diphtérie-Tétanos, sans précision | ||||
VAL242 | Valence papillomavirus, VLP, type 31 | VAL236, VAL236 | VAL236, VAL236 | ||
DIS072 | Infection à VIH | ||||
VAC1067 | Vaccin Streptococcus pyogenes, sans précision | ||||
VAC0390 | TETRACT-HIB | ||||
VAC0084 | Vaccin Grippe prépandémique H5N1, sans précision | ||||
VAL372 | Valence pneumocoque, polyosidique conjuguée, sérotype 20A | VAL184, VAL184 | VAL184, VAL184 | ||
VAC1282 | FLUBIO INFLUENZA HA | ||||
VAC1197 | Vaccin Covid 19 à adénovirus de chimpanzé et à ARNm auto-amplifiant, sans précision | ||||
VAC0965 | ANATOXAL TE TAB | ||||
VAC1064 | Vaccin VIH, sans précision | ||||
VAL069 | Valence covid 19, vecteur viral non réplicatif, adénovirus de chimpanzé ChadOx1 codant la protéine de pointe du SARS-CoV-2 | VAL397, VAL397 | VAL397, VAL397 | ||
VAC0614 | TDAPBOOSTER AJ VACCINES | ||||
VAL287 | Valence grippe, quadrivalente, recombinante | VAL361, VAL361 | VAL361, VAL361 | ||
VAC0832 | Vaccin Herpes Simplex, sans précision | ||||
VAL154 | Valence Haemophilus influenzae type b, oligosides de PRP conjugués à la toxine diphtérique mutante CRM197 | VAL103, VAL103 | VAL103, VAL103 | ||
DIS071 | Hépatite C | ||||
VAL021 | Valence choléra, inactivée, entière, orale | VAL359, VAL359 | VAL062, VAL367, VAL368 | VAL359, VAL359 | VAL062, VAL367, VAL368 |
VAC0085 | T POLIO MERIEUX | ||||
VAL240 | Valence papillomavirus, VLP, type 16 | VAL236, VAL236 | VAL236, VAL236 | ||
VAC1150 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, virus originel, 30 microgrammes, sans précision | ||||
VAC0966 | JYNNEOS | ||||
VAC0615 | VACCIN T.P. PASTEUR | ||||
VAC0833 | COMIRNATY 10 µg BIONTECH-PFIZER | ||||
VAC1065 | Vaccin Lèpre, sans précision | ||||
VAC1198 | Vaccin Chinkungunya, vivant atténué, sans précision | ||||
VAC1283 | INDOVAC | ||||
VAL155 | Valence Haemophilus influenzae type b, polyoside de PRP conjugué à la protéine de membrane externe de Neisseria meningitidis sérogroupe B | VAL103, VAL103 | VAL103, VAL103 | ||
VAL288 | Valence hépatite A, sans précision | VAL125, VAL286 | VAL125, VAL286 | ||
DIS070 | Cytomégalovirus | ||||
VAL022 | Valence variole, vivant atténué, sans précision | VAL418, VAL418 | VAL028, VAL295, VAL294 | VAL418, VAL418 | VAL028, VAL295, VAL294 |
VAL373 | Valence pneumocoque, polyosidique conjuguée, sérotype 23A | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0170 | AFLUNOV | ||||
VAC0301 | MMR | ||||
DIS038 | Papillomavirus | ||||
VAC0216 | ANATOXAL DI TE | ||||
VAC0349 | QUADRIGEN | ||||
VAL027 | Valence covid 19, vecteur viral non réplicatif, adénovirus 26 codant la protéine de pointe du SARS-CoV-2 | VAL070, VAL070 | VAL070, VAL070 | ||
VAL245 | Valence papillomavirus, VLP, type 52 | VAL236, VAL236 | VAL236, VAL236 | ||
VAL378 | Valence hépatite B, antigène de surface recombinante du virus de l'hépatite B (Ag HBs), 15 microgrammes | VAL090, VAL090 | VAL090, VAL090 | ||
VAL112 | Valence grippe, quadrivalente, inactivée, obtenue sur culture cellulaire, fractionnée ou sous-unité, dose normale | VAL360, VAL360 | VAL360, VAL360 | ||
VAC0567 | SHINGRIX | ||||
VAC0434 | VACINA TRIPLICE VIRAL | ||||
VAC0785 | BOOSTAGEN | ||||
VAL330 | Valence covid 19, variant Omicron XBB.1.5, ARNm codant la protéine de pointe du SARS-CoV-2, 25 microgrammes | VAL396, VAL396 | VAL396, VAL396 | ||
VAC0870 | TYPBAR | ||||
VAC0652 | CONVIDECIA | ||||
VAC1414 | Vaccin anti-covid 19 à sous-unité protéique, protéine de pointe recombinante dans des nanoparticules, avec adjuvant (Matrix M), sous-variant Omicron JN.1 | ||||
VAC1329 | FLU-M | ||||
VAC0217 | DITOXIM | ||||
VAL028 | Valence variole, troisième génération, vivant atténué | VAL022, VAL022 | VAL018, VAL296 | VAL022, VAL022 | VAL018, VAL296 |
VAL379 | Valence covid 19, variant Omicron JN.1, ARNm codant la protéine de pointe du SARS-CoV-2, 30 microgrammes | VAL395, VAL395 | VAL395, VAL395 | ||
VAL246 | Valence papillomavirus, VLP, type 45 | VAL236, VAL236 | VAL236, VAL236 | ||
VAL113 | Valence papillomavirus, VLP, bivalent, types 16 et 18 | VAL237, VAL237 | VAL237, VAL237 | ||
VAC0568 | BOOSTRIX-POLIO | ||||
VAL331 | Valence CMV, immunoglobulines | ||||
VAC0435 | VAKSIN CACAR | ||||
VAC0653 | Vaccin Hépatite A et B enfant, sans précision | ||||
VAC0786 | PREVNAR 20 | ||||
VAC0520 | IMVANEX | ||||
VAC1415 | Vaccin polyvalent contre la bactérie Pseudomonas aeruginosa | ||||
VAC0871 | SUPEMTEK | ||||
VAC0214 | DIF-TET-ALL | ||||
VAC0347 | QUADRACEL | ||||
VAC0129 | HB VAX DNA 40 µg | ||||
DIS036 | Choléra | ||||
VAL158 | Valence hépatite B, plasmatique | VAL068, VAL068 | VAL068, VAL068 | ||
VAL025 | Valence paludisme, sans précision | VAL009, VAL311 | VAL009, VAL311 | ||
VAL243 | Valence papillomavirus, VLP, type 33 | VAL236, VAL236 | VAL236, VAL236 | ||
VAL376 | Valence pneumocoque, polyosidique conjuguée, sérotype 31 | VAL184, VAL184 | VAL184, VAL184 | ||
VAL110 | Valence tétanos, immunoglobuline | ||||
VAC0698 | hAd5-COVID-19 | ||||
VAC0783 | R-COVI | ||||
VAC0432 | VACINA DUPLA | ||||
VAC1327 | HEPATITIS B SII | ||||
VAC1412 | Vaccin à ARNm contre la covid 19, subvariant Omicron JN.1, 10 microgrammes, dose pédiatrique (5-11 ans) | ||||
VAC0650 | VAXZEVRIA ASTRAZENECA | ||||
VAC1109 | Vaccin Méningocoque ACW non conjugué, sans précision | ||||
VAC0300 | MEVILIN-L | ||||
VAC0348 | QUADRACEL/HIBEST | ||||
VAL159 | Valence zona, sous-unitaire | VAL160, VAL160 | VAL013 | VAL160, VAL160 | VAL013 |
VAL026 | Valence méningocoque B, protéines de vésicules de membrane externe | VAL118, VAL118 | VAL118, VAL118 | ||
VAL377 | Valence pneumocoque, polyosidique conjuguée, sérotype 35B | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0699 | IIBR's RECOMBINANT VSV-DeltaG-spike VACCINE | ||||
VAL244 | Valence papillomavirus, VLP, type 58 | VAL236, VAL236 | VAL236, VAL236 | ||
VAL111 | Valence charbon, acellulaire | VAL340, VAL340 | VAL415 | VAL340, VAL340 | VAL415 |
VAC0566 | PNEUMOCOCCAL POLYSACCHARIDE VACCINE MSD | ||||
VAC0433 | VACINA TRIPLICE | ||||
VAC0651 | CORONAVAC COVID-19 VACCINE | ||||
VAC1413 | Vaccin à ARNm contre la covid 19, subvariant Omicron JN.1, 3 microgrammes, dose (6 mois-4 ans) | ||||
VAC0784 | PERTAGEN | ||||
VAC1328 | TUBERVAC | ||||
VAC0305 | MOPV | ||||
DIS034 | Leptospirose | ||||
VAC1191 | Vaccin Infections urinaires chez la femme, sans précision | ||||
VAL116 | Valence VRS, anticorps monoclonal, palivizumab | VAL320, VAL320 | VAL320, VAL320 | ||
VAC0438 | VAKSIN SERAP | ||||
VAC0789 | COMVAC4 | ||||
VAL201 | Valence pneumocoque, polyosidique conjuguée, sérotype 19A | VAL184, VAL184 | VAL184, VAL184 | ||
VAL334 | Valence mélanome, sans précision | ||||
VAC0874 | INNOFLU | ||||
VAC0523 | GARDASIL 9 | ||||
VAC0656 | SPIKEVAX 0,2 mg/mL MODERNA | ||||
VAC0741 | COVID-EVAX | ||||
VAL249 | Valence encéphalite japonaise, sans précision | VAL248, VAL089 | VAL248, VAL089 | ||
VAC1418 | Vaccin à ARNm contre la covid 19, subvariant Omicron KP.2, 30 microgrammes, adulte (+ 12 ans) | ||||
DIS033 | Zona | ||||
VAC0306 | MORBILVAX | ||||
VAC1192 | Vaccin pentavalent DTCePHibHepB - Diphtérie-Tétanos-Coqueluche-Hib OC-HépatiteB 10µg, sans précision | ||||
VAL335 | Valence Streptococcus pyogenes, sans précision | ||||
VAC0439 | VAMOAVAX | ||||
VAL202 | Valence pneumocoque, polyosidique conjuguée, sérotype 19F | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0657 | SINOPHARM WUHAN COVID-19 VACCINE | ||||
DIS032 | Rotavirus | ||||
VAC0524 | TEVAX | ||||
VAL420 | Valence botulisme, produits d'immunisation passive | VAL419, VAL419 | VAL063, VAL358 | VAL419, VAL419 | VAL063, VAL358 |
VAC0875 | PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA | ||||
VAC0742 | COVIGEN | ||||
VAC0960 | VIATIM | ||||
VAC1419 | Vaccin Chikungunya à base de VLP (recombinant, adsorbé) | ||||
VAL117 | Valence coqueluche, acellulaire, dose non précisée | VAL003, VAL003 | VAL008, VAL017 | VAL003, VAL003 | VAL008, VAL017 |
VAC0303 | MONIARIX | ||||
VAC0218 | DOUBLE ANIGEN B. | ||||
VAL247 | Valence encéphalite japonaise, virus chimérique vivant atténué | VAL248, VAL248 | VAL248, VAL248 | ||
VAL114 | Valence hépatite B, antigène de surface recombinante du virus de l'hépatite B (Ag HBs), 10 microgrammes | VAL090, VAL090 | VAL090, VAL090 | ||
DIS031 | Dengue | ||||
VAC0569 | INFANRIX-IPV | ||||
VAC0787 | Vaccin DiphTRub - Diphtérie-Tétanos-Rubéole, sans précision | ||||
VAC0436 | VAKSIN CAMPAK KERING | ||||
VAL332 | Valence hépatite C, sans précision | ||||
VAC0654 | Vaccin Hépatite A et B adulte, sans précision | ||||
VAC0521 | FLUENZ TETRA | ||||
VAC0872 | INFLUPOZZI SUBUNITA | ||||
VAC1416 | Vaccin à ARNm contre la covid 19, subvariant Omicron KP.2, 3 microgrammes, dose pédiatrique (6 mois-4 ans) | ||||
VAL029 | Valence grippe, VLP, sans précision | VAL364, VAL364 | VAL363 | VAL364, VAL364 | VAL363 |
VAC1190 | Vaccin Covid 19 à vecteur viral réplicatif, virus de la stomatite vésiculaire codant la protéine de pointe du SARS-CoV-2, sans précision | ||||
VAC0304 | MOPAVAC SEVAC | ||||
VAC0219 | DRYVAX | ||||
DIS079 | Pseudomonas aeruginosa | ||||
VAL115 | Valence hépatite B, antigène de surface recombinante du virus de l'hépatite B (Ag HBs), 20 microgrammes | VAL090, VAL090 | VAL090, VAL090 | ||
VAL248 | Valence encéphalite japonaise, vivant atténué, sans précision | VAL249, VAL249 | VAL100, VAL247 | VAL249, VAL249 | VAL100, VAL247 |
DIS030 | Rage | ||||
VAL333 | Valence VIH, sans précision | ||||
VAC0437 | VAKSIN KOTIPA | ||||
VAL200 | Valence pneumocoque, polyosidique conjuguée, sérotype 18C | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0655 | Vaccin Diphtérie, sans précision | ||||
VAC0788 | Vaccin Haemophilus influenzae b et Poliomyélite, sans précision | ||||
VAC0873 | INFLUPOZZI ADIUVATO | ||||
VAC0740 | PTX-COVID19-B | ||||
VAC1417 | Vaccin à ARNm contre la covid 19, subvariant Omicron KP.2, 10 microgrammes, dose pédiatrique (5-11 ans) | ||||
VAC0341 | PREVNAR | ||||
VAC0123 | PREVENAR 13 | ||||
VAC0256 | IMOVAX MUMPS | ||||
VAC0038 | TICOVAC 0,5 mL | ||||
VAC0389 | TETAMUN SSW | ||||
VAC1103 | HIB-VAX | ||||
VAC1321 | HAEMOPHILUS INFLUENZAE B SII | ||||
VAC1369 | INDIRAB | ||||
VAC1018 | NOORA VACCINE | ||||
VAC0474 | DARONRIX | ||||
VAC1236 | Vaccin Covid 19 à sous-unité protéique, protéine de pointe recombinante dans des nanoparticules, sous-variant Omicron XBB.1.5, sans précision | ||||
VAC0692 | COVAXX | ||||
VAL205 | Valence pneumocoque, polyosidique conjuguée, sérotype 33F | VAL184, VAL184 | VAL184, VAL184 | ||
VAL338 | Valence VRS, anticorps ou vaccin, sans précision | VAL317, VAL318 | VAL317, VAL318 | ||
VAC0124 | FOCETRIA (multidose) | ||||
VAC0257 | IMOVAX PAROTIDITIS | ||||
VAC0039 | TICOVAC 0,25 mL | ||||
VAC1322 | PNEUMOSIL | ||||
VAC1019 | SPIKEVAX 0,1 mg/mL MODERNA | ||||
VAC0475 | FOCLIVIA | ||||
VAC0693 | VXA-COV2-1-COVID | ||||
VAC1104 | DIPHTHERIA ANTITOXIN B.P. | ||||
VAC1237 | Vaccin Paludisme pré-érythrocytaire, sans précision | ||||
VAC0560 | VAXIGRIPTETRA | ||||
VAL339 | Valence Borrelia burgdorferi, sans précision | VAL030 | VAL030 | ||
VAL206 | Valence pneumocoque, polyosidique non conjuguée, sérotype 1 | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0254 | IMOVAX D.T. | ||||
VAC0121 | PRIORIX-TETRA | ||||
VAC0036 | TETAGRIP | ||||
VAC0387 | TETANOL | ||||
VAC0169 | OPTAFLU | ||||
VAC0918 | Vaccin Haemophilus influenzae b, PRP-D, sans précision | ||||
VAL203 | Valence pneumocoque, polyosidique conjuguée, sérotype 22F | VAL184, VAL184 | VAL184, VAL184 | ||
VAL336 | Valence fièvre de la vallée du Rift, sans précision | ||||
VAL421 | Valence fièvre hémorragique d'Argentine, virus Junin, sans précision | VAL173 | VAL173 | ||
VAC1234 | Vaccin Pneumocoque non conjugué 15-valent, sans précision | ||||
VAC1367 | HNVAC | ||||
VAC1101 | DOTARICIN | ||||
VAC1016 | IDFLU | ||||
VAC1149 | Vaccin Choléra vivant atténué oral, sans précision | ||||
VAC0472 | PREPANDRIX | ||||
VAL118 | Valence méningocoque B, sans précision | VAL161, VAL026 | VAL161, VAL026 | ||
VAC0690 | CHINESE-AD5-NCOV-COVID | ||||
VAC0255 | IMOVAX GRIPPE | ||||
VAC0388 | TETASORBAT SSW | ||||
VAC0919 | Vaccin Haemophilus influenzae b, hbOC, sans précision | ||||
VAC0037 | TETRAVAC-ACELLULAIRE | ||||
VAL204 | Valence pneumocoque, polyosidique conjuguée, sérotype 23F | VAL184, VAL184 | VAL184, VAL184 | ||
VAL422 | Valence peste, sans précision | VAL131 | VAL131 | ||
VAC1102 | HIB-IMMUNE | ||||
VAC1235 | Vaccin Rotavirus monovalent RIX4414, sans précision | ||||
VAC1320 | DIPHTHERIA, TETANUS, PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE B SII | ||||
VAC1368 | INCOVACC | ||||
VAC1017 | SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1 (50 µg/50 µg)/mL MULTIDOSE MODERNA | ||||
VAC0473 | PRE-PANDEMIC INFLUENZA VACCINE H5N1 | ||||
VAC0691 | FINLAY-FR-1 | ||||
VAL119 | Valence méningocoque, monovalent, polyosidique non conjugué | VAL234, VAL234 | VAL234, VAL234 | ||
VAL337 | Valence variole, immunoglobuline | VAL418, VAL418 | VAL418, VAL418 | ||
VAC0212 | DI TE PER POL IMPFSTOFF | ||||
VAC0345 | Vaccin Haemophilus influenzae b PRP-T, sans précision | ||||
VAC0127 | HB VAX DNA 5 µg | ||||
VAC0478 | COVAXIS | ||||
VAC1410 | Vaccin à ARNm contre la covid 19, subvariant Omicron JN.1, 25 microgrammes par dose, flacon multidose | ||||
VAC0563 | ALPHA-RIX-TETRA | ||||
VAC0696 | KCONVAC MINHAI COVID-19 VACCINE | ||||
VAC1107 | Vaccin Choléra entier inactivé, sans précision | ||||
VAC0781 | RABIVAC | ||||
VAC0430 | VACCIN DIFTERIC ADSORBIT | ||||
VAL209 | Valence pneumocoque, polyosidique non conjuguée, sérotype 4 | VAL185, VAL185 | VAL185, VAL185 | ||
VAC1325 | GENEVAC-B 10 µg | ||||
VAC0213 | DI-TE-POL | ||||
VAC0346 | PURIVAX | ||||
VAC0128 | HB VAX DNA 10 µg | ||||
VAC0479 | TRIAXIS | ||||
VAC0697 | V590 (COVID-19) | ||||
VAC1411 | Vaccin à ARNm contre la covid 19, subvariant Omicron JN.1, 30 microgrammes, dose adulte (+ 12 ans) | ||||
VAC1326 | GENEVAC-B 20 µg | ||||
VAC0431 | VACCINUM MORBILLORUM VIVUM | ||||
VAC0782 | RASILVAX | ||||
VAC1108 | Vaccin bivalent Covid 19 à ARNm contre le virus originel et le variant Omicron BA.1, sans précision | ||||
VAC0210 | D.S.D.P.T. | ||||
VAC0343 | ProHIBiT | ||||
VAC0258 | IMOVAX R.O.R. | ||||
VAC0125 | AREPANRIX | ||||
VAC1323 | MENFIVE | ||||
VAC0476 | PANDEMIC INFLUENZA VACCINE H5N1 BAXTER | ||||
VAC1238 | Vaccin Hépatite B et Paludisme, sans précision | ||||
VAC0694 | LMU-MVA-SARS-2-S-COVID | ||||
VAC0561 | IMOJEV | ||||
VAC1105 | BAT EMERGENT BIOSOLUTIONS | ||||
VAL207 | Valence pneumocoque, polyosidique non conjuguée, sérotype 2 | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0211 | DAPTACEL | ||||
VAC0344 | Vaccin Haemophilus influenzae b PRP-OMP, sans précision | ||||
VAC0126 | HEVAC B | ||||
VAC0259 | IMOVAX Rabies | ||||
VAC0477 | PUMARIX | ||||
VAC0695 | RBD-HBsAg-VLPs-Covid | ||||
VAC1106 | Vaccin Covid 19 VLP, sans précision | ||||
VAC1239 | Vaccin Pneumocoque conjugué 15-valent, sans précision | ||||
VAC0562 | INFLUVAC TETRA | ||||
VAC1324 | NASOVAC-S | ||||
VAL208 | Valence pneumocoque, polyosidique non conjuguée, sérotype 3 | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0780 | VAXNEUVANCE | ||||
VAC0030 | REVAXIS | ||||
VAC0163 | Vaccin Coqueluche entier inactivé, sans précision | ||||
VAC0296 | MENPOVAX 4 A+C+Y+W135 | ||||
VAC0078 | RUDI-ROUVAX | ||||
VAL071 | Valence typhoïde, inactivée, entière | VAL014, VAL014 | VAL014, VAL014 | ||
VAC0827 | Vaccin ROR-V - Rougeole-Oreillons-Rubéole-Varicelle, sans précision | ||||
VAC0911 | Vaccin Hépatite A, monovalent, dose pédiatrique, sans précision | ||||
VAC1361 | HEPAMUNE B 20 µg | ||||
VAC1010 | TRIAMER | ||||
VAC1143 | Vaccin Covid 19 à vecteur viral non réplicatif, adénovirus codant la protéine de pointe du SARS-CoV-2, sans précision | ||||
VAC1058 | SPIKEVAX XBB.1.5 0,1 mg/mL dose 50 µg MODERNA | ||||
VAC1276 | DTP BIOMED | ||||
VAC0382 | Vaccin Diph-T - Diphtérie-Tétanos, sans précision | ||||
VAC0031 | ROTATEQ | ||||
VAC0164 | INTANZA 9 µg | ||||
VAC0297 | MENPOVAX A+C | ||||
VAC0079 | ENCEPUR | ||||
VAL072 | Valence méningocoque B, contenant la fHbp des sous-familles A et B | VAL161, VAL161 | VAL161, VAL161 | ||
VAL290 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 30 microgrammes | VAL303, VAL303 | VAL303, VAL303 | ||
VAC0828 | Vaccin Rotavirus pentavalent, sans précision | ||||
VAC1011 | DITEKIBOOSTER | ||||
VAC0912 | Vaccin Hépatite A, dose pédiatrique, sans précision | ||||
VAC1362 | SK TD | ||||
VAC1059 | SPIKEVAX XBB.1.5 0,1 mg/mL dose 25 µg MODERNA | ||||
DIS080 | Méningocoque X | ||||
VAC1144 | Vaccin Covid 19 à sous-unité protéique, protéine de pointe du SARS-CoV-2 recombinante, S-2P et CpG1018, sans précision | ||||
VAC1277 | Vaccin contre le chikungunya, sans précision | ||||
VAC0161 | ZOSTAVAX | ||||
VAC0294 | MENCEVAX A | ||||
VAC0076 | DTVax | ||||
VAC0958 | ADIUGRIP | ||||
VAC1274 | d BIOMED | ||||
VAC0957 | VACCINO BCG BERNA | ||||
VAC0824 | Vaccin Hépatite A virosomal, sans précision | ||||
VAC1141 | Vaccin contre la grippe aviaire H5N8, sans précision | ||||
VAC1056 | R21/MATRIX-M | ||||
VAC1189 | Vaccin Covid 19 à vecteur non réplicatif, vaccine Ankara modifiée codant la protéine de pointe du SARS-CoV-2, sans précision | ||||
VAC0162 | Vaccin Brucellose, sans précision | ||||
VAC0295 | MENOMUNE-A/C/Y/W-135 | ||||
VAC0077 | IMOVAX OREILLONS | ||||
VAC0959 | STREPTOPUR | ||||
VAL070 | Valence covid 19, vecteur viral non réplicatif, adénovirus codant la protéine de pointe du SARS-CoV-2, sans précision | VAL397, VAL397 | VAL027, VAL050, VAL292 | VAL397, VAL397 | VAL027, VAL050, VAL292 |
VAC0826 | MEASLES AND RUBELLA VACCINE SII | ||||
VAC1142 | Vaccin Covid 19 à vecteur viral non replicatif avec cellules présentant l'antigène, sans précision | ||||
VAC0910 | Vaccin Hépatite A, entier inactivé, dose adulte, sans précision | ||||
VAC1275 | D BIOMED | ||||
VAC1360 | HEPAMUNE B 10 µg | ||||
VAC0825 | Vaccin Hépatites A et B combiné, sans précision | ||||
VAC1057 | ENGERIX B JUNIOR | ||||
VAC0380 | Vaccin TP - Tétanos-Poliomyélite, sans précision | ||||
VAC0252 | VAXIGRIP ENFANTS | ||||
VAC0385 | TELVACLPTAP | ||||
VAC0034 | SPIROLEPT | ||||
VAL075 | Valence Leptospira icterohaemorrhagiae, inactivée, entière | ||||
VAL293 | Valence charbon, immunoglobuline | ||||
VAL160 | Valence zona, sans précision | VAL020, VAL159 | VAL020, VAL159 | ||
VAC0916 | Vaccin Hépatite B, monovalent pour les patients dialysés, sans précision | ||||
VAC1365 | COMVAC5 | ||||
VAC1014 | PROVARIVAX | ||||
VAC1147 | Anticorps monoclonal humain VRS, nirsevimab, sans précision | ||||
VAC1232 | Vaccin Coqueluche acellulaire, dose réduite, sans précision | ||||
VAC0470 | QUINVAXEM | ||||
VAC0120 | VACCIN VARICELLE MERIEUX | ||||
VAC0253 | VAXIRAB N | ||||
VAC0386 | TETAMYN | ||||
VAC0168 | AMBIRIX | ||||
VAC0035 | STAMARIL | ||||
VAL294 | Valence variole, première génération, vivant atténué | VAL022, VAL022 | VAL022, VAL022 | ||
VAL161 | Valence méningocoque B, multicomposée, sans précision | VAL118, VAL118 | VAL098, VAL072 | VAL118, VAL118 | VAL098, VAL072 |
VAC0917 | Vaccin Hépatite E, sans précision | ||||
VAC1015 | COMBIVAX | ||||
VAC1100 | BOTULISM ANTITOXIN BEHRING | ||||
VAL076 | Valence covid 19, entier inactivé, sans précision | VAL164, VAL164 | VAL265, VAL264 | VAL164, VAL164 | VAL265, VAL264 |
VAC1233 | Vaccin Pneumocoque conjugué 10-valent, sans précision | ||||
VAC1366 | HILLCHOL | ||||
VAC1148 | Vaccin Haemophilus influenzae type b, polyosidique non conjugué, sans précision | ||||
VAC0471 | HEPAVAX-GENE B 20 µg | ||||
VAC0383 | ANATOXAL TE | ||||
VAC0032 | ROUVAX | ||||
VAC0165 | VAQTA 25 U/0,5 mL | ||||
VAC0298 | MERUVAX | ||||
VAL073 | Valence covid 19, vecteur viral replicatif avec cellules présentant l'antigène | VAL162, VAL162 | VAL162, VAL162 | ||
VAL291 | Valence hépatite B, recombinante, trois antigènes (HbS, pré-S1 et pré-S2) | VAL068, VAL068 | VAL068, VAL068 | ||
VAC0914 | Vaccin Hépatite B, monovalent, dose pédiatrique, sans précision | ||||
VAC0829 | Vaccin Rubéole et Oreillons, sans précision | ||||
VAC1230 | Vaccin Méningocoque C et Haemophilus influenzae type b, conjugué à l'anatoxine tétanique, sans précision | ||||
VAC0913 | BIMERVAX | ||||
VAC1363 | HEPAVAX-GENE B 10 µg | ||||
VAC1278 | WALRINVAX | ||||
VAC1012 | PICOVAX | ||||
VAC1145 | Vaccin Hépatite B recombinant, trois antigènes, sans précision | ||||
VAC0251 | HUMOTET-ANTI TETANUS | ||||
VAC0384 | TE/VAC/PTAP | ||||
VAC0166 | VAQTA 50 U | ||||
VAC0033 | RUDIVAX | ||||
VAC0299 | MERUVAX II | ||||
VAL074 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, haute dose | VAL064, VAL064 | VAL064, VAL064 | ||
VAL292 | Valence covid 19, vecteur viral non réplicatif, adénovirus 26 codant la protéine de pointe du SARS-CoV-2, en essai clinique | VAL070, VAL070 | VAL070, VAL070 | ||
VAC0915 | Vaccin Hépatite B, monovalent, dose adulte, sans précision | ||||
VAC1231 | Vaccin pentavalent DTCaHibHepB- Diphtérie-Tétanos-Coqueluche-Hib PRP-Hepatite B 10μg, sans précision | ||||
VAC1146 | Vaccin Grippe quadrivalent, inactivé, haute dose, sans précision | ||||
VAC1279 | Vaccin contre le charbon adsorbé, avec adjuvant | ||||
VAC1364 | BIOHIB | ||||
VAC1013 | FLUBLOK TRIVALENT | ||||
VAL031 | Valence encéphalite à tiques, sans précision | VAL313, VAL312 | VAL313, VAL312 | ||
VAL382 | Valence covid 19, sous-variant Omicron JN.1, sous-unité protéique, protéine de pointe recombinante dans des nanoparticules | VAL107, VAL107 | VAL107, VAL107 | ||
VAC1292 | BIO-TCV | ||||
VAC0539 | DENGVAXIA | ||||
DIS041 | Brucellose | ||||
DIS003 | Coqueluche | ||||
VAC0624 | M-M-Vax | ||||
VAC0757 | NBP 2001 | ||||
VAC1074 | CYFENDUS | ||||
VAL079 | Valence rubéole, vivante atténuée | ||||
VAC0975 | PERTURIX | ||||
VAL164 | Valence covid 19, non vivant, sans précision | VAL157, VAL157 | VAL035, VAL053, VAL039, VAL076, VAL168 | VAL157, VAL157 | VAL035, VAL053, VAL039, VAL076, VAL168 |
VAC0842 | NEORABIS | ||||
VAL297 | Valence méningocoque A, sans précision | VAL037, VAL041 | VAL037, VAL041 | ||
VAC0094 | VACCIN SABIN POLIOVAC MERIEUX | ||||
VAC0095 | VACCIN TAB PASTEUR | ||||
VAL250 | Valence encéphalite japonaise, inactivée, entière, préparée sur tissu cérébral murin | VAL089, VAL089 | VAL089, VAL089 | ||
VAL383 | Valence VRS, ARNm simple brin coiffé en 5' codant pour la glycoprotéine F, stabilisé dans la conformation de préfusion | VAL318, VAL318 | VAL318, VAL318 | ||
VAC1160 | Vaccin Variole vivant de 2ème génération, sans précision | ||||
VAC1293 | VAKSIN BCG KERING | ||||
VAC0408 | TRIPLE ANTIGEN | ||||
DIS040 | Paludisme | ||||
VAC0407 | TRIPLE | ||||
VAC0758 | SPFN COVID 19 VACCINE + AFLQ | ||||
DIS004 | Poliomyélite | ||||
VAC0976 | VACCINO ANTICOLERICO ISI | ||||
VAC1075 | Vaccin Charbon acellulaire, sans précision | ||||
VAC0625 | MORATEN | ||||
VAC0710 | COVID-19 mRNA VACCINE BNT162b2 | ||||
VAL298 | Valence méningocoque C, sans précision | VAL137, VAL057 | VAL137, VAL057 | ||
VAL165 | Valence covid 19, vivant, sans précision | VAL157, VAL157 | VAL162, VAL163, VAL086 | VAL157, VAL157 | VAL162, VAL163, VAL086 |
VAC0843 | NOVIRAB | ||||
VAL032 | Valence typhoïde, non conjuguée, antigène capsulaire polyosidique Vi | VAL014, VAL014 | VAL014, VAL014 | ||
VAC0180 | ACTACEL | ||||
VAL162 | Valence covid 19, vecteur viral réplicatif, sans précision | VAL165, VAL165 | VAL073, VAL398 | VAL165, VAL165 | VAL073, VAL398 |
VAL295 | Valence variole, deuxième génération, vivant atténué | VAL022, VAL022 | VAL022, VAL022 | ||
VAL380 | Valence covid 19, variant Omicron JN.1, ARNm codant la protéine de pointe du SARS-CoV-2, 10 microgrammes | VAL395, VAL395 | VAL395, VAL395 | ||
VAC1072 | Vaccin Covid 19 à ARNm, virus originel, 25 µg, sans précision | ||||
VAC1290 | MOPV1 BIO FARMA | ||||
VAC0319 | OMNIHIB | ||||
DIS005 | Haemophilus influenzae b | ||||
VAC0888 | QUATTVAXEM | ||||
VAC0404 | TRIPACEL | ||||
VAC0622 | EOLARIX | ||||
VAC0973 | VIROFLU | ||||
VAC0755 | ADJUVANTED INACTIVATED VACCINE AGAINST SARS-CoV-2 | ||||
VAC0840 | ADDIGRIP | ||||
VAL077 | Valence oreillons, vivant atténué | VAL183, VAL183 | VAL183, VAL183 | ||
VAC0092 | VACCIN CHOLERIQUE PASTEUR | ||||
VAL163 | Valence covid 19, vecteur viral non replicatif, sans précision | VAL165, VAL165 | VAL167, VAL397 | VAL165, VAL165 | VAL167, VAL397 |
VAL030 | Valence Borrelia burgdorferi, recombinante, protéine de surface externe A (OspA) | VAL339, VAL339 | VAL339, VAL339 | ||
VAL381 | Valence covid 19, variant Omicron JN.1, ARNm codant la protéine de pointe du SARS-CoV-2, 3 microgrammes | VAL395, VAL395 | VAL395, VAL395 | ||
VAC1073 | Vaccin Maladie de Lyme (anti-Borrelia burgdorferi), sans précision | ||||
VAC1291 | MOPV2 BIO FARMA | ||||
VAC0889 | MONO OPV3 | ||||
VAC0538 | VACCIN BCG SYNTHAVERSE | ||||
VAC0405 | TRIPEDIA | ||||
VAC0756 | MV-014-212 | ||||
VAC0841 | INFLUVAC 0,25 mL | ||||
VAL078 | Valence méningocoque Y, polyoside conjugué | VAL299, VAL299 | VAL277, VAL276, VAL275 | VAL299, VAL299 | VAL277, VAL276, VAL275 |
VAC0623 | Vaccin Rougeole et Oreillons, sans précision | ||||
VAL296 | Valence variole, troisième génération, non réplicatif, Virus modifié de la vaccine d'Ankara, | VAL028, VAL028 | VAL028, VAL028 | ||
VAC0974 | MENCEVAX AC | ||||
DIS006 | Hépatite B | ||||
VAC0093 | VACCIN DT TAB PASTEUR | ||||
VAC0183 | AIMMUGEN | ||||
VAC0098 | HEXAVAC | ||||
VAC1381 | MEASLES AND RUBELLA VACCINE ZYDUS | ||||
VAC1296 | DTP BIO FARMA | ||||
VAC0979 | VACCINO ANTITETANICO ISI | ||||
VAC0713 | Vaccin Typhoïde polyosidique, sans précision | ||||
VAL168 | Valence covid 19, ARN, sans précision | VAL164, VAL164 | VAL043 | VAL164, VAL164 | VAL043 |
VAC0846 | VACCIN POLIOMYELITIQUE ORAL BIVALENT TYPES 1 et 3 | ||||
VAC1030 | GEMCOVAC-19 | ||||
VAC1163 | Vaccin Pneumocoque conjugué 20-valent, sans précision | ||||
VAL035 | Valence covid 19, ADN plasmidique codant la protéine de pointe du SARS-CoV-2 | VAL164, VAL164 | VAL164, VAL164 | ||
VAL386 | Valence grippe aviaire, A(H5), sans précision | VAL051, VAL385 | VAL051, VAL385 | ||
VAC0931 | FLUBLOK QUADRIVALENT | ||||
VAL253 | Valence rage, immunoglobuline, origine équine | VAL016, VAL016 | VAL016, VAL016 | ||
VAL120 | Valence méningocoque, polyvalent, polyoside non conjugué | VAL234, VAL234 | VAL234, VAL234 | ||
VAC1078 | ENVACGEN | ||||
VAC0050 | HAVRIX 720 U/0,5 mL | ||||
VAC0051 | INFANRIXTETRA | ||||
VAC0184 | ALDIANA | ||||
VAC0099 | MENINVACT | ||||
VAC0848 | VACCIN BCG INSTITUT MERIEUX | ||||
VAC0714 | VACCIN CONTRE LA COVID-19 (INACTIVE, AVEC ADJUVANT) VALNEVA | ||||
VAC1164 | Vaccin quadrivalent DTCaHib- Diphtérie-Tétanos-Coqueluche-Hib PRP, sans précision | ||||
VAC0932 | Vaccin Grippe quadrivalent recombinant, sans précision | ||||
VAC1297 | TT BIO FARMA | ||||
VAC1382 | SKYTYPHOID | ||||
VAC0847 | VACCIN PNEUMOCOCCIQUE SARBACH | ||||
VAL169 | Valence covid 19, ARNm auto-amplifiant (AAA) | VAL303, VAL303 | VAL303, VAL303 | ||
VAC1031 | SPIKEVAX 50 µg MONODOSE MODERNA | ||||
VAL036 | Valence papillomavirus, VLP, nonavalent, types 6, 11, 16, 18, 31, 33, 45, 52 et 58 | VAL237, VAL237 | VAL237, VAL237 | ||
VAL254 | Valence rage, inactivée, entière, type Semple, préparée sur tissu cérébral de chèvre ou de mouton infecté par le virus de la rage, inactivé par du phénol ou de la ß-propiolactone, contient de la myéline | VAL256, VAL256 | VAL256, VAL256 | ||
VAL387 | Valence covid 19, variant Omicron JN.1, ARNm codant la protéine de pointe du SARS-CoV-2, 25 microgrammes | VAL395, VAL395 | VAL395, VAL395 | ||
VAL121 | Valence poliomyélite, trivalente, inactivée, entière, orale | VAL042, VAL042 | VAL042, VAL042 | ||
VAC1079 | VAX-SPIRAL | ||||
VAC0096 | VACCIN GRIPPAL RONCHESE (VGR) | ||||
VAL251 | Valence encéphalite japonaise, inactivée, dérivée de cellules Vero | VAL089, VAL089 | VAL402, VAL401 | VAL089, VAL089 | VAL402, VAL401 |
DIS001 | Diphtérie | ||||
VAC1161 | Vaccin quadrivalent DTCeP - Diphtérie-Tétanos-Coqueluche-Hib PRP, sans précision | ||||
VAC0409 | TRIPLE SABIN | ||||
VAC0977 | ENTEROVACCINO ISI | ||||
VAC0626 | MoRu Viraten | ||||
VAC0759 | EUCORVAC-19 | ||||
VAC0844 | VERORABVAX | ||||
VAC1076 | UROMUNE (MV 140) | ||||
VAC1294 | BIO-TD | ||||
VAL166 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, dose pédiatrique | VAL122, VAL122 | VAL122, VAL122 | ||
VAC0711 | Vaccin Typhoïde conjugué, sans précision | ||||
VAL299 | Valence méningocoque Y, sans précision | VAL078, VAL139 | VAL078, VAL139 | ||
VAL033 | Valence poliomyélite, vivante atténuée, orale, monovalente type 2 | VAL133, VAL133 | VAL133, VAL133 | ||
VAL384 | Valence lèpre, sans précision | ||||
VAC0097 | VACCIN LEPTOSPIRES ICTEROHEMORRAGIAE PASTEUR | ||||
VAC0628 | Immravax | ||||
VAC1380 | ZYVAC TCV | ||||
VAC0845 | VACCIN POLIOMYELITIQUE ORAL PRODUIT SUR CELLULES VERO MERIEUX | ||||
VAC1077 | ENVAX-A71 | ||||
VAC0627 | MORUMAN | ||||
VAC0712 | Vaccin Typhoïde et Hépatite A, sans précision | ||||
VAC1162 | Vaccin Covid 19 bivalent à ARNm contre le virus originel et le variant Omicron BA.1, 15 microgrammes, sans précision | ||||
DIS002 | Tétanos | ||||
VAC0978 | VAC.DIFTO TETANO ISI | ||||
VAC1295 | DT BIO FARMA | ||||
VAL167 | Valence covid 19, vecteur viral non replicatif avec cellules présentant l'antigène | VAL163, VAL163 | VAL163, VAL163 | ||
VAL034 | Valence diphtérique, anatoxine, dose réduite | VAL083, VAL083 | VAL083, VAL083 | ||
VAL252 | Valence rage, immunoglobuline, origine humaine | VAL016, VAL016 | VAL016, VAL016 | ||
VAC0930 | AD5-NCOV COVID-19 INHALATION VACCINE | ||||
VAL385 | Valence grippe aviaire, A(H5N8) | VAL386, VAL386 | VAL386, VAL386 | ||
VAC0182 | ADACEL | ||||
VAC0313 | MUMPS inactivated | ||||
VAC0228 | ERVEVAX RA 27/3 | ||||
VAL039 | Valence covid 19, VLP, protéine de pointe recombinante | VAL164, VAL164 | VAL164, VAL164 | ||
VAL124 | Valence choléra, vivante atténuée, sans précision | VAL081, VAL081 | VAL357 | VAL081, VAL081 | VAL357 |
VAL257 | Valence rage, inactivée, entière, préparée sur culture cellulaire, sans précision | VAL080, VAL080 | VAL259, VAL260, VAL258, VAL261 | VAL080, VAL080 | VAL259, VAL260, VAL258, VAL261 |
VAC0579 | CLAIRYG 50 mg/mL | ||||
VAL342 | Valence Klebsiella pneumoniæ, sans précision | VAL345, VAL345 | VAL345, VAL345 | ||
VAC0446 | VCDT | ||||
VAC0664 | GX-19-DNA-Covid | ||||
VAC0797 | Vaccin Diphtérie, Tétanos et Coqueluche, sans précision | ||||
VAC0531 | TETANOS ADSORBE MERIEUX | ||||
VAC1426 | Vaccin bivalent recombinant contre le papillomavirus humain (types 16 et 18) (Pichia pastoris) | ||||
VAC0882 | CANDID 1 | ||||
VAC1208 | Vaccin quadrivalent DTCeHepB - Diphtérie-Tétanos-Coqueluche-HépatiteB 10µg, sans précision | ||||
VAC0229 | FLU SHIELD | ||||
VAL258 | Valence rage, inactivée, entière, préparée sur culture de cellules diploïdes humaines (HDCV) MRC-5, inactivation par la ß-propiolactone | VAL257, VAL257 | VAL257, VAL257 | ||
VAL125 | Valence hépatite A, inactivée, entière, sans précision | VAL288, VAL288 | VAL283, VAL130, VAL284 | VAL288, VAL288 | VAL283, VAL130, VAL284 |
VAC0447 | VDA VACCIN DIFTERIC ADSORBIT | ||||
VAC0798 | Vaccin Haemophilus influenzae b et Méningocoque C, sans précision | ||||
VAL210 | Valence pneumocoque, polyosidique non conjuguée, sérotype 5 | VAL185, VAL185 | VAL185, VAL185 | ||
VAL343 | Valence Enterococcus fæcalis, sans précision | VAL345, VAL345 | VAL345, VAL345 | ||
VAC0532 | TETANUS VACCIN | ||||
VAC0665 | COVAXIN BHARAT BIOTECH COVID-19 VACCINE | ||||
VAC0883 | ENTEROVACCINO TIFICO SCLAVO | ||||
VAC1209 | Vaccin Rougeole, entier inactivé, sans précision | ||||
VAC1427 | Vaccin entier inactivé contre l'encéphalite japonaise, préparé sur cellules Vero, 6 microgrammes | ||||
VAC0311 | MUMATEN BERNA PRODUCTSNA | ||||
DIS048 | Méningocoques | ||||
VAC0226 | Diptheria, Tetanus and Acellular Pertussis Combined Walvax vaccine | ||||
VAC0359 | RIMEVAX | ||||
VAC0008 | GRIPGUARD | ||||
VAL037 | Valence méningocoque A, polyoside non conjugué | VAL297, VAL297 | VAL297, VAL297 | ||
VAL388 | Valence covid 19, variant Omicron JN.1, ARNm codant la protéine de pointe du SARS-CoV-2, 50 microgrammes | VAL395, VAL395 | VAL395, VAL395 | ||
VAL255 | Valence rage, inactivée, entière, type Fuenzalida, préparée sur tissu cérébral de souriceau à la mamelle infecté par le virus de la rage, teneur moindre en myéline | VAL256, VAL256 | VAL256, VAL256 | ||
VAL122 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, sans adjuvant | VAL231, VAL231 | VAL015, VAL166, VAL094 | VAL231, VAL231 | VAL015, VAL166, VAL094 |
VAC0577 | TRIPACEL HYBRID | ||||
VAL340 | Valence charbon, sans précision | VAL111 | VAL111 | ||
VAC0444 | VAXEM-HIB | ||||
VAC0662 | OSAKA-DNA-COVID / AG0301-COVID19 | ||||
VAC1424 | Vaccin pneumococcique polyosidique conjugué, 10-valent, séroptypes 1, 5, 6A, 6B, 7F, 9V, 14, 19A, 19F et 23F | ||||
VAC0880 | Vaccin pentavalent DTCoqHibP - Diphtérie-Tétanos-Coqueluche-Hib-Polio, sans précision | ||||
VAC0795 | Vaccin Coqueluche acellulaire, sans précision | ||||
VAC1206 | Vaccin Covid 19 à ARNm auto-amplifiant, sans précision | ||||
VAC1339 | BIMERVAX XBB.1.16 | ||||
VAC0312 | MUMPS LIVE | ||||
VAC0227 | EPAXAL | ||||
VAC0009 | HBVAXPRO 10 µg | ||||
DIS047 | Méningocoque Y | ||||
VAL038 | Valence covid 19, vecteur viral réplicatif, virus de la rougeole codant la protéine de pointe du SARS-CoV-2 | VAL398, VAL398 | VAL398, VAL398 | ||
VAL256 | Valence rage, inactivée, entière, préparée sur tissu cérébral animal infecté par le virus de la rage, sans précision | VAL080, VAL080 | VAL254, VAL255 | VAL080, VAL080 | VAL254, VAL255 |
VAL389 | Valence Pseudomonas aeruginosa, 7 immunotypes | ||||
VAL123 | Valence rotavirus, vivant atténué, pentavalent | VAL106, VAL106 | VAL106, VAL106 | ||
VAC0578 | INFANRIX-HIB | ||||
VAC0796 | Vaccin Coqueluche, sans précision | ||||
VAC0445 | VAXIPAR | ||||
VAL341 | Valence Escherichia coli, sans précision | VAL345, VAL345 | VAL345, VAL345 | ||
VAC0881 | Vaccin Encéphalite Japonaise vivant atténué, sans précision | ||||
VAC0663 | CADILA-DNA-COVID | ||||
VAC0530 | TETANOL PUR | ||||
VAC1425 | Vaccin typhoïdique, antigène Vi conjugué à la protéine CRM197 | ||||
VAC1207 | Vaccin Covid 19 à vecteur viral réplicatif, virus de la maladie de Newcastle codant la protéine de pointe du SARS-CoV-2, sans précision | ||||
VAC0317 | NABI-HB | ||||
DIS046 | Méningocoque W | ||||
VAC1070 | FLUZONE HIGH-DOSE QUADRIVALENT SOUTHERN HEMISPHERE | ||||
VAL346 | Valence entérovirus A71 | ||||
VAL213 | Valence pneumocoque, polyosidique non conjuguée, sérotype 8 | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0668 | KENTUCKY-RBD-COVID | ||||
VAC0535 | VAXELIS | ||||
VAC0620 | IXCHIQ | ||||
VAC0753 | INACTIVATED SARS-COV-2 VACCINE FAKHRAVAC (MIVAC) | ||||
VAC0886 | MONO OPV1 | ||||
VAC0971 | VACCINO ANTIVAIOLOSO LANCY | ||||
VAC0090 | VACCIN BRUCELLIQUE P.I. à usage humain | ||||
VAL128 | Valence grippe, sans précision | VAL140, VAL364, VAL366 | VAL140, VAL364, VAL366 | ||
DIS045 | Méningocoque B | ||||
VAC0318 | NOTHAV | ||||
VAC1071 | Anticorps ou vaccin VRS, sans précision | ||||
VAL214 | Valence pneumocoque, polyosidique non conjuguée, sérotype 9N | VAL185, VAL185 | VAL185, VAL185 | ||
VAL347 | Valence Leptospira canicola, inactivée, entière | ||||
VAC0669 | ARCTURUS-RNA-COVID | ||||
VAC0754 | INACTIVATED KOCAK-19 INAKTIF ADJUVANT COVID-19 VACCINE | ||||
VAC0403 | TRINIVAC | ||||
VAC0972 | VIROFLUSOMA | ||||
DIS008 | Rougeole | ||||
VAC0887 | POLIORAL | ||||
VAC0621 | MENC VACCINE FUNED | ||||
VAC0091 | VACCIN CCB PASTEUR | ||||
VAL129 | Valence herpes simplex, sans précision | ||||
VAC0315 | MUMPSVAX | ||||
DIS044 | Méningocoque A | ||||
VAL259 | Valence rage, inactivée, entière, purifiée et préparée sur culture de cellules d’embryon de poulet (PCECV), souche fixe du virus de la rage Flury LEP-25 multipliée sur cultures primaires de fibroblastes de poulet, virus inactivé par la ß-propiolactone | VAL257, VAL257 | VAL257, VAL257 | ||
VAL126 | Valence Ebola, sans précision | VAL108, VAL109, VAL007 | VAL108, VAL109, VAL007 | ||
VAL344 | Valence Proteus vulgaris, sans précision | VAL345, VAL345 | VAL345, VAL345 | ||
VAC0448 | VICPS (TYPHIM VI) | ||||
DIS043 | Méningocoque C | ||||
VAC0666 | JCOVDEN | ||||
DIS009 | Oreillons | ||||
VAL211 | Valence pneumocoque, polyosidique non conjuguée, sérotype 6B | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0884 | DIF PER TET ALL | ||||
VAC0799 | Vaccin DTHib - Diphtérie-Tétanos-Hib, sans précision | ||||
VAC0400 | TRIACELLUVAX | ||||
VAC1428 | Vaccin anti-covid 19 à sous-unité protéique, protéine RBD recombinante homodimérique, variant Omicron XBB.1.16, avec adjuvant (SQBA) | ||||
VAL127 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée | VAL230, VAL230 | VAL064, VAL350 | VAL230, VAL230 | VAL064, VAL350 |
VAC0449 | VIRELON T 20 | ||||
DIS042 | Typhus exanthématique | ||||
VAL212 | Valence pneumocoque, polyosidique non conjuguée, sérotype 7F | VAL185, VAL185 | VAL185, VAL185 | ||
VAL345 | Valence infections urinaires, sans précision | VAL344, VAL343, VAL341, VAL342 | VAL344, VAL343, VAL341, VAL342 | ||
VAC0885 | INFLUPOZZI ZONALE | ||||
VAC0534 | MENJUGATE 10 µg | ||||
VAC0667 | NUVAXOVID | ||||
VAC0401 | TRIHIBIT | ||||
VAC0752 | COVISHIELD | ||||
VAC0970 | TETATOX | ||||
VAC1429 | TETANEA | ||||
VAC0220 | DT MERIEUX | ||||
VAC0353 | R-VAC | ||||
VAC0135 | Vaccin Poliomyélite, sans précision | ||||
VAC0002 | AGRIPPAL | ||||
VAC0268 | IPOL | ||||
VAL302 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 50 microgrammes | VAL303, VAL303 | VAL303, VAL303 | ||
VAC1333 | COMIRNATY KP.2 10 µg | ||||
VAC1200 | Vaccin Grippe quadrivalent, sur culture cellulaire, sans précision | ||||
VAC0486 | NIMENRIX | ||||
VAC1115 | Vaccin pentavalent DTCaHibP - Diphtérie-Tétanos-Coqueluche-Hib PRP-Polio, sans précision | ||||
VAC1248 | Vaccin Grippe/Covid 19, à ARNm, sans précision | ||||
VAL217 | Valence pneumocoque, polyosidique non conjuguée, sérotype 11A | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0003 | AVAXIM 160 U | ||||
VAC0354 | RA27/3 | ||||
VAC0136 | Vaccin DTCe - Diphtérie-Tétanos-Coqueluche, sans précision | ||||
VAL303 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL043, VAL043 | VAL135, VAL181, VAL289, VAL180, VAL290, VAL169, VAL302, VAL306, VAL304, VAL310, VAL327 | VAL043, VAL043 | VAL135, VAL181, VAL289, VAL180, VAL290, VAL169, VAL302, VAL306, VAL304, VAL310, VAL327 |
VAC1201 | Vaccin Dengue tétravalent, vivant atténué recombinant chimérique basé sur le vaccin fièvre jaune 17D, sans précision | ||||
VAC1334 | COMIRNATY KP.2 30 µg | ||||
VAC0487 | MENHIBRIX | ||||
VAC1249 | Vaccin Grippe, inactivé trivalent, haute dose, voie intradermique, sans précision | ||||
VAC1116 | Vaccin Rage, entier inactivé, préparé sur culture de cellules Vero, sans précision | ||||
VAC0790 | Vaccin DTHepB - Diphtérie-Tétanos-Hépatite B, sans précision | ||||
VAL218 | Valence pneumocoque, polyosidique non conjuguée, sérotype 12F | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0351 | QUINTUPLE | ||||
VAC0133 | Vaccin Variole, sans précision | ||||
VAC0266 | INFLUENZA HA VACCINE KOVAX | ||||
VAC0399 | TRIACEL | ||||
VAC0048 | GENHEVAC B PASTEUR | ||||
VAL215 | Valence pneumocoque, polyosidique non conjuguée, sérotype 9V | VAL185, VAL185 | VAL185, VAL185 | ||
VAL300 | Valence méningocoque W, sans précision | VAL136, VAL138 | VAL136, VAL138 | ||
VAC1113 | Vaccin Covid 19 à sous-unité protéique, protéine de pointe recombinante, sans précision | ||||
VAC1246 | VACCIN COVID-GRIPPE ARN MRNA-1083 | ||||
VAC1331 | CELLDEMIC | ||||
VAC1379 | ZYVAC MMR | ||||
VAC1028 | RECOMBIVAX HB DIALYSÉ | ||||
VAC0484 | RABIVAX-S | ||||
VAL348 | Valence Leptospira pomona, inactivée, entière | ||||
VAC0352 | R-HB VACCINE | ||||
VAC0001 | ACT-HIB | ||||
VAC0134 | Vaccin BCG, sans précision | ||||
VAC0267 | IPAD TP | ||||
VAC0049 | HAVRIX 1440 U/1mL | ||||
VAL301 | Valence grippe, trivalente, recombinante | VAL361, VAL361 | VAL361, VAL361 | ||
VAC1114 | Vaccin Typhoïde et Hépatite A, antigène capsulaire polyosidique, sans précision | ||||
VAC1332 | COMIRNATY KP.2 3 µg | ||||
VAC1029 | QUINTANRIX | ||||
VAC0485 | TETAGAM P (immunoglobuline) | ||||
VAC1247 | Vaccin Hépatite A, sans précision | ||||
VAC0570 | HIBERIX | ||||
VAL216 | Valence pneumocoque, polyosidique non conjuguée, sérotype 10A | VAL185, VAL185 | VAL185, VAL185 | ||
VAL349 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, adjuvant | VAL231, VAL231 | VAL231, VAL231 | ||
VAC0224 | ECOLARIX | ||||
VAC0357 | RESPIGAM, RSV-IVIG | ||||
VAC0139 | PENT-HIBEST | ||||
VAC0006 | FLUVIRINE | ||||
VAC1422 | Vaccin anti-covid 19 à sous-unité protéique, protéine N recombinante | ||||
VAC0575 | FSME-IMMUN | ||||
VAC1337 | CONVACELL | ||||
VAC0442 | VARICELLON | ||||
VAC0660 | CHINESE-IMB-INACTIVATED-COVID | ||||
VAC0793 | TETADIF | ||||
VAC1204 | Vaccin Covid 19 à sous-unité protéique, protéine de pointe recombinante, avec adjuvant, sans précision | ||||
VAL306 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 3 microgrammes | VAL303, VAL303 | VAL303, VAL303 | ||
VAC1119 | Vaccin Covid 19 à virus entier inactivé, autorisé, sans précision | ||||
VAC0310 | MOVIVAC | ||||
VAC0225 | EIPV | ||||
VAC0007 | GARDASIL | ||||
VAC0358 | Immunoglobuline Rage origine humaine, sans précision | ||||
VAL080 | Valence rage, inactivée, entière, sans précision | VAL262, VAL257, VAL256 | VAL262, VAL257, VAL256 | ||
VAC0576 | FLUVIRAL | ||||
VAC0443 | SEVAC VARIE | ||||
VAC0794 | Vaccin Tétanos avec Ig T, sans précision | ||||
VAC1205 | Vaccin Ebola, vecteur viral vivant non réplicatif recombinant Ad26.ZEBOV, sans précision | ||||
VAC1338 | ZOONOTIC | ||||
VAC1423 | Vaccin contre la grippe pandémique à virus influenza A(H1N1)pdm09 vivant atténué | ||||
VAC0661 | INOVIO-DNA-COVID | ||||
VAL307 | Valence covid 19, variant Omicron BA.4/BA.5, ARNm codant la protéine de pointe du SARS-CoV-2, 15 microgrammes | VAL394, VAL394 | VAL394, VAL394 | ||
VAC0222 | TRIPVAC | ||||
VAC0355 | RABAVERT | ||||
VAC0137 | Vaccin Diphtérie et Tétanos, sans précision | ||||
VAC0004 | D.T. POLIO MERIEUX | ||||
VAC1420 | ARNm simple brin coiffé en 5' codant la glycoprotéine F du virus respiratoire syncytial stabilisé dans la conformation de préfusion | ||||
VAC1202 | Vaccin Covid 19 à virus vivant atténué, sans précision | ||||
VAC0488 | PENTAXIM | ||||
VAC1117 | Vaccin Covid 19 bivalent à ARNm contre le virus originel et le variant Omicron BA.4/5, 5 microgrammes, sans précision | ||||
VAC0573 | AGRIFLU | ||||
VAC1335 | INCELLIPAN | ||||
VAL219 | Valence pneumocoque, polyosidique non conjuguée, sérotype 14 | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0791 | Vaccin hexavalent DTPCoqHibHepB - Diphtérie-Tétanos-Coqueluche-Polio-Hib-Hépatite B, sans précision | ||||
VAL304 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 15 microgrammes | VAL303, VAL303 | VAL303, VAL303 | ||
VAC0223 | DUAL ANTIGEN SII | ||||
VAC0356 | RECOMBIVAX HB PÉDIATRIQUE | ||||
VAC0005 | DUKORAL | ||||
VAC0138 | Vaccin DiphTPCoq - Diphtérie-Tétanos-Coqueluche-Polio, sans précision | ||||
VAC0489 | TRIMOVAX | ||||
VAC1421 | Vaccin anti-covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, virus originel | ||||
VAC0574 | Td POLIO ADSORBED | ||||
VAC1118 | Vaccin Entérovirus A71, sans précision | ||||
VAC0792 | Vaccin pentavalent DTCoqPHepB - Diphtérie-Tétanos-Coqueluche-Polio-Hépatite B, sans précision | ||||
VAC0441 | SKYVARICELLA INJ | ||||
VAC1203 | Vaccin Brucellose, protéique (antigène P.I.), sans précision | ||||
VAC1336 | KOSTAIVE | ||||
VAL305 | Valence covid 19, variant Omicron BA.1, ARNm codant la protéine de pointe du SARS-CoV-2, 15 microgrammes | VAL393, VAL393 | VAL393, VAL393 | ||
VAC0260 | IMOVAX Rabies I.D. | ||||
VAC0393 | TICE BCG | ||||
VAC0175 | A.D.T. BOOSTER | ||||
VAC0042 | VACCIN BCG SSI | ||||
VAL083 | Valence diphtérique, anatoxine, dose non précisée | VAL414, VAL414 | VAL097, VAL034 | VAL414, VAL414 | VAL097, VAL034 |
VAC0706 | FLUZONE QUADRIVALENT | ||||
VAC0839 | Vaccin Brucellose entier inactivé, sans précision | ||||
VAC1022 | COMIRNATY 3 µg 6 MOIS-4 ANS BIONTECH-PFIZER | ||||
VAC0923 | Anticorps monoclonal VRS, sans précision | ||||
VAC1240 | Vaccin Méningocoque B à 4 composants, sans précision | ||||
VAC1373 | ROTAVAC 5D | ||||
VAC1155 | Vaccin Hépatite B plasmatique, sans précision | ||||
VAC1288 | VAKSIN POLIOMYELITIS BIO FARMA | ||||
VAC0261 | IMOVAX RAGE | ||||
VAC0394 | TIG | ||||
VAC0043 | BOOSTRIXTETRA | ||||
VAC0176 | A.K.D.S. | ||||
VAL084 | Valence covid 19, vecteur viral réplicatif, virus de la stomatite vésiculaire codant la protéine de pointe du SARS-CoV-2 | VAL398, VAL398 | VAL398, VAL398 | ||
VAC0707 | CORONAVIRUS SARS-CoV-2 INACTIVÉ | ||||
VAC0925 | Vaccin Grippe trivalent inactivé, sans précision | ||||
VAC1241 | Vaccin Zona, glycoprotéine E (gE) de surface du virus varicelle-zona (VZV), sans précision | ||||
VAC0924 | FLUZONE INTRADERMAL | ||||
VAC1374 | TYPBAR-TCV | ||||
VAC1289 | VAKSIN POLIOMYELITIS BIVALEN BIO FARMA | ||||
VAC1023 | COMIRNATY ORIGINAL/OMICRON BA.4-5 (15/15 µg) BIONTECH-PFIZER | ||||
VAC1156 | Immunoglobuline Botulisme, sans précision | ||||
VAC0040 | TYAVAX | ||||
VAC0173 | FLUENZ | ||||
VAC0088 | Vaccin DTP - Diphtérie-Tétanos-Polio, sans précision | ||||
VAL081 | Valence choléra, sans précision | VAL124, VAL359 | VAL124, VAL359 | ||
VAC0837 | COVOVAX SII | ||||
VAC0703 | ADJUVANTED PROTEIN SUBUNIT (RBD) | ||||
VAC1153 | Vaccin Méningocoque ACWY quadrivalent, conjugué à l'anatoxine diphtérique, sans précision | ||||
VAC0921 | Vaccin Encéphalite Japonaise, sans précision | ||||
VAC1286 | VAKSIN COVID-19 BIO FARMA | ||||
VAC1371 | REVAC-B MCF | ||||
VAC0836 | FLUAD TETRA | ||||
VAC1020 | VACCIN HEPATITE A AVENTIS PASTEUR MSD | ||||
VAC1068 | Vaccin Fièvre de la vallée du Rift, sans précision | ||||
VAL308 | Valence covid 19, variant Omicron BA.4/BA.5, ARNm codant la protéine de pointe du SARS-CoV-2, 25 microgrammes | VAL394, VAL394 | VAL394, VAL394 | ||
VAC0391 | TETRAMUNE | ||||
VAC0392 | TETRAVAX | ||||
VAC0041 | TYPHIM VI | ||||
VAC0174 | PROQUAD | ||||
VAL082 | Valence papillomavirus, types non précisés | VAL237, VAL236 | VAL237, VAL236 | ||
VAC0838 | COVOVAX NOVAVAX | ||||
VAC0705 | INFLUSPLIT TETRA | ||||
VAC0922 | Vaccin Adénovirus, type 4 et type 7, vivant atténué, voie orale, sans précision | ||||
VAC1372 | ROTAVAC | ||||
VAC1021 | COMIRNATY ORIGINAL/OMICRON BA.1 (15/15 µg) BIONTECH-PFIZER | ||||
VAC1154 | Vaccin Oreillons entier inactivé, sans précision | ||||
VAC1069 | Immunoglobuline Vaccine, sans précision | ||||
VAC1287 | VAKSIN HEPATITIS B BIO FARMA | ||||
VAL309 | Valence covid 19, variant Omicron BA.4/BA.5, ARNm codant la protéine de pointe du SARS-CoV-2, 5 microgrammes | VAL394, VAL394 | VAL394, VAL394 | ||
VAC0131 | Vaccin Rage, sans précision | ||||
VAC0264 | INFANRIX | ||||
VAC0397 | TRESIVAC LYOPHILIZED | ||||
VAC0046 | ENGERIX B 20 µg | ||||
VAC0179 | ACELLULAR D.P.T. KOVAX | ||||
VAL172 | Valence fièvre Q (Coxiella burnetii), sans précision | ||||
VAL390 | Valence chikungunya, sans précision | VAL060, VAL391 | VAL060, VAL391 | ||
VAC0928 | Vaccin Hépatite A vivant atténué, sans précision | ||||
VAC1026 | SOBERANA 02 FINLAY-FR-2 COVID-19 VACCINE | ||||
VAC1111 | Vaccin Encéphalite Japonaise, entier inactivé, préparé sur cellules Vero, sans précision | ||||
VAL087 | Valence dengue, vivante atténuée, tétravalente, chimérique recombinante basée sur le vaccin contre la fièvre jaune 17D | VAL150, VAL150 | VAL150, VAL150 | ||
VAC1244 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, variant Omicron XBB.1.5, 30 microgrammes, sans précision | ||||
VAC1377 | VAXIFLU-4 | ||||
VAC1159 | Vaccin Grippe trivalent, recombinant, sans précision | ||||
VAC0482 | VEPACEL | ||||
VAC0350 | QUATRO-VIRELON | ||||
VAC0265 | INFLU-KOVAX | ||||
VAC0132 | Vaccin Tétanos, sans précision | ||||
VAC0398 | TRI-IMMUNOL | ||||
VAC0047 | FLUARIX | ||||
VAC0929 | Vaccin Grippe quadrivalent inactivé, dose pédiatrique, sans précision | ||||
VAL173 | Valence fièvre hémorragique d'Argentine, vivant atténué, virus Junin | VAL421, VAL421 | VAL421, VAL421 | ||
VAL040 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, sans adjuvant, dose normale | VAL064, VAL064 | VAL064, VAL064 | ||
VAL391 | Valence chikungunya, VLP | VAL390, VAL390 | VAL390, VAL390 | ||
VAC1330 | FLU-M TETRA | ||||
VAC1245 | Vaccin Méningocoque ABCWY, sans précision | ||||
VAL088 | Valence varicelle, immunoglobuline | ||||
VAC1378 | VACTYPH | ||||
VAC1112 | Vaccin Grippe quadrivalent, vivant atténué, sans précision | ||||
VAC1027 | KOVIVAC CHUMAKOV COVID-19 VACCINE | ||||
VAC0483 | FLUAD PAEDIATRICS | ||||
VAC0262 | IMOVAX RUBEOLA | ||||
VAC0395 | TITIFICA | ||||
VAC0044 | CERVARIX | ||||
VAC0177 | AC VAX | ||||
VAL085 | Valence poliomyélite, vivante atténuée, orale, monovalente type 3 | VAL133, VAL133 | VAL133, VAL133 | ||
VAL170 | Valence hépatite B, antigène de surface recombinante du virus de l'hépatite B (Ag HBs), 5 microgrammes | VAL090, VAL090 | VAL090, VAL090 | ||
VAC0926 | FLUCELVAX TRIVALENT | ||||
VAC0708 | CORVAX12 | ||||
VAC1242 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, variant Omicron XBB.1.5, 25 microgrammes, sans précision | ||||
VAC1157 | Vaccin Variole de 3ème génération, virus modifié de la vaccine d'Ankara, sans précision | ||||
VAC1375 | TWINRAB | ||||
VAC1024 | SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (50 µg/50 µg)/mL MODERNA | ||||
VAC0480 | FENDRIX | ||||
VAC0263 | IMOVAX SARAMPION | ||||
VAC0130 | Vaccin ROR, sans précision | ||||
VAC0045 | ENGERIX B 10 µg | ||||
VAC0396 | BIOPOLIO | ||||
VAC0178 | ACEL-IMUNE | ||||
VAL086 | Valence covid 19, vivant atténué, sans précision | VAL165, VAL165 | VAL165, VAL165 | ||
VAC0709 | COVI-VAC | ||||
VAL171 | Valence encéphalite équine vénézuélienne, sans précision | ||||
VAC0927 | Vaccin Covid 19 à ARNm, dose pédiatrique, sans précision | ||||
VAC1110 | Vaccin Méningocoque C non conjugué, sans précision | ||||
VAC1376 | ZYCOV-D | ||||
VAC1025 | CORBEVAX | ||||
VAC1158 | Vaccin Covid 19 à ARNm contre le variant Omicron XBB.1.5, 3 microgrammes, sans précision | ||||
VAC1243 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, variant Omicron XBB.1.5, 50 microgrammes, sans précision | ||||
VAC0481 | TRIVIVAX | ||||
VAL261 | Valence rage, inactivée, entière, préparée en culture primaire de cellules rénales de hamster (PHKCV), souche Beijing, inactivation par le formol | VAL257, VAL257 | VAL257, VAL257 | ||
VAL394 | Valence covid 19, variant Omicron BA.4/BA.5, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL149, VAL149 | VAL307, VAL308, VAL309, VAL326, VAL411 | VAL149, VAL149 | VAL307, VAL308, VAL309, VAL326, VAL411 |
VAC1171 | Vaccin Grippe trivalent, inactivé, haute dose, sans précision | ||||
VAC0419 | SHANTT | ||||
VAC0769 | SC-Ad6-1 | ||||
VAC0418 | TRIVIVAC Y | ||||
VAC0987 | TANRIX | ||||
DIS053 | Maladie de Lyme | ||||
VAC1086 | PNEUMUNE | ||||
VAC0503 | Immunoglobuline Rage origine équine, sans précision | ||||
VAC0636 | FLUMIST QUADRIVALENT | ||||
VAC0721 | ADIMRSC-2F | ||||
VAL176 | Valence virus parainfluenza humains, sans précision | ||||
VAC0854 | Vaccin Poliomyélite oral monovalent type 3 - mOPV3, sans précision | ||||
VAL043 | Valence covid 19, ARNm codant la protéine de pointe du SARS-CoV-2, autorisé | VAL168, VAL168 | VAL149, VAL303 | VAL168, VAL168 | VAL149, VAL303 |
VAC0191 | ARILVAX | ||||
VAL262 | Valence rage, inactivée, entière, préparée sur oeufs embryonnés (VOE), sans précision | VAL080, VAL080 | VAL263 | VAL080, VAL080 | VAL263 |
VAC1390 | HEALIVE | ||||
VAC1172 | Anatoxine Diphtérie, dose réduite, sans précision | ||||
VAC0988 | VACCINO MENINGOCOCCICO POLISACCARIDICO TETRAVALENTE GSK | ||||
VAC0637 | IPAD DT | ||||
VAC0855 | Vaccin DiphTP - Diphtérie-Tétanos-Polio, sans précision | ||||
DIS052 | Botulisme | ||||
VAC1087 | HYPERTET | ||||
VAC0504 | INFANRIX POLIO HIB NOURRISSONS | ||||
VAC0940 | SPUTNIK-LIGHT | ||||
VAC0722 | COVIGENIX VAX-001 | ||||
VAL177 | Valence Haemophilus influenzae type b, sans précision | VAL103, VAL049 | VAL103, VAL049 | ||
VAL044 | Valence varicelle, sans précision | ||||
VAL395 | Valence covid 19, variant Omicron JN.1, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL417, VAL417 | VAL379, VAL381, VAL380, VAL388, VAL387, VAL406 | VAL417, VAL417 | VAL379, VAL381, VAL380, VAL388, VAL387, VAL406 |
VAC0192 | ATTENUVAX | ||||
VAL174 | Valence Hantavirus, sans précision | ||||
VAL041 | Valence méningocoque A, polyoside conjugué | VAL297, VAL297 | VAL271, VAL269, VAL270 | VAL297, VAL297 | VAL271, VAL269, VAL270 |
VAL392 | Valence grippe aviaire, A(H5N1), ARNm | VAL051, VAL051 | VAL051, VAL051 | ||
VAC1084 | BAYTET | ||||
DIS051 | Charbon | ||||
VAC0549 | Vaccin dTP - Diphtérie-Tétanos-Polio, dose réduite, sans précision | ||||
VAC0416 | TRIVIRATEN | ||||
VAC0767 | ChAdV68 SAM-LNP rS-TCE GRITSTONE ONCOLOGY COVID-19 VACCINE | ||||
VAC0852 | Vaccin Poliomyélite oral monovalent type 2 - mOPV2, sans précision | ||||
VAL089 | Valence encéphalite japonaise, inactivée, sans précision | VAL249, VAL249 | VAL251, VAL250 | VAL249, VAL249 | VAL251, VAL250 |
VAC0634 | MVABEA | ||||
VAC0501 | EQUIRAB (immunoglobuline) | ||||
VAC0985 | VACCINO TAB TE ISI | ||||
VAL042 | Valence poliomyélite, sans précision | VAL056, VAL133, VAL121 | VAL056, VAL133, VAL121 | ||
VAL393 | Valence covid 19, variant Omicron BA.1, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL149, VAL149 | VAL178, VAL305, VAL412 | VAL149, VAL149 | VAL178, VAL305, VAL412 |
VAL260 | Valence rage, inactivée, entière, préparée sur culture de cellules Vero (PVRV), souche Wistar, inactivation par la ß-propiolactone | VAL257, VAL257 | VAL257, VAL257 | ||
VAC1170 | Vaccin Covid 19 à vecteur viral non réplicatif, adénovirus de chimpanzé ChadOx1 codant la protéine de pointe du SARS-CoV-2, sans précision | ||||
VAC0417 | TRIVIVAC SEVAC | ||||
VAC0635 | PREFLUCEL | ||||
VAC0768 | COVIVAC | ||||
VAC1085 | MYCOBAX | ||||
VAC0502 | Immunoglobuline Rage, sans précision | ||||
VAC0986 | H ATETAL ISI | ||||
VAL175 | Valence leishmaniose, sans précision | ||||
DIS050 | Grippe aviaire | ||||
VAC0853 | Vaccin Poliomyélite oral monovalent type 1 - mOPV1, sans précision | ||||
VAC0720 | S-268019 | ||||
VAC0190 | ANATETALL | ||||
VAC0195 | BEGRIVAC | ||||
VAC0062 | VAXIGRIP | ||||
VAL350 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, adjuvant, dose normale | VAL127, VAL127 | VAL127, VAL127 | ||
VAC0859 | Vaccin HPV quadrivalent, sans précision | ||||
VAC1260 | COMIRNATY JN.1 3 µg | ||||
VAC0508 | JEEV 3 µg | ||||
VAC0725 | COH04S1 | ||||
VAC1175 | Vaccin Grippe trivalent, inactivé culture cellulaire, dose normale, sans précision | ||||
VAC0943 | Vaccin Rage cellules diploïdes, sans précision | ||||
VAC1393 | PROVARIX | ||||
VAC0858 | Vaccin HPV bivalent, sans précision | ||||
VAC1042 | Vaccin Covid 19 à vecteur viral non replicatif, sans précision | ||||
VAL047 | Valence hépatite B, immunoglobuline | ||||
VAL265 | Valence covid 19, entier inactivé, en essai clinique | VAL076, VAL076 | VAL076, VAL076 | ||
VAL398 | Valence covid 19, vecteur viral réplicatif, virus codant la protéine de pointe du SARS-CoV-2 | VAL162, VAL162 | VAL084, VAL038, VAL066, VAL095 | VAL162, VAL162 | VAL084, VAL038, VAL066, VAL095 |
VAL132 | Valence poliomyélite, vivante atténuée, orale, monovalente type 1 | VAL133, VAL133 | VAL133, VAL133 | ||
VAC0810 | Vaccin Méningocoque polyosidique polyvalent, sans précision | ||||
VAC0280 | MUMPS-MEASLES VACCINE MICROGEN | ||||
VAC0063 | TETRACOQ | ||||
VAC0196 | BIAVAX | ||||
VAC0509 | BIKEN | ||||
VAC0727 | ADCLD-COV19 | ||||
VAC0944 | Vaccin Choléra entier inactivé, voie orale, sans précision | ||||
VAC1394 | POLIO SINOVAC VACCINE | ||||
VAC0726 | ADCOVID | ||||
VAC0811 | Vaccin Méningocoque B, sans précision | ||||
VAC1043 | Vaccin Covid 19 à sous-unité protéique, sans précision | ||||
VAC1176 | Vaccin Covid 19 à vecteur viral non réplicatif, adénovirus 5 codant les protéines S et N du SARS-CoV-2, sans précision | ||||
VAL048 | Valence oreillons, inactivée, entière | VAL183, VAL183 | VAL183, VAL183 | ||
VAC1261 | NUVAXOVID JN.1 | ||||
VAL399 | Valence typhoïde, antigène Vi conjugué à l’anatoxine tétanique | VAL002, VAL002 | VAL002, VAL002 | ||
VAL133 | Valence poliomyélite, vivante atténuée, orale, monovalente, sans précision | VAL042, VAL042 | VAL033, VAL085, VAL132 | VAL042, VAL042 | VAL033, VAL085, VAL132 |
VAL266 | Valence méningocoque C, polyoside conjugué à l'anatoxine tétanique | VAL057, VAL057 | VAL057, VAL057 | ||
VAL351 | Valence grippe, trivalente, virosomale, sans précision | VAL362, VAL362 | VAL362, VAL362 | ||
VAC0281 | LM - 3 RIT | ||||
VAL130 | Valence hépatite A, virosome | VAL125, VAL125 | VAL125, VAL125 | ||
VAC1040 | AREXVY | ||||
VAC0639 | ADACEL POLIO | ||||
VAC1391 | BILIVE | ||||
VAC0856 | Vaccin DTCaHib - Diphtérie-Tétanos-Coqueluche-Hib, sans précision | ||||
VAC1088 | HYPERRAB | ||||
VAC0638 | IPAD POLIO | ||||
VAC0505 | HIBEST | ||||
VAC0723 | GLS-5310 | ||||
VAC1173 | Vaccin Covid 19 à vecteur viral réplicatif, virus influenza codant la protéine de pointe du SARS-CoV-2, sans précision | ||||
VAC0989 | HANTAVAX | ||||
VAL178 | Valence covid 19, variant Omicron BA.1, ARNm codant la protéine de pointe du SARS-CoV-2, 25 microgrammes | VAL393, VAL393 | VAL393, VAL393 | ||
VAL045 | Valence paratyphoïde, inactivée, entière | VAL014, VAL014 | VAL014, VAL014 | ||
VAL263 | Valence rage, inactivée, entière, préparée sur cellules d’embryon de canard, inactivation par la ß-propiolactone | VAL262, VAL262 | VAL262, VAL262 | ||
VAC0941 | Immunoglobuline Charbon, sans précision | ||||
VAL396 | Valence covid 19, variant Omicron XBB.1.5, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL417, VAL417 | VAL323, VAL324, VAL325, VAL330, VAL329 | VAL417, VAL417 | VAL323, VAL324, VAL325, VAL330, VAL329 |
VAC0193 | AVAC-1, AVA | ||||
VAC0060 | VARILRIX | ||||
VAC0194 | B-CAPSA | ||||
VAC1392 | 23-VALENT SINOVAC | ||||
VAC0507 | HEXACIMA | ||||
VAC0506 | Vaccin pentavalent DTCaHibP - Diphtérie-Tétanos-Coqueluche-Hib-Polio, sans précision | ||||
VAC0857 | Vaccin DTCoqHepB - Diphtérie-Tétanos-Coqueluche-Hépatite B, sans précision | ||||
VAL179 | Valence méningocoque, monovalent, polyosidique conjugué | VAL234, VAL234 | VAL234, VAL234 | ||
VAC0724 | CHULACOV19 | ||||
VAC1041 | Vaccin Covid 19 à ARN, sans précision | ||||
VAC1174 | Vaccin pentavalent DTCaPHepB - Diphtérie-Tétanos-Coqueluche-Polio-Hépatite B 10µg, sans précision | ||||
VAL046 | Valence Typhus | ||||
VAL397 | Valence covid 19, vecteur viral non réplicatif codant la protéine de pointe du SARS-CoV-2, sans précision | VAL163, VAL163 | VAL070, VAL101, VAL069, VAL054, VAL319 | VAL163, VAL163 | VAL070, VAL101, VAL069, VAL054, VAL319 |
VAC0942 | Vaccin Rage embryon de poulet, sans précision | ||||
VAL264 | Valence covid 19, entier inactivé, autorisé | VAL076, VAL076 | VAL076, VAL076 | ||
VAL131 | Valence peste, inactivée, entière | VAL422, VAL422 | VAL422, VAL422 | ||
VAC1089 | HYPERHEP B | ||||
VAC0061 | VARIVAX | ||||
VAC0325 | PEDIARIX | ||||
VAC0107 | CELVAPAN | ||||
DIS014 | Tuberculose | ||||
VAL269 | Valence méningocoque A, polyoside conjugué à la protéine CRM197 | VAL041, VAL041 | VAL041, VAL041 | ||
VAL136 | Valence méningocoque W, polyoside conjugué | VAL300, VAL300 | VAL272, VAL273, VAL274 | VAL300, VAL300 | VAL272, VAL273, VAL274 |
VAL003 | Valence coqueluche, sans précision | VAL117, VAL010 | VAL117, VAL010 | ||
VAL221 | Valence pneumocoque, polyosidique non conjuguée, sérotype 15F | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0458 | ZAANTIDE antitoxin | ||||
VAL354 | Valence pneumocoque, polyosidique conjuguée, sérotype 9N | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0543 | HEXAXIM | ||||
VAC0676 | CUREVAC-RNA-COVID | ||||
VAC0410 | TRIPLE VIRAL | ||||
VAC0761 | V-01 | ||||
VAC1305 | MRBEV | ||||
VAC0894 | Vaccin Adénovirus, sans précision | ||||
VAC1438 | Vaccin grippe, trivalent, inactivé, fractionné ou sous-unité, adjuvant | ||||
VAC0326 | PEDVAXHIB | ||||
VAC0108 | PANDEMRIX | ||||
VAL137 | Valence méningocoque C, polyoside non conjugué | VAL298, VAL298 | VAL298, VAL298 | ||
VAL004 | Valence choléra, inactivée, entière, injectable | VAL359, VAL359 | VAL359, VAL359 | ||
VAL355 | Valence pneumocoque, polyosidique conjuguée, sérotype 17F | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0459 | ZAANTITE | ||||
VAC0677 | CHINESE-PLA-ARN-Covid | ||||
VAL222 | Valence pneumocoque, polyosidique non conjuguée, sérotype 17F | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0895 | Vaccin Encéphalite équine vénézuélienne, sans précision | ||||
VAC0544 | TETRAXIM | ||||
VAC0411 | TRIVACUNA LETI | ||||
VAC0980 | VAC.DPT ISI | ||||
VAC0762 | COV2 SAM (LNP) VACCINE | ||||
VAC1439 | Vaccin méningocoque, polyvalent, polyosidique conjugué | ||||
VAC1306 | TYPHIBEV | ||||
VAC0323 | PAVIVAC-SEVAC | ||||
VAC0105 | PANENZA | ||||
VAC0238 | FUNED-CEME | ||||
VAL049 | Valence Haemophilus influenzae type b, polyoside non conjuguée | VAL177, VAL177 | VAL177, VAL177 | ||
VAL267 | Valence méningocoque C, polyoside conjugué à l'anatoxine diphtérique | VAL057, VAL057 | VAL057, VAL057 | ||
VAL134 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, voie intradermique, sans précision | VAL230, VAL230 | VAL230, VAL230 | ||
VAL001 | Valence grippe, trivalente, vivante atténuée, dose normale | VAL140, VAL140 | VAL140, VAL140 | ||
VAC0456 | WELLTRIVAX TRIVALENTE | ||||
VAL352 | Valence grippe, quadrivalente, virosomale, sans précision | VAL362, VAL362 | VAL362, VAL362 | ||
VAC0892 | POLIOVAX-IN | ||||
VAC0541 | BOOSTRIX | ||||
VAC0674 | PASTEUR-MSD MEASLES VECTOR COVID | ||||
VAC1303 | VLA15 | ||||
VAC1436 | Vaccin rage, inactivé, entier, préparé sur tissu cérébral animal infecté par le virus de la rage, sans précision | ||||
VAC1218 | Vaccin Méningocoque A polyosidique conjugué à l'anatoxine tétanique, sans précision | ||||
DIS059 | Peste | ||||
VAC0324 | Vaccin Pneumocoque conjugué 7-valent, sans précision | ||||
VAC0106 | Q-Pan H1N1 | ||||
DIS011 | Varicelle | ||||
VAL135 | Valence covid 19, ARNm codant la protéine de pointe du SARS-CoV-2, en essai clinique | VAL303, VAL303 | VAL303, VAL303 | ||
DIS010 | Rubéole | ||||
VAL268 | Valence méningocoque C, polyoside conjugué à la protéine CRM197 | VAL057, VAL057 | VAL057, VAL057 | ||
VAL002 | Valence typhoïde, conjuguée, antigène capsulaire polyosidique Vi lié à une protéine porteuse | VAL014, VAL014 | VAL399, VAL400 | VAL014, VAL014 | VAL399, VAL400 |
VAL353 | Valence pneumocoque, polyosidique conjuguée, sérotype 2 | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0457 | YF-VAX | ||||
VAC0675 | IMPERIAL-COLLEGE-RNA-COVID | ||||
VAL220 | Valence pneumocoque, polyosidique non conjuguée, sérotype 15B | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0542 | Vaccin D.T.P. Pasteur | ||||
VAC1304 | BERAB | ||||
VAC1437 | Vaccin méningocoque, monovalent, polyosidique conjugué | ||||
VAC0893 | VACCINO ANTICOLERICO SCLAVO | ||||
VAC0760 | RECOV | ||||
VAC1219 | Vaccin hexavalent DTCeHibMCV-A-C-T - Diphtérie-Tétanos-Coqueluche-Hib PRP-Méningocoque A et C, conjugué à l'anatoxine tétanique, sans précision | ||||
VAC1082 | BAYHEP B | ||||
DIS058 | Virus Respiratoire Syncytial | ||||
VAL225 | Valence pneumocoque, polyosidique non conjuguée, sérotype 19F | VAL185, VAL185 | VAL185, VAL185 | ||
VAL358 | Valence botulisme, immunoglobuline | VAL420, VAL420 | VAL420, VAL420 | ||
VAC0414 | TRIVAX-HIB | ||||
VAC0765 | DS-5670a | ||||
VAC0983 | VACCINO ANTIPOL ISI | ||||
VAL310 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 5 microgrammes | VAL303, VAL303 | VAL303, VAL303 | ||
VAC0898 | Vaccin Leishmaniose, sans précision | ||||
VAC0632 | OPVERO | ||||
VAC0850 | NEISVAC-C | ||||
VAC1309 | NOVEL ORAL (nOPV) TYPE 2 BIOLOGICAL E. LTD | ||||
VAL007 | Valence Ebola, vecteur réplicatif virus de la stomatite vésiculaire recombinant (rVSV) - glycoprotéine GP d'EBOV | VAL126, VAL126 | VAL126, VAL126 | ||
VAC1083 | BAYRAB | ||||
DIS057 | Covid 19 | ||||
VAL226 | Valence pneumocoque, polyosidique non conjuguée, sérotype 20 | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0899 | Vaccin Virus Parainfluenza humains, sans précision | ||||
VAL311 | Valence paludisme, pré-érythrocytaire R21/Matrix-M | VAL025, VAL025 | VAL025, VAL025 | ||
VAC0415 | TRIVB | ||||
VAC0633 | ZABDENO | ||||
VAC0984 | VACCINO ANTIVAIOLOSO ISI | ||||
VAC0851 | POLIO SABIN MONO TWO (ORAL) GSK | ||||
VAC0766 | HDT-301 | ||||
VAC0500 | FAVIRAB | ||||
VAL008 | Valence coqueluche, acellulaire, dose standard | VAL117, VAL117 | VAL117, VAL117 | ||
VAL359 | Valence choléra, inactivée, entière, sans précision | VAL081, VAL081 | VAL021, VAL004 | VAL081, VAL081 | VAL021, VAL004 |
VAC1080 | COVAXIN | ||||
VAC0327 | PENTA | ||||
DIS056 | Chikungunya | ||||
VAC0109 | FOCETRIA (unidose) | ||||
VAL138 | Valence méningocoque W, polyoside non conjugué | VAL300, VAL300 | VAL300, VAL300 | ||
VAL005 | Valence rougeole, vivante atténuée | VAL182, VAL182 | VAL182, VAL182 | ||
VAL223 | Valence pneumocoque, polyosidique non conjuguée, sérotype 18C | VAL185, VAL185 | VAL185, VAL185 | ||
VAL356 | Valence pneumocoque, polyosidique conjuguée, sérotype 20 | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0896 | Vaccin Fièvre Q, sans précision | ||||
VAC0545 | EUVAX B 20 µg | ||||
VAC0678 | Medicago-VLP-Covid | ||||
VAC0412 | TRIVAX | ||||
VAC0763 | mRNA-1273.351 | ||||
VAC0981 | VACCINO PERTOSSE ISI | ||||
VAC1307 | JEEV 6 µg | ||||
DIS055 | Ebola | ||||
VAC0328 | PENTACEL | ||||
VAC1081 | BAYGAM | ||||
VAL006 | Valence brucellose, sans précision | VAL146, VAL147 | VAL146, VAL147 | ||
VAL357 | Valence choléra, vivante atténuée, orale | VAL124, VAL124 | VAL124, VAL124 | ||
VAC0679 | MEDIGEN-S-2P-CpH1018-COVID | ||||
VAL224 | Valence pneumocoque, polyosidique non conjuguée, sérotype 19A | VAL185, VAL185 | VAL185, VAL185 | ||
DIS054 | Hépatite E | ||||
VAC0546 | DULTAVAX | ||||
VAC0413 | TRIVAX-AD | ||||
VAC0631 | MENINVACTKIT | ||||
VAC0764 | MRT5500 | ||||
VAC0897 | Vaccin Hantavirus, sans précision | ||||
VAC0982 | VACCINO TIFICO ISI | ||||
VAC1308 | DT BIOLOGICAL E LTD | ||||
VAL139 | Valence méningocoque Y, polyoside non conjugué | VAL299, VAL299 | VAL299, VAL299 | ||
VAC0232 | FLULAVAL | ||||
VAC0014 | INFANRIX HEXA | ||||
VAC0365 | RUBELLA VACCINE MICROGEN | ||||
VAC0147 | Vaccin Grippe A(H1N1)2009, sans précision | ||||
VAL314 | Valence encéphalite à tiques, inactivée, entière, souche Neudörfl, dose adulte | VAL313, VAL313 | VAL313, VAL313 | ||
VAC1212 | Vaccin Poliomyélite, trivalent, entier inactivé oral, sans précision | ||||
VAC1345 | ZEROTYPH | ||||
VAC1430 | Vaccin Covid 19 bivalent à ARNm contre le virus originel et le variant Omicron BA.4/5, 25 microgrammes, sans précision | ||||
VAC0498 | IMOGAM RAGE | ||||
VAC1127 | Immunoglobuline Hépatite A, Rougeole, Varicelle et Rubéole, sans précision | ||||
VAL229 | Valence pneumocoque, polyosidique non conjuguée, sérotype 33F | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0450 | VIROVAC MASSLING, PEROTID, RUBELLA | ||||
VAC0233 | FLUMIST | ||||
VAC0366 | RUBELLA-KOVAX | ||||
VAC0148 | Vaccin Leptospirose, sans précision | ||||
VAC0015 | INFANRIXQUINTA | ||||
VAL400 | Valence typhoïde, antigène Vi conjugué à la protéine CRM197 | VAL002, VAL002 | VAL002, VAL002 | ||
VAC1431 | Vaccin VRS, sans précision | ||||
VAC1213 | Vaccin Choléra contenant la sous-unité B recombinante de la toxine cholérique et des bactéries V. cholerae O1 entières inactivées, sans précision | ||||
VAC0499 | BENIRAB (immunoglobuline) | ||||
VAC1128 | Vaccin Covid 19 à ADN plasmidique, sans précision | ||||
VAC1346 | FLU QUADRIVALENT MCV | ||||
VAC0451 | VIVOTIF | ||||
VAL315 | Valence encéphalite à tiques, entière inactivée, souche Neudörfl, dose pédiatrique | VAL313, VAL313 | VAL313, VAL313 | ||
VAC0230 | FLUAD | ||||
VAC0012 | IMMUGRIP | ||||
VAC0363 | ROTASHIELD | ||||
VAC0145 | Vaccin Encéphalite à tiques, sans précision | ||||
VAC0278 | LIRUGEN | ||||
VAC0809 | Vaccin Méningocoque polyosidique monovalent, sans précision | ||||
VAL312 | Valence encéphalite à tiques, inactivée, entière, souche K23 | VAL031, VAL031 | VAL031, VAL031 | ||
VAC1125 | Vaccin Hépatite B, sans précision | ||||
VAC1210 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, virus original, 100 microgrammes, sans précision | ||||
VAC1343 | BORYUNG CELL CULTURE-DERIVED JAPANESE ENCEPHALITIS VACCINE | ||||
VAC0496 | GAMMATETANOS (immunoglobuline) | ||||
VAC1258 | COMIRNATY JN.1 30 µg | ||||
VAL009 | Valence paludisme, protéine de surface du sporozoïte | VAL025, VAL025 | VAL025, VAL025 | ||
VAL227 | Valence pneumocoque, polyosidique non conjuguée, sérotype 22F | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0231 | FLUKOVAX | ||||
VAC0364 | RUBEATEN BERNA PRODUCTS | ||||
VAC0146 | Vaccin Encéphalite Japonaise vivant atténué 14-14-2, sans précision | ||||
VAC0013 | IMOVAX POLIO | ||||
VAL313 | Valence encéphalite à tiques, inactivée, entière, souche Neudörfl, dose non précisée | VAL031, VAL031 | VAL314, VAL315 | VAL031, VAL031 | VAL314, VAL315 |
VAC1344 | BORYUNG JAPANESE ENCEPHALITIS VACCINE | ||||
VAC1211 | Vaccin Méningocoque C polyosidique conjugué à la protéine CRM197, sans précision | ||||
VAC0497 | Immunoglobuline Tétanos, sans précision | ||||
VAC1126 | Vaccin pentavalent DTCeHibP - Diphtérie-Tétanos-Coqueluche-Hib PRP-Polio, sans précision | ||||
VAC1259 | COMIRNATY JN.1 10 µg | ||||
VAC0582 | TRUMENBA | ||||
VAL228 | Valence pneumocoque, polyosidique non conjuguée, sérotype 23F | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0321 | ORIMUNE | ||||
VAC0103 | MENACTRA | ||||
VAC0236 | FLUZONE HIGH-DOSE | ||||
VAC0018 | MENCEVAX ACWY | ||||
VAC0369 | RUBEOVAX | ||||
DIS018 | Typhoïde | ||||
VAL091 | Valence typhoïde, vivante atténuée, souche Ty21a, orale | VAL014, VAL014 | VAL014, VAL014 | ||
VAC1301 | BE Td | ||||
VAC0454 | VVR CANTACUZINO | ||||
VAC1216 | Vaccin quadrivalent DTCaHepB - Diphtérie-Tétanos-Coqueluche-Hépatite B 10µg, sans précision | ||||
VAC1349 | TY BIOMED | ||||
VAC1434 | Vaccin méningocoque A, sans précision | ||||
VAC0672 | VAXINE-SPIKE-COVID | ||||
VAL318 | Valence VRS, vaccin, sans précision | VAL338, VAL338 | VAL316, VAL322, VAL383 | VAL338, VAL338 | VAL316, VAL322, VAL383 |
VAC0890 | NEOTYF | ||||
VAL403 | Valence méningocoque X, sans précision | VAL404 | VAL404 | ||
VAC0322 | PARIORIX | ||||
VAC0104 | HUMENZA | ||||
DIS017 | Fièvre jaune | ||||
VAC0019 | MENINGITEC | ||||
VAL092 | Valence fièvre jaune | ||||
VAC0673 | QUEENSLAND-SPIKE-MF59-COVID | ||||
VAC1435 | Vaccin rage, inactivé, entier, préparé sur culture cellulaire, sans précision | ||||
VAC0891 | PNEUMOPUR | ||||
VAC1217 | Vaccin Hépatite B et Haemophilus influenzae type b, sans précision | ||||
VAC0540 | IPAD T | ||||
VAL319 | Valence covid 19, vecteur viral non réplicatif, adénovirus codant la protéine de pointe du SARS-CoV-2, par inhalation | VAL397, VAL397 | VAL397, VAL397 | ||
VAC1302 | COMBE FIVE | ||||
VAL404 | Valence méningocoque X, polyoside conjugué | VAL403, VAL403 | VAL403, VAL403 | ||
VAC0234 | FLUOGEN | ||||
VAC0101 | Vaccin Hépatite B, recombinant, sans précision | ||||
VAC0367 | RUBELLOVAC | ||||
VAC0016 | INFLUVAC | ||||
DIS016 | Hépatite A | ||||
VAC0149 | Vaccin Méningocoque B:14:P1.7,16, sans précision | ||||
VAL401 | Valence encéphalite japonaise, inactivée, dérivée de cellules Vero, 3 microgrammes | VAL251, VAL251 | VAL251, VAL251 | ||
VAC1432 | Vaccin Fièvre hémorragique d'Argentine, virus Junin, sans précision | ||||
VAC0585 | Vaccin dTcaP - Diphtérie-Tétanos-Coqueluche-Polio, dose réduite, sans précision | ||||
VAC1129 | Vaccin Covid 19 à sous-unité protéique, protéine de pointe recombinante dans des nanoparticules, sans précision | ||||
VAC0452 | VT (VACINA TRIPLICE) | ||||
VAC1214 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, contre le variant Omicron XBB.1.5, 10µg, sans précision | ||||
VAC1347 | EFLUELDA TIV-HD | ||||
VAC0670 | SPOUTNIK V | ||||
VAL316 | Valence VRS, recombinante, antigène RSVPreF3 dérivé de la protéine F | VAL318, VAL318 | VAL318, VAL318 | ||
VAC0320 | Vaccin Poliomyélite oral trivalent, sans précision | ||||
VAC0102 | Vaccin Hépatite A inactivé, sans précision | ||||
VAC0235 | FLUVIRIN | ||||
DIS015 | Grippe saisonnière | ||||
VAC0368 | RUBELOGEN | ||||
VAC0017 | M-M-RVAXPRO | ||||
VAL090 | Valence hépatite B, antigène de surface recombinante du virus de l'hépatite B (Ag HBs), sans précision | VAL068, VAL068 | VAL115, VAL114, VAL012, VAL170, VAL378 | VAL068, VAL068 | VAL115, VAL114, VAL012, VAL170, VAL378 |
VAL402 | Valence encéphalite japonaise, inactivée, dérivée de cellules Vero, 6 microgrammes | VAL251, VAL251 | VAL251, VAL251 | ||
VAC1300 | BEVAC 20 µg | ||||
VAC1433 | Vaccin peste, sans précision | ||||
VAC0586 | ERVEBO | ||||
VAC1348 | TETANA | ||||
VAC0453 | VTV (VACINA TRIPLICE VIRAL) | ||||
VAC0671 | CLOVER-SPIKE-SCB-2019-COVID | ||||
VAC1215 | Vaccin hexavalent DTCaHibPHepB - Diphtérie-Tétanos-Coqueluche-Hib OMP-Polio-Hépatite B 10µg, sans précision | ||||
VAL317 | Valence VRS, anticorps, sans précision | VAL338, VAL338 | VAL148, VAL320 | VAL338, VAL338 | VAL148, VAL320 |
VAC0490 | KINRIX | ||||
VAC0272 | KAKSOISROKOTE DUBBELVACCIN | ||||
VAC0054 | VACCIN RABIQUE PASTEUR | ||||
VAC0187 | AMARIL | ||||
VAL095 | Valence covid 19, vecteur viral réplicatif, virus de la maladie de Newcastle codant la protéine de pointe du SARS-CoV-2 | VAL398, VAL398 | VAL398, VAL398 | ||
VAC0718 | CIGB-66 | ||||
VAC0936 | VACCIN PNEUMOCOCCIQUE POLYOSIDIQUE AVENTIS PASTEUR MSD | ||||
VAL180 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 100 microgrammes | VAL303, VAL303 | VAL303, VAL303 | ||
VAC1252 | JE-CV | ||||
VAC0935 | VACCIN RABIQUE INACTIVE MERIEUX | ||||
VAC1385 | GC FLU QUADRIVALENT | ||||
VAC0802 | Vaccin Poliomyélite monovalent oral - type non connu, sans précision | ||||
VAC1034 | HEBERBIOVAC B 10 µg | ||||
VAC1167 | Vaccin Coqueluche acellulaire, dose standard, sans précision | ||||
VAL407 | Valence covid 19, variant Omicron KP.2, ARNm codant la protéine de pointe du SARS-CoV-2, 3 microgrammes | VAL406, VAL406 | VAL406, VAL406 | ||
VAC0140 | INTANZA | ||||
VAC0273 | KIKHOSTE-VAKSINE | ||||
VAC0188 | QUIMI-HIB | ||||
VAL096 | Valence BCG | ||||
VAL181 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 25 microgrammes | VAL303, VAL303 | VAL303, VAL303 | ||
VAC0937 | Vaccin Botulisme, sans précision | ||||
VAC0804 | Vaccin Charbon, sans précision | ||||
VAC0719 | NANOCOVAX | ||||
VAC1120 | Vaccin Leptospirose, trivalent, sans précision | ||||
VAC1253 | CHIMERIVAX-JE | ||||
VAC0803 | Polio Sabin One and Three GSK | ||||
VAC1168 | Vaccin quadrivalent DTCeHib- Diphtérie-Tétanos-Coqueluche-Hib OC, sans précision | ||||
VAC1386 | GCFLU | ||||
VAC1035 | HEBERBIOVAC HB 20 µg | ||||
VAL408 | Valence covid 19, variant Omicron KP.2, ARNm codant la protéine de pointe du SARS-CoV-2, 10 microgrammes | VAL406, VAL406 | VAL406, VAL406 | ||
VAC0491 | TENIVAC | ||||
VAC0052 | VACCIN MENINGOCOCCIQUE A+C | ||||
VAC0185 | ALDITEANA | ||||
VAL093 | Valence rougeole, inactivée, entière | VAL182, VAL182 | VAL182, VAL182 | ||
VAC0849 | Vaccin Tularémie, sans précision | ||||
VAC0716 | SARS-COV-2-RBD-FC FUSION PROTEIN | ||||
VAC0933 | TICOVAC 2,7µg | ||||
VAC1383 | CYVAC | ||||
VAC0800 | Vaccin DTCoqHib - Diphtérie-Tétanos-Coqueluche-Hib, sans précision | ||||
VAC0715 | ERUCOV-VAC | ||||
VAC1032 | SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1 (25 µg/25 µg) MODERNA | ||||
VAC1165 | Anatoxine Diphtérie, dose standard, sans précision | ||||
VAC1250 | EUVICHOL-S | ||||
VAC1298 | BETT | ||||
VAL405 | Valence grippe pandémique H1N1 2009, vivante atténuée | VAL058, VAL058 | VAL058, VAL058 | ||
VAC0270 | Vaccin Poliomyélite inactivé, sans précision | ||||
VAC0271 | ISTIVAC | ||||
VAC0186 | ALDITERPERA | ||||
VAC0053 | PRIORIX | ||||
VAL094 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, sans adjuvant, haute dose | VAL122, VAL122 | VAL122, VAL122 | ||
VAC0717 | CIGB-669 | ||||
VAC0801 | Vaccin Hépatite B et Haemophilus influenzae b, sans précision | ||||
VAC1033 | COMIRNATY ORIGINAL/OMICRON BA.4-5 (5/5 µg) BIONTECH-PFIZER | ||||
VAC0934 | VACCIN OREILLONS AVENTIS PASTEUR MSD | ||||
VAC1251 | EUVICHOL-PLUS | ||||
VAC1384 | BARYCELA | ||||
VAC1166 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, en cours d'essai clinique, sans précision | ||||
VAC1299 | BEVAC 10 µg | ||||
VAL406 | Valence covid 19, variant Omicron KP.2, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL395, VAL395 | VAL408, VAL407, VAL409 | VAL395, VAL395 | VAL408, VAL407, VAL409 |
VAC0361 | RIT - LM-2 | ||||
VAC0010 | HBVAXPRO 40 µg | ||||
VAC0276 | LIOVAX | ||||
VAC0143 | Vaccin Haemophilus influenzae B, sans précision | ||||
VAC0058 | TWINRIX 10 µg | ||||
VAL184 | Valence pneumocoque, polyosidique conjugué, sans précision | VAL105, VAL105 | VAL186, VAL201, VAL194, VAL192, VAL187, VAL204, VAL202, VAL200, VAL198, VAL190, VAL188, VAL191, VAL189, VAL199, VAL203, VAL195, VAL196, VAL205, VAL193, VAL197, VAL355, VAL353, VAL354, VAL356, VAL373, VAL369, VAL377, VAL372, VAL376, VAL371, VAL375, VAL370, VAL374 | VAL105, VAL105 | VAL186, VAL201, VAL194, VAL192, VAL187, VAL204, VAL202, VAL200, VAL198, VAL190, VAL188, VAL191, VAL189, VAL199, VAL203, VAL195, VAL196, VAL205, VAL193, VAL197, VAL355, VAL353, VAL354, VAL356, VAL373, VAL369, VAL377, VAL372, VAL376, VAL371, VAL375, VAL370, VAL374 |
VAL051 | Valence grippe aviaire, A(H5N1) | VAL386, VAL386 | VAL392 | VAL386, VAL386 | VAL392 |
VAC0807 | Vaccin Choléra et Typhoïde inactivé, sans précision | ||||
VAC1341 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, variant Omicron XBB.1.5, dose non précisée | ||||
VAC1256 | Vaccin hexavalent DTCeHibPHepB - Diphtérie-Tétanos-Coqueluche-Hib-Polio-Hépatite B 15µg, sans précision | ||||
VAL099 | Valence grippe pandémique H1N1 2009, inactivée | VAL058, VAL058 | VAL058, VAL058 | ||
VAC1389 | INLIVE | ||||
VAC1123 | Vaccin Grippe trivalent, vivant atténué, sans précision | ||||
VAC1038 | Vaccin Encéphalite à tiques, souche Neudörfl, dose adulte, sans précision | ||||
VAC0494 | TRITANRIX HepB | ||||
VAC0362 | RIT - LM-3 | ||||
VAC0144 | Vaccin Choléra, sans précision | ||||
VAC0011 | HBVAXPRO 5 µg | ||||
VAC0277 | LIRUBEL | ||||
VAL185 | Valence pneumocoque, polyosidique non conjuguée, sans précision | VAL105, VAL105 | VAL226, VAL221, VAL209, VAL224, VAL212, VAL229, VAL217, VAL220, VAL208, VAL223, VAL211, VAL228, VAL214, VAL216, VAL219, VAL207, VAL222, VAL210, VAL225, VAL227, VAL213, VAL215, VAL218, VAL206, VAL232, VAL233 | VAL105, VAL105 | VAL226, VAL221, VAL209, VAL224, VAL212, VAL229, VAL217, VAL220, VAL208, VAL223, VAL211, VAL228, VAL214, VAL216, VAL219, VAL207, VAL222, VAL210, VAL225, VAL227, VAL213, VAL215, VAL218, VAL206, VAL232, VAL233 |
VAC0808 | Vaccin Haemophilus influenzae b et Ménigocoque CY, sans précision | ||||
VAC0059 | TYPHERIX | ||||
VAL052 | Valence papillomavirus, VLP, quadrivalente, types 6, 11, 16 et 18 | VAL237, VAL237 | VAL237, VAL237 | ||
VAL270 | Valence méningocoque A, polyoside conjugué à l'anatoxine diphtérique | VAL041, VAL041 | VAL041, VAL041 | ||
VAC1124 | Vaccin Covid 19 à virus entier inactivé, en essai clinique, sans précision | ||||
VAC1257 | Vaccin Choléra, entier inactivé oral, bivalent contenant les bactéries V. cholerae O1 et O139 entières inactivées, sans précision | ||||
VAC1342 | IPVAX | ||||
VAC1039 | Vaccin Covid 19 à ARNm, virus originel, 50 µg, sans précision | ||||
VAC0495 | BEXSERO | ||||
VAC0580 | CLAIRYG | ||||
VAC0141 | MENVEO | ||||
VAC0274 | LANCY VAXINA | ||||
VAC0056 | VACCIN TETANIQUE PASTEUR | ||||
VAC0189 | ANADIFTERALL | ||||
VAL097 | Valence diphtérique, anatoxine, dose standard | VAL083, VAL083 | VAL083, VAL083 | ||
VAL182 | Valence rougeole, sans précision | VAL005, VAL093 | VAL005, VAL093 | ||
VAC0805 | Vaccin Choléra, entier inactivé, injectable, sans précision | ||||
VAC0938 | Vaccin Grippe quadrivalent, sans précision | ||||
VAC1121 | Vaccin hexavalent DTCaHibPHepB - Diphtérie-Tétanos-Coqueluche-Hib-Polio-Hépatite B 10µg, sans précision | ||||
VAC1387 | SINSAVAC | ||||
VAC1036 | SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 25 µg/25 µg MODERNA | ||||
VAC1169 | Vaccin Covid 19 bivalent à ARNm contre le virus originel et le variant Omicron BA.4/5, 15 microgrammes, sans précision | ||||
VAC1254 | CAPVAXIVE | ||||
VAL409 | Valence covid 19, variant Omicron KP.2, ARNm codant la protéine de pointe du SARS-CoV-2, 30 microgrammes | VAL406, VAL406 | VAL406, VAL406 | ||
VAC0492 | AFLURIA | ||||
VAC0360 | RIMPARIX | ||||
VAC0275 | LAVANTUU TIROKOTE | ||||
VAC0057 | TWINRIX 20 µg | ||||
VAL183 | Valence oreillons, sans précision | VAL048, VAL077 | VAL048, VAL077 | ||
VAL050 | Valence covid 19, vecteur viral non réplicatif, adénovirus 5 codant la protéine de pointe du SARS-CoV-2, sans précision | VAL070, VAL070 | VAL070, VAL070 | ||
VAC0939 | PREHEVBRIO | ||||
VAC0806 | Vaccin Choléra, vivant atténué, sans précision | ||||
VAC1340 | SPIKEVAX BA.1 0,1 mg/mL dose 50 µg | ||||
VAC1037 | Vaccin Encéphalite à tiques, souche Neudörfl, dose pédiatrique, sans précision | ||||
VAC1122 | Vaccin Variole vivant de 1ère génération, sans précision | ||||
VAL098 | Valence méningocoque B, 4 composants | VAL161, VAL161 | VAL161, VAL161 | ||
VAC1255 | HEXASIIL | ||||
VAC1388 | BIVAC POLIO | ||||
VAL273 | Valence méningocoque W, polyoside conjugué à l'anatoxine diphtérique | VAL136, VAL136 | VAL136, VAL136 | ||
VAL140 | Valence grippe, vivant atténué, sans précision | VAL128, VAL128 | VAL059, VAL001 | VAL128, VAL128 | VAL059, VAL001 |
DIS066 | Hantavirus | ||||
VAC1050 | BEYFORTUS 100 mg (nirsevimab) | ||||
VAC1183 | Vaccin Ebola à vecteur viral non réplicatif, sans précision | ||||
VAC0648 | Vaccin Covid 19, sans précision | ||||
VAC0999 | WETVAX APSV | ||||
VAC0866 | Vaccin Méningocoque A conjugué, sans précision | ||||
VAC1098 | XANAFLU | ||||
VAC0515 | INFANRIX-POLIO | ||||
DIS065 | Fièvre Q | ||||
VAC0951 | IMOVAX POLIO ORALE | ||||
VAC0600 | Vaccin Poliomyélite bivalent OPV 1-3, sans précision | ||||
VAL188 | Valence pneumocoque, polyosidique conjuguée, sérotype 4 | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0733 | HEPLISAV-B | ||||
VAL055 | Valence rougeole, immunoglobuline | ||||
VAC0070 | DT BIS | ||||
VAL141 | Valence rotavirus, vivant atténué, monovalent RIX4414 | VAL106, VAL106 | VAL106, VAL106 | ||
VAC1051 | PFIZER COMIRNATY-30 XBB.1.5 | ||||
VAC0867 | Antitoxine Diphtérie, sans précision | ||||
VAC1099 | BABYBIG | ||||
VAC0649 | EFLUELDA QIV-HD | ||||
VAC0516 | ABHAYRAB | ||||
VAC0734 | POLIO BOOSTRIX | ||||
DIS064 | Encéphalite équine vénézuélienne | ||||
VAC1184 | Vaccin Méningocoque C polyosidique conjugué à l'anatoxine tétanique, sans précision | ||||
VAL189 | Valence pneumocoque, polyosidique conjuguée, sérotype 5 | VAL184, VAL184 | VAL184, VAL184 | ||
VAL056 | Valence poliomyélite, trivalente, inactivée, entière, injectable | VAL042, VAL042 | VAL042, VAL042 | ||
VAC0601 | Vaccin DTC - Diphtérie-Tétanos-Coqueluche, sans précision | ||||
VAL274 | Valence méningocoque W, polyoside conjugué à la protéine CRM197 | VAL136, VAL136 | VAL136, VAL136 | ||
VAC0952 | IMOVAX COLERA | ||||
VAC0071 | D.T. BIS - RUDIVAX | ||||
VAC1409 | Vaccin à ARNm contre la covid 19 , subvariant Omicron JN.1, 50 microgrammes par dose, flacon multidose | ||||
VAL053 | Valence covid 19, sous-unité protéique, sans précision | VAL164, VAL164 | VAL104, VAL410 | VAL164, VAL164 | VAL104, VAL410 |
VAL271 | Valence méningocoque A, polyoside conjugué à l'anatoxine tétanique | VAL041, VAL041 | VAL041, VAL041 | ||
VAC1181 | Vaccin pentavalent DTCeHibHepB - Diphtérie-Tétanos-Coqueluche-Hib PRP-HépatiteB 10µg, sans précision | ||||
VAC0428 | VA-MENGOC-BC | ||||
DIS063 | Adénovirus | ||||
VAC0646 | CECOLIN | ||||
VAC0779 | BATREVAC | ||||
VAC1096 | MORCVAX | ||||
VAC0513 | HEPATYRIX | ||||
VAC0997 | Vaccin Pneumocoque conjugué 13-valent, sans précision | ||||
VAL186 | Valence pneumocoque, polyosidique conjuguée, sérotype 1 | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0864 | Immunoglobuline Varicelle, sans précision | ||||
VAC0731 | DITANRIX | ||||
VAC1408 | ENIVACHB | ||||
VAL272 | Valence méningocoque W, polyoside conjugué à l'anatoxine tétanique | VAL136, VAL136 | VAL136, VAL136 | ||
VAC1182 | Vaccin Méningocoque ACWY polyosidique conjugué à l'anatoxine tétanique, sans précision | ||||
VAC0429 | VACCIN COMBINAT DIFTERO-TETANIC | ||||
DIS062 | Fièvre hémorragique d'Argentine | ||||
VAC0998 | LC16 | ||||
VAC1097 | CYTOGAM | ||||
VAC0647 | ROTASIIL | ||||
VAC0514 | ROTARIX | ||||
VAC0732 | COVAC-1 - COVAC-2 | ||||
VAC0950 | IMOVAX DTP | ||||
VAL187 | Valence pneumocoque, polyosidique conjuguée, sérotype 3 | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0865 | Vaccin Méningocoque A non conjugué, sans précision | ||||
VAL054 | Valence covid 19, vecteur non réplicatif, vaccine Ankara modifiée codant la protéine de pointe du SARS-CoV-2 | VAL397, VAL397 | VAL397, VAL397 | ||
VAC0074 | D.T. COQ MERIEUX | ||||
VAC0955 | PULMOVAX | ||||
VAC0737 | GBP510 | ||||
VAC0822 | Vaccin Grippe vivant atténué, sans précision | ||||
VAC1054 | COMIRNATY ORIGINAL/OMICRON BA.4-5 (1,5/1,5 µg) | ||||
VAC1187 | Vaccin Covid 19 à vecteur viral réplicatif, virus de la rougeole codant la protéine de pointe du SARS-CoV-2, sans précision | ||||
VAL059 | Valence grippe, quadrivalente, vivante atténuée, dose normale | VAL140, VAL140 | VAL140, VAL140 | ||
VAC1272 | PSEUDOVAC | ||||
VAL277 | Valence méningocoque Y, polyoside conjugué à l'anatoxine diphtérique | VAL078, VAL078 | VAL078, VAL078 | ||
VAL144 | Valence hépatite A, inactivée, entière, monovalente, dose adulte | VAL284, VAL284 | VAL284, VAL284 | ||
VAL011 | Valence covid 19, sous-unité protéique, protéine de pointe recombinante (domaine RBD) | VAL104, VAL104 | VAL413 | VAL104, VAL104 | VAL413 |
VAL362 | Valence grippe, virosomal, sans précision | VAL364, VAL364 | VAL352, VAL351 | VAL364, VAL364 | VAL352, VAL351 |
DIS061 | Tularémie | ||||
VAC0292 | MEASLES VACCINE DK3 | ||||
VAC0293 | MENAFRIVAC | ||||
VAC0739 | RAZI COV PARS | ||||
VAC0823 | Vaccin Grippe VLP, sans précision | ||||
VAC1055 | NUVAXOVID XBB.1.5 | ||||
VAL278 | Valence Adénovirus, vivant atténué, voie orale, sans précision | ||||
VAC1140 | Vaccin Covid 19 bivalent à ARNm contre le virus originel et le variant Omicron BA.4/5, 25 microgrammes, sans précision | ||||
VAC0956 | VACCINO COLERICO BERNA | ||||
VAC1273 | DT BIOMED | ||||
VAL145 | Valence hépatite A, inactivée, entière, bivalent (hépatites A et B), dose adulte | VAL284, VAL284 | VAL284, VAL284 | ||
VAL012 | Valence hépatite B, antigène de surface recombinante du virus de l'hépatite B (Ag HBs), 40 microgrammes (dose pour patient dialysé) | VAL090, VAL090 | VAL090, VAL090 | ||
VAL230 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, sans précision | VAL058, VAL058 | VAL127, VAL134 | VAL058, VAL058 | VAL127, VAL134 |
DIS060 | Herpès | ||||
VAC1188 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, virus originel, 3 microgrammes, sans précision | ||||
VAL363 | Valence grippe, trivalente, VLP, sans précision | VAL029, VAL029 | VAL029, VAL029 | ||
VAC0160 | Vaccin Zona vivant atténué, sans précision | ||||
VAL360 | Valence grippe, inactivée, obtenue sur culture cellulaire, fractionnée ou sous-unité, dose normale, sans précision | VAL364, VAL364 | VAL285, VAL112 | VAL364, VAL364 | VAL285, VAL112 |
VAC1270 | SPIKEVAX JN.1 0,1 mg/mL dose 50 µg | ||||
VAC0518 | STAMARIL (multidose) | ||||
VAC0517 | FLUARIXTETRA | ||||
VAC0602 | Vaccin DTCa - Diphtérie-Tétanos-Coqueluche, dose standard, sans précision | ||||
VAC0735 | POLIOINFANRIX | ||||
VAC0868 | MENPOVAX A | ||||
VAC1052 | PFIZER COMIRNATY-10 XBB.1.5 | ||||
VAC1185 | Vaccin Covid 19 à vecteur viral non réplicatif, adénovirus 26 codant la protéine de pointe du SARS-CoV-2, sans précision | ||||
VAL057 | Valence méningocoque C, polyoside conjugué | VAL298, VAL298 | VAL268, VAL266, VAL267 | VAL298, VAL298 | VAL268, VAL266, VAL267 |
VAC0953 | PROCOMVAX | ||||
VAL142 | Valence hépatite A, inactivée, entière, monovalente, dose pédiatrique | VAL283, VAL283 | VAL283, VAL283 | ||
VAC0820 | Vaccin Grippe entier inactivé, sans précision | ||||
VAL275 | Valence méningocoque Y, polyoside conjugué à la protéine CRM197 | VAL078, VAL078 | VAL078, VAL078 | ||
VAC0290 | MASERN-IMPFSTOFF SSW | ||||
VAC0072 | JE-VAX | ||||
VAC0073 | IXIARO | ||||
VAL361 | Valence grippe, recombinante, sans précision | VAL364, VAL364 | VAL287, VAL301 | VAL364, VAL364 | VAL287, VAL301 |
VAC1271 | TYT BIOMED | ||||
VAC0736 | TRIAXIS POLIO | ||||
VAC1186 | Vaccin Covid 19 à vecteur viral replicatif avec cellules présentant l'antigène, sans précision | ||||
VAC0954 | JAPANESE ENCEPHALITIS VACCINE | ||||
VAC0869 | MENPOVAX C | ||||
VAC1053 | PFIZER COMIRNATY-3 XBB.1.5 | ||||
VAL058 | Valence grippe, inactivée, fractionnée ou sous-unité, sans précision | VAL365, VAL365 | VAL230, VAL099, VAL024, VAL405 | VAL365, VAL365 | VAL230, VAL099, VAL024, VAL405 |
VAC0603 | COMVAC3 | ||||
VAL276 | Valence méningocoque Y, polyoside conjugué à l'anatoxine tétanique | VAL078, VAL078 | VAL078, VAL078 | ||
VAL143 | Valence hépatite A, inactivée, entière, bivalent (hépatites A et B), dose pédiatrique | VAL283, VAL283 | VAL283, VAL283 | ||
VAC0821 | Vaccin Grippe inactivé, fractionné ou sous-unité, sans précision | ||||
VAL010 | Valence coqueluche, inactivée, entière | VAL003, VAL003 | VAL003, VAL003 | ||
VAC0291 | MEASLES VACCINE AIK-C STRAIN POLYVAC | ||||
VAC1090 | MENZB | ||||
VAC0204 | CAM-KOVAX | ||||
VAC0337 | PNU-IMUNE 23 | ||||
VAL148 | Valence VRS, immunoglobuline | VAL317, VAL317 | VAL317, VAL317 | ||
VAL015 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, sans adjuvant, dose normale | VAL122, VAL122 | VAL122, VAL122 | ||
VAL366 | Valence grippe, ARN, sans précision | VAL128, VAL128 | VAL128, VAL128 | ||
VAC0688 | INTRANASAL FLU-BASED RBD DelNS1-2019-nCoV-RBD-OPT1 COVID-19 Vaccine | ||||
VAL100 | Valence encéphalite japonaise, vivant atténué, souche 14-14-2 | VAL248, VAL248 | VAL248, VAL248 | ||
VAL233 | Valence pneumocoque, polyosidique non conjuguée, sérotype 25 | VAL185, VAL185 | VAL185, VAL185 | ||
VAC0555 | COMBACT-HIB | ||||
VAC0991 | FLULAVAL QUADRIVALENT | ||||
VAC0640 | TRITANRIX HepB+Hib | ||||
VAC1402 | EASYSIX | ||||
VAC0773 | ABNCoV2 | ||||
VAC1317 | CERVAVAC | ||||
VAC1091 | VARIZIG | ||||
VAC0205 | CD.JEVAX | ||||
VAC0338 | POLIACEL | ||||
DIS025 | Pneumocoque | ||||
VAL149 | Valence covid 19, variant omicron, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL043, VAL043 | VAL394, VAL393, VAL417 | VAL043, VAL043 | VAL394, VAL393, VAL417 |
VAL016 | Valence rage, immunoglobuline, sans précision | VAL253, VAL252 | VAL253, VAL252 | ||
VAL234 | Valence méningocoque, sans précision | VAL235, VAL119, VAL179, VAL120 | VAL235, VAL119, VAL179, VAL120 | ||
VAL367 | Valence choléra, V. cholerae O1, entière inactivée, orale | VAL021, VAL021 | VAL021, VAL021 | ||
VAL101 | Valence covid 19, vecteur non réplicatif, virus de la maladie de Newcastle codant la protéine de pointe du SARS-CoV-2 | VAL397, VAL397 | VAL397, VAL397 | ||
VAC0556 | MENITORIX | ||||
VAC0689 | CHINESE-RECOMBINANT-Sf9-COVID | ||||
VAC0774 | FSME-IMMUN 0,25 mL | ||||
VAC0423 | TWINRIX JUNIOR | ||||
VAC0641 | GLOBORIX | ||||
VAC0992 | AFLURIA QUADRIVALENT | ||||
VAC1403 | EASYFIVE-TT | ||||
VAC1318 | DIPHTHERIA, TETANUS, PERTUSSIS AND HEPATITIS B SII | ||||
VAC0202 | BVAC | ||||
VAC0335 | PLUSERIX | ||||
VAL146 | Valence brucellose, inactivée, entière | VAL006, VAL006 | VAL006, VAL006 | ||
VAL279 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, dose pédiatrique | VAL064, VAL064 | VAL064, VAL064 | ||
VAL013 | Valence zona, glycoprotéine E (gE) de surface du virus varicelle-zona (VZV) | VAL159, VAL159 | VAL159, VAL159 | ||
VAL364 | Valence grippe, non vivante, sans précision | VAL128, VAL128 | VAL029, VAL360, VAL365, VAL362, VAL361 | VAL128, VAL128 | VAL029, VAL360, VAL365, VAL362, VAL361 |
VAC0468 | ZATRIBAVAX | ||||
VAC0686 | MULTI-PEPTIDE-pVAC-COVID | ||||
VAC1400 | SHANIPV | ||||
VAL231 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée | VAL024, VAL024 | VAL122, VAL349 | VAL024, VAL024 | VAL122, VAL349 |
VAC0553 | Vaccin pentavalent DTCeHibP - Diphtérie-Tétanos-Coqueluche-Hib-Polio, sans précision | ||||
VAC1315 | MUMPS SII | ||||
VAC0420 | BIO-TT | ||||
VAC0771 | VBI-2902a | ||||
VAC0203 | C.D.T. | ||||
VAC0336 | PNEUMOVAX | ||||
VAL147 | Valence brucellose, antigène protéique P.I. (phénol-insoluble) | VAL006, VAL006 | VAL006, VAL006 | ||
VAL014 | Valence typhoïde, sans précision | VAL045, VAL032, VAL071, VAL002, VAL091 | VAL045, VAL032, VAL071, VAL002, VAL091 | ||
VAC0469 | ZATRIVAX | ||||
VAL232 | Valence pneumocoque, polyosidique non conjuguée, sérotype 6A | VAL185, VAL185 | VAL185, VAL185 | ||
VAL365 | Valence grippe, non vivante, obtenue sur culture d'œufs, sans précision | VAL364, VAL364 | VAL058, VAL152 | VAL364, VAL364 | VAL058, VAL152 |
VAC0554 | PEDIACEL | ||||
VAC0687 | UB-612 COVID-19 Vaccine | ||||
VAC0421 | TUSSITRUPIN FORTE | ||||
VAC0772 | SARS-CoV-2 VLP Vaccine | ||||
VAC0990 | ALPHARIX | ||||
VAC1316 | RUBELLA SII | ||||
VAC1401 | 9-VALENT HPV VACCINE INNOVAX | ||||
VAC1094 | OROCHOL | ||||
VAC0208 | CERTIVA | ||||
VAL237 | Valence papillomavirus, VLP, polyvalent | VAL082, VAL082 | VAL036, VAL113, VAL052 | VAL082, VAL082 | VAL036, VAL113, VAL052 |
VAL104 | Valence covid 19, sous-unité protéique, protéine de pointe recombinante | VAL053, VAL053 | VAL011, VAL107, VAL061, VAL416 | VAL053, VAL053 | VAL011, VAL107, VAL061, VAL416 |
VAL322 | Valence VRS, recombinante, glycoprotéines F des sous-types A et B | VAL318, VAL318 | VAL318, VAL318 | ||
VAC0426 | TYPHOID VACCINE WYETH | ||||
VAC0644 | QDENGA | ||||
VAC0995 | IMVAMUNE | ||||
VAC0862 | Immunoglobuline Rougeole, sans précision | ||||
VAC0777 | ADJUPANRIX | ||||
VAC0511 | SILGARD | ||||
VAC1406 | SPUTNIK V | ||||
VAL019 | Valence diphtérique, antitoxine | VAL414, VAL414 | VAL414, VAL414 | ||
VAC1095 | MVA85A | ||||
VAC1180 | Vaccin Maladie de Lyme, recombinant, sans précision | ||||
VAC0209 | COMVAX | ||||
VAL105 | Valence pneumocoque, sans précision | VAL185, VAL184 | VAL185, VAL184 | ||
VAC0778 | VAXCHORA | ||||
VAC0427 | TYPHOID-KOVAX | ||||
VAL323 | Valence covid 19, variant Omicron XBB.1.5, ARNm codant la protéine de pointe du SARS-CoV-2, 30 microgrammes | VAL396, VAL396 | VAL396, VAL396 | ||
VAC0863 | Immunoglobuline Hépatite B, sans précision | ||||
VAC0512 | Vaccin Typhus, sans précision | ||||
VAC0645 | IMMU ORR | ||||
VAC0730 | DENDRITIC CELL AV-COVID-19 VACCINE | ||||
VAC0996 | ACAM2000 | ||||
VAL238 | Valence papillomavirus, VLP, type 6 | VAL236, VAL236 | VAL236, VAL236 | ||
VAC1407 | NOVOHIB | ||||
VAC0206 | CELLUVAX | ||||
VAC0339 | Vaccin Pneumocoque non conjugué 23-valent, sans précision | ||||
DIS068 | Virus parainfluenza humains | ||||
VAC1092 | KAMRAB | ||||
VAL017 | Valence coqueluche, acellulaire, dose réduite | VAL117, VAL117 | VAL117, VAL117 | ||
VAL368 | Valence choléra, V. cholerae O139, inactivée, entière, orale | VAL021, VAL021 | VAL021, VAL021 | ||
VAL235 | Valence méningocoque, polyvalent, polyosidique conjugué | VAL234, VAL234 | VAL234, VAL234 | ||
VAL102 | Valence hépatite E, recombinante, peptidique | ||||
VAL320 | Valence VRS, anticorps monoclonal, sans précision | VAL317, VAL317 | VAL116, VAL321 | VAL317, VAL317 | VAL116, VAL321 |
VAC0424 | Vaccin Typhoïde oral vivant atténué, sans précision | ||||
VAC0642 | FLUZONE HIGH-DOSE QUADRIVALENT | ||||
VAC0775 | Vaccin DTCeHib - Diphtérie-Tétanos-Coqueluche-Hib, sans précision | ||||
VAC0993 | TD ADSORBED | ||||
VAC1404 | EASYFOUR-TT | ||||
VAC0860 | Vaccin HPV nonavalent, sans précision | ||||
VAC1319 | DIPHTHERIA, TETANUS, PERTUSSIS AND HAEMOPHILUS INFLUENZAE B SII | ||||
VAC0207 | CENDEVAX | ||||
DIS067 | Leishmaniose | ||||
VAC1093 | HEPAGAM | ||||
VAL236 | Valence papillomavirus, VLP, monovalent | VAL082, VAL082 | VAL239, VAL245, VAL243, VAL241, VAL246, VAL238, VAL244, VAL242, VAL240 | VAL082, VAL082 | VAL239, VAL245, VAL243, VAL241, VAL246, VAL238, VAL244, VAL242, VAL240 |
VAL369 | Valence pneumocoque, polyosidique conjuguée, sérotype 15A | VAL184, VAL184 | VAL184, VAL184 | ||
VAL103 | Valence Haemophilus influenzae type b, conjuguée, sans précision | VAL177, VAL177 | VAL156, VAL155, VAL154, VAL153 | VAL177, VAL177 | VAL156, VAL155, VAL154, VAL153 |
VAC0776 | TETRABIK | ||||
VAC0425 | TYNE | ||||
VAC0994 | VARIVAX II | ||||
VAL321 | Valence VRS, anticorps monoclonal, nirsévimab | VAL320, VAL320 | VAL320, VAL320 | ||
VAC0510 | HEXYON | ||||
VAC0643 | Vaccin Méningocoques ACWY conjugué, sans précision | ||||
VAC0861 | Vaccin Méningocoque B multicomposé, sans précision | ||||
VAC1405 | EASYFOURPOL | ||||
VAL018 | Valence variole, troisième génération, virus de la vaccine à réplication minimale | VAL028, VAL028 | VAL028, VAL028 | ||
VAC0111 | Vaccin Fièvre jaune, sans précision | ||||
VAC0244 | HEPRECOMB | ||||
VAC0377 | TRIPLE ANTIGEN SII | ||||
VAC0908 | Vaccin Adénovirus de type 7, sans précision | ||||
VAC0159 | Vaccin Varicelle, sans précision | ||||
VAC0026 | PREVIGRIP | ||||
VAL411 | Valence covid 19, variant Omicron BA.4/BA.5, ARNm codant la protéine de pointe du SARS-CoV-2, 50 microgrammes | VAL394, VAL394 | VAL394, VAL394 | ||
VAC1442 | Vaccin grippe, quadrivalent, virosomale, sans précision | ||||
VAC1224 | Vaccin VRS, recombinant, glycoprotéines F (préfusion) des sous-types A et B du VRS, sans précision | ||||
VAC1139 | Vaccin Covid 19 à vecteur non réplicatif, virus de la maladie de Newcastle codant la protéine de pointe du SARS-CoV-2, sans précision | ||||
VAC0595 | FLUCELVAX TETRA | ||||
VAC1006 | SHANVAC B | ||||
VAC1357 | EUPOLIO | ||||
VAC0462 | ZAMEVAX A+C | ||||
VAC0680 | COVILO SINOPHARM COVID-19 VACCINE | ||||
VAL108 | Valence Ebola, vecteur viral vivant non réplicatif recombinant Ad26.ZEBOV | VAL126, VAL126 | VAL126, VAL126 | ||
VAL326 | Valence covid 19, variant Omicron BA.4/BA.5, ARNm codant la protéine de pointe du SARS-CoV-2, 1,5 microgrammes | VAL394, VAL394 | VAL394, VAL394 | ||
VAC0330 | PENTACT-HIB | ||||
VAC0245 | HEPTAVAX B | ||||
VAC0112 | Vaccin Typhoïde, sans précision | ||||
VAC0027 | R.O.R. VAX | ||||
VAC0378 | SYNAGIS (PALIZIVUMAB) | ||||
VAC0909 | Antitoxine Botulisme, sans précision | ||||
VAL412 | Valence covid 19, variant Omicron BA.1, ARNm codant la protéine de pointe du SARS-CoV-2, 50 microgrammes | VAL393, VAL393 | VAL393, VAL393 | ||
VAC1310 | SII TD-VAC | ||||
VAC1443 | Vaccin grippe, trivalent, virosomal, sans précision | ||||
VAC0596 | Vaccin pentavalent DTCaHibHepB - Diphtérie-Tétanos-Coqueluche-Hib-Hépatite B, sans précision | ||||
VAC1007 | ISTIVAC4 | ||||
VAC0463 | ZAMOVAX | ||||
VAC1225 | Vaccin Diphtérie, Tétanos, Typhoïde et Paratyphoïde A et B, sans précision | ||||
VAC1358 | SKYCELLFLU QUADRIVALENT | ||||
VAL109 | Valence Ebola, vecteur viral non réplicatif, Vaccine Ankara modifiée | VAL126, VAL126 | VAL126, VAL126 | ||
VAC0681 | GRAD-COV2 COVID-19 VACCINE REITHERA | ||||
VAL327 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 1,5 microgrammes | VAL303, VAL303 | VAL303, VAL303 | ||
VAC0242 | HBY | ||||
VAC0375 | SEROBACTERIN | ||||
VAC0157 | Vaccin Pneumocoque, sans précision | ||||
VAC0024 | PNEUMO 23 | ||||
VAC0906 | Vaccin Zona, sans précision | ||||
VAL324 | Valence covid 19, variant Omicron XBB.1.5, ARNm codant la protéine de pointe du SARS-CoV-2, 10 microgrammes | VAL396, VAL396 | VAL396, VAL396 | ||
VAC1440 | Vaccin grippe, quadrivalent, inactivé, fractionné ou sous-unité, adjuvant, dose normale | ||||
VAC1004 | TEDIVAX | ||||
VAC1355 | EUPENTA | ||||
VAC1222 | Anticorps monoclonal humain VRS, palivizumab, sans précision | ||||
VAC1137 | Vaccin Encéphalite à tiques, entier inactivé, souche K23, sans précision | ||||
VAC0593 | VERORAB | ||||
VAC0460 | ZADITEADVAX | ||||
VAL239 | Valence papillomavirus, VLP, type 11 | VAL236, VAL236 | VAL236, VAL236 | ||
VAL106 | Valence rotavirus, vivant atténué, sans précision | VAL123, VAL141 | VAL123, VAL141 | ||
VAC0110 | Vaccin Grippe, sans précision | ||||
VAC0243 | HEPA-B INJECTION | ||||
VAC0025 | PREVENAR | ||||
VAC0376 | SHANCHOL | ||||
VAC0907 | Vaccin Adénovirus de type 4, sans précision | ||||
VAC0158 | Vaccin Rotavirus, sans précision | ||||
VAL325 | Valence covid 19, variant Omicron XBB.1.5, ARNm codant la protéine de pointe du SARS-CoV-2, 3 microgrammes | VAL396, VAL396 | VAL396, VAL396 | ||
VAL410 | Valence covid 19, sous-unité protéique, protéine N recombinante | VAL053, VAL053 | VAL053, VAL053 | ||
VAC1223 | Immunoglobuline VRS, sans précision | ||||
VAC1356 | EUVAX B 10 µg | ||||
VAC1441 | Vaccin grippe, quadrivalent, inactivé, fractionné ou sous-unité, voie intradermique, sans précision | ||||
VAC0594 | MENQUADFI | ||||
VAC1005 | REVAC-B PLUS ADULT VACCINE | ||||
VAC1138 | Vaccin Covid 19 à sous-unité protéique recombinante | ||||
VAC0461 | ZADITEVAX | ||||
VAL107 | Valence covid 19, sous-unité protéique, protéine de pointe recombinante dans des nanoparticules | VAL104, VAL104 | VAL328, VAL382 | VAL104, VAL104 | VAL328, VAL382 |
VAC0200 | BIOTHRAX | ||||
VAC0333 | PFIZER VAX-MEASLES K INACTIVATED | ||||
VAC0115 | AVAXIM 80 U PEDIATRIQUE | ||||
VAC0248 | HINKUYS KAROKOE | ||||
VAC0599 | Vaccin pentavalent DTCoqHibHepB - Diphtérie-Tétanos-Coqueluche-Hib-Hépatite B, sans précision | ||||
VAC0466 | ZATETRAVAX | ||||
VAC0684 | QAZVAC | ||||
VAC1446 | Vaccin encéphalite japonaise, inactivé, dérivé de cellules Vero, 3 microgrammes | ||||
VAC1228 | Vaccin VRS, recombinant, antigène RSVPreF3 dérivé de la protéine F, sans précision | ||||
VAC0551 | Vaccin DTCaP - Diphtérie-Tétanos-Coqueluche-Polio, sans précision | ||||
VAC1313 | BCG SII | ||||
VAL415 | Valence charbon, acellulaire, absorbé, adjuvant | VAL111, VAL111 | VAL111, VAL111 | ||
VAC0201 | BIVIRATEN BERNA | ||||
VAC0334 | PFIZER VAX-MEASLES L | ||||
VAC0249 | RUBELLA VACCINE HPV-77 | ||||
DIS029 | Variole-Mpox | ||||
VAC0116 | R.O.R SANOFI PASTEUR | ||||
VAC0467 | ZATEVAX | ||||
VAC0552 | Vaccin hexavalent DTPCaHibHepB - Diphtérie-Tétanos-Polio-Coqueluche acellulaire -Hib-Hépatite B, sans précision | ||||
VAC0685 | VIDPREVTYN BETA | ||||
VAC0770 | NDV-HXP-S | ||||
VAC1314 | MEASLES SII | ||||
VAL416 | Valence covid 19, sous-unité protéique, adjuvant, protéine de pointe recombinante | VAL104, VAL104 | VAL104, VAL104 | ||
VAC1229 | Vaccin Méningocoque B (à protéines de vésicules de membrane externe) et C, sans précision | ||||
VAC0113 | Vaccin rubéole, vivant atténué, sans précision | ||||
VAC0246 | HIBERNA PRODUCTSIX | ||||
VAC0379 | T-IMMUN | ||||
DIS028 | Encéphalite japonaise | ||||
VAC0028 | RABIPUR | ||||
VAL413 | Valence covid 19, sous-variant Omicron XBB.1.16 , sous-unité protéique, protéine de pointe recombinante (domaine RBD) | VAL011, VAL011 | VAL011, VAL011 | ||
VAC1311 | Vaccin Méningocoques ACWXY conjugué, sans précision | ||||
VAC1444 | Vaccin grippe, trivalent, VLP, sans précision | ||||
VAC1008 | DITEMER | ||||
VAC1359 | SKYCELLFLU TRIVALENT | ||||
VAC0464 | ZAMRUVAX | ||||
VAC0682 | FLUQUADRI | ||||
VAC1226 | Vaccin Hépatites A et B, dose pédiatrique, sans précision | ||||
VAL328 | Valence covid 19, sous-variant Omicron XBB.1.5, sous-unité protéique, protéine de pointe recombinante dans des nanoparticules | VAL107, VAL107 | VAL107, VAL107 | ||
VAC0332 | PENTAVALENTE | ||||
VAC0114 | Vaccin Rougeole, vivant atténué, sans précision | ||||
DIS027 | Encéphalite à tiques | ||||
VAC0247 | HIBTITER | ||||
VAC0029 | REPEVAX | ||||
VAC1312 | TT SII | ||||
VAC0598 | Vaccin pentavalent DTCeHibHepB - Diphtérie-Tétanos-Coqueluche-Hib-Hépatite B, sans précision | ||||
VAC0465 | ZARUVAX | ||||
VAC1227 | Vaccin Hépatite B, dose pédiatrique, sans précision | ||||
VAC1445 | Vaccin grippe aviaire, A(H5N1), ARNm | ||||
VAC0550 | Vaccin RR - Rougeole-Rubéole, sans précision | ||||
VAC0683 | EpiVacCorona | ||||
VAL329 | Valence covid 19, variant Omicron XBB.1.5, ARNm codant la protéine de pointe du SARS-CoV-2, 50 microgrammes | VAL396, VAL396 | VAL396, VAL396 | ||
VAL414 | Valence diphtérique, sans précision | VAL083, VAL019 | VAL083, VAL019 | ||
VAC1009 | TETAMER | ||||
VAC0151 | Vaccin Méningocoques A + C, sans précision | ||||
VAC0284 | LYOVAC ATTENUVAX | ||||
VAC0066 | DTCP PASTEUR | ||||
VAC0199 | BIMMUGEN | ||||
VAL192 | Valence pneumocoque, polyosidique conjuguée, sérotype 7F | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0948 | BACITHRAX | ||||
VAC0815 | Vaccin Pneumocoque et Haemophilus influenzae b, sans précision | ||||
VAC1131 | Vaccin Pneumocoque non conjugué 17-valent, sans précision | ||||
VAC1264 | Vaccin A(H5) contre la grippe aviaire, sans précision | ||||
VAC0814 | Vaccin Pneumocoque conjugué, sans précision | ||||
VAC1179 | Vaccin Choléra et Typhoïde, injectable, sans précision | ||||
VAC1397 | PANFLU | ||||
VAC1046 | BEYFORTUS 50 mg (nirsevimab) | ||||
VAL419 | Valence botulisme, produits d'immunisation active ou passive | VAL280, VAL420 | VAL280, VAL420 | ||
VAC0370 | RVA RABIES VACCINE ABSORBED BIOPORT | ||||
VAC0152 | Vaccin Méningocoques ACWY non conjugué, sans précision | ||||
VAC0285 | LYOVAC MERUVAX | ||||
VAC0067 | HAVRIX 360 U | ||||
VAL193 | Valence pneumocoque, polyosidique conjuguée, sérotype 8 | VAL184, VAL184 | VAL184, VAL184 | ||
VAL060 | Valence chikungunya, vivant atténué | VAL390, VAL390 | VAL390, VAL390 | ||
VAC0816 | PEDATYPH | ||||
VAC0949 | IMOVAX BCG | ||||
VAC0900 | PREVENAR 20 | ||||
VAC1132 | Vaccin Covid 19 bivalent à ARNm contre le virus originel et le variant Omicron BA.4/5, 1,5 microgrammes, sans précision | ||||
VAC1350 | T SIS BIOMED | ||||
VAC1398 | PANFLU.1 | ||||
VAC1047 | ABRYSVO | ||||
VAC1265 | CLODIVAC | ||||
VAC0282 | LTEANAS IMUNA | ||||
VAC0064 | PENTACOQ | ||||
VAC0197 | BIAVAX II | ||||
VAL190 | Valence pneumocoque, polyosidique conjuguée, sérotype 6A | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0728 | aAPC COVID-19 VACCINE | ||||
VAC0812 | Vaccin Peste entier inactivé, sans précision | ||||
VAC1044 | Vaccin Covid 19 à virus entier inactivé, sans précision | ||||
VAC0945 | Vaccin Méningocoque sérogroupe inconnu, sans précision | ||||
VAC1262 | MRESVIA | ||||
VAC1395 | MUMPS SINOVAC VACCINE | ||||
VAC1177 | Vaccin Variole de 3ème génération, virus de la vaccine vivant à réplication minimale, sans précision | ||||
VAL417 | Valence covid 19, variant Omicron BA.2, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL149, VAL149 | VAL396, VAL395 | VAL149, VAL149 | VAL396, VAL395 |
VAC0283 | LYMERIX | ||||
VAC0150 | Vaccin Méningocoque C conjugué, sans précision | ||||
VAC0198 | BIKEN-HB | ||||
VAC0729 | LV-SMENP-DC vaccine | ||||
VAL191 | Valence pneumocoque, polyosidique conjuguée, sérotype 6B | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0947 | IMMU-PHILUS | ||||
VAC1263 | Vaccin covid à ARNm codant la protéine de pointe du SARS-COV-2, autorisé | ||||
VAC0946 | TYPHIDRALL | ||||
VAC1396 | ANFLU | ||||
VAC0813 | Vaccin Pneumocoque non conjugué, sans précision | ||||
VAC1130 | Vaccin Grippe saisonnière trivalent inactivé et anatoxine tétanique, sans précision | ||||
VAC1045 | INFANRIX-IPV/HIB | ||||
VAC1178 | Vaccin Dengue tétravalent, vivant atténué recombinant chimérique, sans précision | ||||
VAL418 | Valence variole, produits d'immunisation active ou passive | VAL022, VAL337 | VAL022, VAL337 | ||
VAC0240 | GUNEVAX | ||||
VAC0373 | SALK | ||||
VAC0155 | Vaccin Dengue, sans précision | ||||
VAC0022 | NEISVAC | ||||
VAC0288 | M-R VAX II | ||||
VAL196 | Valence pneumocoque, polyosidique conjuguée, sérotype 11A | VAL184, VAL184 | VAL184, VAL184 | ||
VAC0819 | Vaccin Encéphalite Japonaise entier inactivé, sans précision | ||||
VAL063 | Valence botulisme, antitoxine | VAL420, VAL420 | VAL420, VAL420 | ||
VAL281 | Valence Adénovirus de type 7, vivant atténué, voie orale, sans précision | ||||
VAC0904 | Vaccin Rage préparé sur embryon de canard, sans précision | ||||
VAC1220 | Vaccin Méningocoque CY et Haemophilus influenzae type b, conjugué à l'anatoxine tétanique, sans précision | ||||
VAC1135 | Vaccin Covid 19 à vecteur viral non réplicatif, adénovirus codant la protéine de pointe du SARS-CoV-2, par inhalation, sans précision | ||||
VAC1268 | SPIKEVAX JN.1 50 µg | ||||
VAC1002 | Q-VAX | ||||
VAC1353 | IL-YANG FLU VACCINE | ||||
VAC0591 | VIVAXIM | ||||
VAC0241 | HAEMOPHILUS INFLUENZAE B CONJUGATE VACCINE - SERUM INSTITUTE OF INDIA | ||||
VAC0023 | PENTAVAC | ||||
VAC0374 | SANDOVAC | ||||
VAC0156 | Vaccin HPV, sans précision | ||||
VAC0289 | M-VAX PFIZER | ||||
VAL064 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, sans adjuvant | VAL127, VAL127 | VAL040, VAL074, VAL279 | VAL127, VAL127 | VAL040, VAL074, VAL279 |
VAL282 | Valence Adénovirus de type 4, vivant atténué, voie orale, sans précision | ||||
VAC0905 | Vaccin Rage PHKCV, sans précision | ||||
VAC1003 | TEDIVAX PRO ADULTO | ||||
VAC1136 | Vaccin Pneumocoque conjugué 23-valent, sans précision | ||||
VAC1221 | Vaccin trivalent Diphtérie, Tétanos et Rubéole, sans précision | ||||
VAL197 | Valence pneumocoque, polyosidique conjuguée, sérotype 12F | VAL184, VAL184 | VAL184, VAL184 | ||
VAC1354 | EUFORVAC | ||||
VAC1269 | SPIKEVAX JN.1 0,1 mg/mL dose 25 µg | ||||
VAC0592 | SPEEDA | ||||
VAC0371 | POLIO SABIN GSK | ||||
VAC0153 | Vaccin Oreillons, sans précision | ||||
VAC0020 | MENJUGATEKIT 10 µg | ||||
VAC0286 | M-M-R II | ||||
VAC0068 | MONOVAX | ||||
VAL194 | Valence pneumocoque, polyosidique conjuguée, sérotype 9V | VAL184, VAL184 | VAL184, VAL184 | ||
VAL061 | Valence covid 19, sous-unité protéique, protéine de pointe du SARS-CoV-2 recombinante, S-2P et CpG1018 | VAL104, VAL104 | VAL104, VAL104 | ||
VAC0817 | Vaccin Typhoïde entier inactivé, sans précision | ||||
VAC1000 | VACV VACCINIA VIRUS LISTER ELSTREE | ||||
VAC1351 | TETANA PRO | ||||
VAC0901 | MENCEVAX ACW | ||||
VAC1048 | DECAVAC | ||||
VAC1133 | Vaccin Méningocoque ACWY polyosidique conjugué, sans précision | ||||
VAC1266 | PENMENVY | ||||
VAC1399 | TERTRANFLU | ||||
VAC0021 | MUTAGRIP | ||||
VAC0372 | SAHIA | ||||
VAC0287 | M-R VAX | ||||
VAC0154 | Vaccin Paludisme, sans précision | ||||
VAC0069 | MENOMUNE | ||||
VAL195 | Valence pneumocoque, polyosidique conjuguée, sérotype 10A | VAL184, VAL184 | VAL184, VAL184 | ||
VAL062 | Valence choléra, sous-unité, recombinante de la toxine cholérique B (rCTB) | VAL021, VAL021 | VAL021, VAL021 | ||
VAC0903 | Vaccin Rage type Fuenzalida, sans précision | ||||
VAL280 | Valence botulisme, anatoxine | VAL419, VAL419 | VAL419, VAL419 | ||
VAC0818 | Vaccin Typhoïde et Paratyphoïde, sans précision | ||||
VAC1352 | TERATECT | ||||
VAC0902 | Vaccin Rage type Semple, sans précision | ||||
VAC1267 | VIMKUNYA | ||||
VAC1001 | V4020 VEEV VACCINE | ||||
VAC1134 | Vaccin Fièvre hémorragique d'Argentine, vivant atténué, virus Junin, sans précision | ||||
VAC1049 | TDVAX | ||||
VAC0590 | VACCIN BCG AJVACCINES |
Additional Language Displays
Code | Deutsch (German, de) | English (English, en) | French (fr) | gr | lv | Polskie (Polish, pl) | Portuguese (pt) |
VAL152 | Inf-I | INF-I | Inf-I | Inf-I | Inf-I | Inf-I | Inf-I |
VAL370 | PCV-15C | VPC-15C | |||||
VAC1062 | CMV-Immunglobulin | CMV immune globulin | CMV ανοσοσφαιρίνη | CMV imūnglobulīns | Immunoglobulina CMV | Imunoglobulina CMV | |
DIS078 | Lepra | Leprosy | Λέπρα | Lēproze | Trąd | Lepra | |
VAC1280 | 21-valent pneumococcal conjugate vaccine, unspecified | ||||||
VAC0878 | |||||||
VAC0527 | |||||||
VAC0745 | |||||||
VAC1195 | COVID-19 vaccine with non-replicating viral vector, adenovirus 26 encoding the spike protein of SARS-CoV-2, in clinical trial, unspecified | ||||||
VAC0830 | Subunit shingles vaccine, unspecified | Subunit shingles vaccine, unspecified | Subunit shingles vaccine, unspecified | Subunit shingles vaccine, unspecified | Subunit shingles vaccine, unspecified | Subunit shingles vaccine, unspecified | |
VAL067 | T | T | T | T | T | T | T |
VAC0612 | |||||||
VAL285 | Trivalente inaktivierte Influenza-Valenz aus Zellkultur, spalt- oder untereinheitlich, normale Dosis | INF-CC3 | Inf-CC3 | Τρισθενής αδρανοποιημένη βαλεντία της γρίπης που προέρχεται από κυτταροκαλλιέργεια, κλασματοποιημένη ή υπομονάδα, κανονική δόση | Trivalenta inaktivēta gripas valence, iegūta no šūnu kultūras, frakcionēta vai apakšvienība, normāla deva | Trójwalentna inaktywowana wartość przeciwko grypie uzyskana z hodowli komórkowej, dzielona lub podjednostkowa, normalna dawka | alência vacinal trivalente inativada da gripe obtida por cultura celular, fracionada ou de subunidade, dose normal |
VAC0963 | |||||||
VAC0082 | |||||||
VAL020 | Shingles-L | Shingles-LA | Zona-V | Shingles-L | Shingles-L | Shingles-L | Shingles-L |
VAL371 | PCV-16F | VPC-16F | |||||
DIS077 | Enterovirus | ||||||
VAC1281 | |||||||
VAC0529 | |||||||
VAC0528 | |||||||
VAC0613 | |||||||
VAC0879 | |||||||
VAC1063 | Hepatitis-C-Impfstoff, nicht näher bezeichnet | Hepatitis C vaccine, unspecified | Εμβόλιο ηπατίτιδας C, απροσδιόριστο | C hepatīta vakcīna, neprecizēta | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu C, nieokreślona | Vacina contra hepatite C, não especificada | |
DIS076 | Harnwegsinfektion | Urinary infection | Ουρολοίμωξη | Urīnceļu infekcija | Infekcja dróg moczowych | Infecção urinária | |
VAC1196 | Japanese encephalitis vaccine, whole inactivated prepared from murine brain tissue, unspecified | ||||||
VAL068 | HepB | HepB | HepB | HepB | HepB | HepB | HepB |
VAC0964 | |||||||
VAL153 | PRP-D | PRP-D | PRP-D | PRP-D | PRP-D | PRP-D | PRP-D |
VAC0831 | Ebola vaccine, unspecified | Ebola vaccine, unspecified | Ebola vaccine, unspecified | Ebola vaccine, unspecified | Ebola vaccine, unspecified | Ebola vaccine, unspecified | |
VAL286 | HepA-LAV | HepA-LA | HepA-VVA | HepA-LAV | HepA-LAV | HepA-LAV | HepA-LAV |
VAC0083 | |||||||
VAL283 | HepA-PED | HepA-PED | HepA-PED | HepA-PED | HepA-PED | HepA-PED | HepA-PED |
VAL150 | Den | Den | Den | Den | Den | Den | Den |
VAC1193 | Japanese encephalitis vaccine, live recombinant attenuated, unspecified | ||||||
VAC0307 | |||||||
VAC1060 | |||||||
DIS075 | Rift-Valley-Fieber | Rift Valley fever | Πυρετός της κοιλάδας Rift | Rifta ielejas drudzis | Gorączka Doliny Rift | Febre do Vale do Rift | |
VAC0525 | |||||||
VAC0658 | |||||||
VAC0743 | |||||||
VAC0961 | |||||||
VAL198 | PCV-14 | PCV-14 | VPC-14 | PCV-14 | PCV-14 | PCV-14 | PCV-14 |
VAC0876 | |||||||
VAC0610 | Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified | Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified | Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified | Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified | Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified | Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified | |
VAL065 | RC-TDV | RC-TDV | RC-TDV | RC-TDV | RC-TDV | RC-TDV | RC-TDV |
VAC0080 | |||||||
VAL284 | HepA-ADU | HepA-ADU | HepA-ADU | HepA-ADU | HepA-ADU | HepA-ADU | HepA-ADU |
VAL151 | Tular | Tular | Tular | Tular | Tular | Tular | Tular |
VAC1061 | |||||||
VAC1194 | Tetanus, typhoid and paratypoid A and B vaccines, unspecified | ||||||
VAC0308 | |||||||
VAC0309 | |||||||
VAC0659 | |||||||
VAC0877 | |||||||
DIS074 | Streptococcus pyogenes | Streptococcus pyogenes | Streptococcus pyogenes | Streptococcus pyogenes | Streptococcus pyogenes | Streptococcus pyogenes | |
VAC0526 | |||||||
VAC0611 | |||||||
VAC0962 | |||||||
VAL199 | PCV-15B | PCV-15B | VPC-15B | PCV-15B | PCV-15B | PCV-15B | PCV-15B |
VAC0744 | |||||||
VAL066 | COVID-VVr-S-Influ | COVID-VVr-S-Influ | Covid-VVr-S-Influ | COVID-VVr-S-Influ | COVID-VVr-S-Influ | COVID-VVr-S-Influ | COVID-VVr-S-Influ |
VAC0086 | |||||||
DIS073 | Melanom | Melanoma | Μελάνωμα | Melanoma | Czerniak | Melanoma | |
VAC1066 | Melanom-Impfstoff, nicht näher bezeichnet | Melanoma vaccine, unspecified | Εμβόλιο μελανώματος, απροσδιόριστο | Melanomas vakcīna, neprecizēta | Szczepionka na czerniaka, nieokreślona | Vacina contra melanoma, não especificada | |
VAL289 | COVID-mRNA-S-10 | COVID-mRNA-S-ORI-10 | Covid-ARNm-S-ORI-10 | COVID-mRNA-S-ORI-10 | COVID-mRNA-S-ORI-10 | COVID-mRNA-S-ORI-10 | COVID-mRNA-S-ORI-10 |
VAC0701 | |||||||
VAC1151 | Quadrivalent DTPeP vaccine - Diphtheria-Tetanus-Pertussis-Polio, unspecified | ||||||
VAC0967 | |||||||
VAC1284 | |||||||
VAL156 | PRP-T | PRP-T | PRP-T | PRP-T | PRP-T | PRP-T | PRP-T |
VAL023 | INF-SUid3 | Inf-SUid3 | |||||
VAL241 | HVP-18 | HPV-18 | VPH-18 | HVP-18 | HVP-18 | HVP-18 | HVP-18 |
VAC1199 | Recombinant vesicular stomatitis replicative viral vector Ebola vaccine (rVSV) - EBOV GP glycoprotein, unspecified | ||||||
VAL374 | PCV-23B | VPC-23B | |||||
VAC0171 | |||||||
VAC0172 | |||||||
VAC0087 | |||||||
VAC0969 | |||||||
VAC1370 | |||||||
VAC1285 | |||||||
VAC0968 | |||||||
VAC0835 | |||||||
VAL157 | COVID | COVID | Covid | COVID | COVID | COVID | COVID |
VAC0702 | |||||||
VAC1152 | Meningococcal B vaccine containing fHbp of subfamilies A and B, unspecified | ||||||
VAL024 | Trivalente inaktivierte Influenza-Valenz, Spalt- oder Untereinheit, ohne Spezifikation | INF-SU3 | Inf-SU3 | Τρισθενής αδρανοποιημένη βαλεντία της γρίπης, κλασματοποιημένη ή υπομονάδα, χωρίς διευκρίνιση | Trivalenta inaktivēta gripas valence, frakcionēta vai apakšvienība, bez precizējuma | Trójwalentna inaktywowana wartość przeciwko grypie, dzielona lub podjednostkowa, bez określenia | Valência vacinal trivalente inativada da gripe, fracionada ou de subunidade, sem especificação |
VAL375 | PCV-24F | VPC-24F | |||||
VAC0920 | Diphtherie-Tetanus-Td-Impfstoff, nicht näher bezeichnet | Diphtheria-tetanus Td vaccine, unspecified | Εμβόλιο διφθερίτιδας-τετάνου Td, απροσδιόριστο | Difterijas-stingumkrampju Td vakcīna, neprecizēta | Szczepionka przeciw błonicy i tężcowi Td, nieokreślona | Vacina difteria-tétano Td, não especificada | |
VAL242 | HVP-31 | HPV-31 | VPH-31 | HVP-31 | HVP-31 | HVP-31 | HVP-31 |
DIS072 | HIV infektion | HIV infection | HIV λοίμωξη | HIV infekcija | Zakażenie wirusem HIV | Infecção pelo VIH | |
VAC1067 | Impfstoff gegen Streptococcus pyogenes, nicht näher bezeichnet | Streptococcus pyogenes vaccine, unspecified | Εμβόλιο Streptococcus pyogenes, απροσδιόριστο | Streptococcus pyogenes vakcīna, neprecizēta | Szczepionka Streptococcus pyogenes, nieokreślona | Vacina contra Streptococcus pyogenes, não especificada | |
VAC0390 | |||||||
VAC0084 | H5N1 pre-pandemic influenza vaccine, unspecified | H5N1 pre-pandemic influenza vaccine, unspecified | H5N1 pre-pandemic influenza vaccine, unspecified | H5N1 pre-pandemic influenza vaccine, unspecified | H5N1 pre-pandemic influenza vaccine, unspecified | H5N1 pre-pandemic influenza vaccine, unspecified | |
VAL372 | PCV-20A | VPC-20A | |||||
VAC1282 | |||||||
VAC1197 | COVID-19 vaccine with chimpanzee adenovirus and self-amplifying mRNA, unspecified | ||||||
VAC0965 | |||||||
VAC1064 | HIV-Impfstoff, nicht näher bezeichnet | HIV vaccine, unspecified | Εμβόλιο HIV, απροσδιόριστο | HIV vakcīna, neprecizēta | Szczepionka przeciwko wirusowi HIV, nieokreślona | Vacina contra HIV, não especificada | |
VAL069 | COVID-VVnr-S-ChAdOx1 | COVID-VVnr-S-ChAdOx1 | Covid-VVnr-S-ChAdOx1 | COVID-VVnr-S-ChAdOx1 | COVID-VVnr-S-ChAdOx1 | COVID-VVnr-S-ChAdOx1 | COVID-VVnr-S-ChAdOx1 |
VAC0614 | |||||||
VAL287 | Quadrivalente rekombinante Influenza-Valenz | INF-R4 | Inf-R4 | Tετρασθενής ανασυνδυασμένη βαλεντία της γρίπης | Četrvalenta rekombinanta gripas valence | Czterowalentna rekombinowana wartość przeciwko grypie | Valência vacinal tetravalente recombinante contra a gripe |
VAC0832 | Herpes Simplex vaccine, unspecified | Herpes Simplex vaccine, unspecified | Herpes Simplex vaccine, unspecified | Herpes Simplex vaccine, unspecified | Herpes Simplex vaccine, unspecified | Herpes Simplex vaccine, unspecified | |
VAL154 | HbOC | HbOC | HbOC | HbOC | HbOC | HbOC | HbOC |
DIS071 | Hepatitis C | Hepatitis C | Ηπατίτιδα Γ | C hepatīts | Wirusowe zapalenie wątroby typu C | Hepatite C | |
VAL021 | O-Chol-I | CHOL-I-O | O-Chol-I | O-Chol-I | O-Chol-I | O-Chol-I | O-Chol-I |
VAC0085 | |||||||
VAL240 | HVP-16 | HPV-16 | VPH-16 | HVP-16 | HVP-16 | HVP-16 | HVP-16 |
VAC1150 | COVID-19 mRNA vaccine encoding the spike protein of SARS-CoV-2, original virus, 30 micrograms, unspecified | ||||||
VAC0966 | |||||||
VAC0615 | |||||||
VAC0833 | |||||||
VAC1065 | Leprosy vaccine | Leprosy vaccine | Leprosy vaccine | Leprosy vaccine | Leprosy vaccine | Leprosy vaccine | |
VAC1198 | Chinkungunya vaccine, live attenuated, unspecified | ||||||
VAC1283 | |||||||
VAL155 | PRP-OMP | PRP-OMP | PRP-OMP | PRP-OMP | PRP-OMP | PRP-OMP | PRP-OMP |
VAL288 | HepA | HepA | HepA | HepA | HepA | HepA | HepA |
DIS070 | Cytomegalovirus | Cytomegalovirus | κυτταρομεγαλοϊός | Citomegalovīruss | Wirus cytomegalii | Citomegalovírus | |
VAL022 | Smallpox-L | POX-LA | POX-V | Smallpox-L | Smallpox-L | Smallpox-L | Smallpox-L |
VAL373 | PCV-23A | VPC-23A | |||||
VAC0170 | |||||||
VAC0301 | |||||||
DIS038 | Humane Papillomviren | Papillomavirus | Ιός θηλώματος | Cilvēka papilomas vīrusa infekcija | Wirus brodawczaka ludzkiego | Vírus do papiloma humano | |
VAC0216 | |||||||
VAC0349 | |||||||
VAL027 | COVID-VVnr-S-Ad26 | COVID-VVnr-S-Ad26 | Covid-VVnr-S-Ad26 | COVID-VVnr-S-Ad26 | COVID-VVnr-S-Ad26 | COVID-VVnr-S-Ad26 | COVID-VVnr-S-Ad26 |
VAL245 | HVP-52 | HPV-52 | VPH-52 | HVP-52 | HVP-52 | HVP-52 | HVP-52 |
VAL378 | rHBsAg-15 | rAgHBs-15 | |||||
VAL112 | Quadrivalente inaktivierte Influenza-Valenz aus Zellkultur, spalt- oder untereinheitlich, normale Dosis | INF-CC4 | Inf-CC4 | Τετρασθενής αδρανοποιημένη βαλεντία της γρίπης που προέρχεται από κυτταροκαλλιέργεια, κλασματοποιημένη ή υπομονάδα, κανονική δόση | Četrvalenta inaktivēta gripas valence, iegūta no šūnu kultūras, frakcionēta vai apakšvienība, normāla deva | Czterowalentna inaktywowana wartość przeciwko grypie uzyskana z hodowli komórkowej, dzielona lub podjednostkowa, normalna dawka | Valência vacinal tetravalente inativada da gripe obtida por cultura celular, fracionada ou de subunidade, dose normal |
VAC0567 | |||||||
VAC0434 | |||||||
VAC0785 | |||||||
VAL330 | COVID-mRNA-S-OMI-XBB.1.5-25 | Covid-ARNm-S-OMI-XBB.1.5-25 | COVID-mRNA-S-OMI-XBB.1.5-25 | ||||
VAC0870 | |||||||
VAC0652 | |||||||
VAC1414 | COVID-19 vaccine, protein subunit, recombinant spike protein nanoparticles, with adjuvant (Matrix M), Omicron JN.1 subvariant | ||||||
VAC1329 | |||||||
VAC0217 | |||||||
VAL028 | POX-3G | POX-3G | POX-3G | POX-3G | POX-3G | POX-3G | POX-3G |
VAL379 | COVID-mRNA-S-OMI-JN.1-30 | Covid-ARNm-S-OMI-JN.1-30 | |||||
VAL246 | HVP-45 | HPV-45 | VPH-45 | HVP-45 | HVP-45 | HVP-45 | HVP-45 |
VAL113 | HPV-02-valent | HPV-02-valent | VPH-02-valent | HPV-02-valent | HPV-02-valent | HPV-02-valent | HPV-02-valent |
VAC0568 | |||||||
VAL331 | CMV-Ig | CMV-Ig | CMV-Ig | CMV-Ig | CMV-Ig | CMV-Ig | CMV-Ig |
VAC0435 | |||||||
VAC0653 | Hepatitis A + Hepatitis B vaccine Child, unspecified | Hepatitis A + Hepatitis B vaccine Child, unspecified | Hepatitis A + Hepatitis B vaccine Child, unspecified | Hepatitis A + Hepatitis B vaccine Child, unspecified | Hepatitis A + Hepatitis B vaccine Child, unspecified | Hepatitis A + Hepatitis B vaccine Child, unspecified | |
VAC0786 | |||||||
VAC0520 | |||||||
VAC1415 | Polyvalent vaccine against pus bacterium Pseudomonas aeruginosa | ||||||
VAC0871 | |||||||
VAC0214 | |||||||
VAC0347 | |||||||
VAC0129 | |||||||
DIS036 | Cholera | Cholera | Χολέρα | Holera | Cholera | Cólera | |
VAL158 | pHBsAg | pHBsAg | pAgHBs | pHBsAg | pHBsAg | pHBsAg | pHBsAg |
VAL025 | Mala | Mala | Palu | Mala | Mala | Mala | Mala |
VAL243 | HPV-33 | HPV-33 | VPH-33 | HPV-33 | HPV-33 | HPV-33 | HPV-33 |
VAL376 | PCV-31 | VPC-31 | |||||
VAL110 | T-Ig | T-Ig | T-Ig | T-Ig | T-Ig | T-Ig | T-Ig |
VAC0698 | |||||||
VAC0783 | |||||||
VAC0432 | |||||||
VAC1327 | |||||||
VAC1412 | COVID-19 mRNA vaccine, subvariant Omicron JN.1, 10 micrograms, paediatric dose (5-11 years) | ||||||
VAC0650 | |||||||
VAC1109 | ACW unconjugated meningococcal vaccine, unspecified | ||||||
VAC0300 | |||||||
VAC0348 | |||||||
VAL159 | Shingles-SU | Shingles-SU | Zona-SU | Shingles-SU | Shingles-SU | Shingles-SU | Shingles-SU |
VAL026 | MenB-OMP | MenB-OMP | MenB-OMP | MenB-OMP | MenB-OMP | MenB-OMP | MenB-OMP |
VAL377 | PCV-35B | VPC-35B | |||||
VAC0699 | |||||||
VAL244 | HVP-58 | HPV-58 | VPH-58 | HVP-58 | HVP-58 | HVP-58 | HVP-58 |
VAL111 | Bant | Bant | Bant | Bant | Bant | Bant | Bant |
VAC0566 | |||||||
VAC0433 | |||||||
VAC0651 | |||||||
VAC1413 | COVID-19 mRNA vaccine, subvariant Omicron JN.1, 3 micrograms, dose (6 months-4 years) | ||||||
VAC0784 | |||||||
VAC1328 | |||||||
VAC0305 | |||||||
DIS034 | Leptospirose | Leptospirosis | Λεπτοσπείρωση | Leptospiroze | Leptospirozy | Leptospirose | |
VAC1191 | Vaccine for the prevention of urinary infections in women, unspecified | ||||||
VAL116 | RSV-mAb-pal | RSV-mAb-pal | VRS-mAb-pal | RSV-mAb-pal | RSV-mAb-pal | RSV-mAb-pal | RSV-mAb-pal |
VAC0438 | |||||||
VAC0789 | |||||||
VAL201 | PCV-19A | PCV-19A | VPC-19A | PCV-19A | PCV-19A | PCV-19A | PCV-19A |
VAL334 | MEL | MEL | |||||
VAC0874 | |||||||
VAC0523 | |||||||
VAC0656 | |||||||
VAC0741 | |||||||
VAL249 | JE | JE | EJ | JE | JE | JE | JE |
VAC1418 | COVID-19 mRNA vaccine, subvariant Omicron KP.2, 30 micrograms, adult (+ 12 years) | ||||||
DIS033 | Herpes Zoster | Shingles | ζώνη | Jostas roze | Półpasiec | Herpes zoster | |
VAC0306 | |||||||
VAC1192 | Pentavalent vaccine DTPePHibHepB - Diphtheria-Tetanus-Pertussis-Hib OC-HepatitisB 10µg, unspecified | ||||||
VAL335 | SPYO | SPYO | |||||
VAC0439 | |||||||
VAL202 | PCV-19F | PCV-19F | VPC-19F | PCV-19F | PCV-19F | PCV-19F | PCV-19F |
VAC0657 | |||||||
DIS032 | Rotavirus | Rotavirus | Ροταϊός | Rotavīruss | Rotawirusy | Rotavírus | |
VAC0524 | |||||||
VAL420 | BOT-passive | BOT-passive | |||||
VAC0875 | |||||||
VAC0742 | |||||||
VAC0960 | |||||||
VAC1419 | Chikungunya VLP vaccine (recombinant, adsorbed) | ||||||
VAL117 | Acel | Acel | Acel | Acel | Acel | Acel | Acel |
VAC0303 | |||||||
VAC0218 | |||||||
VAL247 | JE-LAR | JE-LAR | EJ-VRA | JE-LAR | JE-LAR | JE-LAR | JE-LAR |
VAL114 | rHBsAg-10 | rHBsAg-10 | rAgHBs-10 | rHBsAg-10 | rHBsAg-10 | rHBsAg-10 | rHBsAg-10 |
DIS031 | Denguefieber | Dengue fever | Δάγκειος πυρετός | Tropu drudzis | Denga | Dengue | |
VAC0569 | |||||||
VAC0787 | Diphtheria-Tetanus-Rubella, unspecified | Diphtheria-Tetanus-Rubella, unspecified | Diphtheria-Tetanus-Rubella, unspecified | Diphtheria-Tetanus-Rubella, unspecified | Diphtheria-Tetanus-Rubella, unspecified | Diphtheria-Tetanus-Rubella, unspecified | |
VAC0436 | |||||||
VAL332 | Hepatitis-C-Valenz, ohne Spezifikation | HepC | HepC | Βαλεντία της ηπατίτιδας C, χωρίς διευκρίνιση | C hepatīta valence, bez precizējuma | Wartość przeciwko wirusowemu zapaleniu wątroby typu C, bez określenia | Valência vacinal da hepatite C, sem especificação |
VAC0654 | Hepatitis A + Hepatitis B vaccine Adult, unspecified | Hepatitis A + Hepatitis B vaccine Adult, unspecified | Hepatitis A + Hepatitis B vaccine Adult, unspecified | Hepatitis A + Hepatitis B vaccine Adult, unspecified | Hepatitis A + Hepatitis B vaccine Adult, unspecified | Hepatitis A + Hepatitis B vaccine Adult, unspecified | |
VAC0521 | |||||||
VAC0872 | |||||||
VAC1416 | COVID-19 mRNA vaccine, subvariant Omicron KP.2, 3 micrograms, paediatric dose (6 months-4 years) | ||||||
VAL029 | Inf-VLP | INF-VLP | Inf-VLP | Inf-VLP | Inf-VLP | Inf-VLP | Inf-VLP |
VAC1190 | COVID-19 vaccine with replicative viral vector, vesicular stomatitis virus encoding the SARS-CoV-2 spike protein, unspecified | ||||||
VAC0304 | |||||||
VAC0219 | |||||||
DIS079 | Pseudomonas aeruginosa | Pseudomonas aeruginosa | Pseudomonas aeruginosa | Pseudomonas aeruginosa | Pseudomonas aeruginosa | Pseudomonas aeruginosa | |
VAL115 | Hepatitis-B-Impfstoff, rekombinantes Hepatitis-B-Virus-Oberflächenantigen (HBsAg), 20 Mikrogramm | rHBsAg-20 | rAgHBs-20 | Εμβόλιο ηπατίτιδας Β, ανασυνδυασμένο αντιγόνο επιφανείας του ιού της ηπατίτιδας Β (HBsAg), 20 μικρογραμμάρια | Hepatīta B vakcīna, rekombinants hepatīta B vīrusa virsmas antigēns (HBsAg), 20 mikrogrami | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu B, rekombinowany antygen powierzchniowy wirusa zapalenia wątroby typu B (HBsAg), 20 mikrogramów | Vacina contra a hepatite B, antigénio de superfície recombinante do vírus da hepatite B (HBsAg), 20 microgramas |
VAL248 | JE-LAV | JE-LA | EJ-VVA | JE-LAV | JE-LAV | JE-LAV | JE-LAV |
DIS030 | Tollwut | Rabies | Οργή | Trakumsērga | Wścieklizna | Raiva | |
VAL333 | HIV | VIH | |||||
VAC0437 | |||||||
VAL200 | PCV-18C | PCV-18C | VPC-18C | PCV-18C | PCV-18C | PCV-18C | PCV-18C |
VAC0655 | Diphtheria vaccine, unspecified | Diphtheria vaccine, unspecified | Diphtheria vaccine, unspecified | Diphtheria vaccine, unspecified | Diphtheria vaccine, unspecified | Diphtheria vaccine, unspecified | |
VAC0788 | Hib-IPV, unspecified | Hib-IPV, unspecified | Hib-IPV, unspecified | Hib-IPV, unspecified | Hib-IPV, unspecified | Hib-IPV, unspecified | |
VAC0873 | |||||||
VAC0740 | |||||||
VAC1417 | COVID-19 mRNA vaccine, subvariant Omicron KP.2, 10 micrograms, paediatric dose (5-11 years) | ||||||
VAC0341 | |||||||
VAC0123 | |||||||
VAC0256 | |||||||
VAC0038 | |||||||
VAC0389 | |||||||
VAC1103 | |||||||
VAC1321 | |||||||
VAC1369 | |||||||
VAC1018 | |||||||
VAC0474 | |||||||
VAC1236 | COVID-19 protein subunit vaccine, recombinant spike protein in nanoparticles, Omicron subvariant XBB.1.5, unspecified | ||||||
VAC0692 | |||||||
VAL205 | PCV-33F | PCV-33F | VPC-33F | PCV-33F | PCV-33F | PCV-33F | PCV-33F |
VAL338 | RSV | RSV | VRS | RSV | RSV | RSV | RSV |
VAC0124 | |||||||
VAC0257 | |||||||
VAC0039 | |||||||
VAC1322 | |||||||
VAC1019 | |||||||
VAC0475 | |||||||
VAC0693 | |||||||
VAC1104 | |||||||
VAC1237 | Pre-erythrocytic malaria vaccine, unspecified | ||||||
VAC0560 | |||||||
VAL339 | Lyme | Lyme | |||||
VAL206 | PPSV-01 | PPSV-01 | VPP-01 | PPSV-01 | PPSV-01 | PPSV-01 | PPSV-01 |
VAC0254 | |||||||
VAC0121 | |||||||
VAC0036 | |||||||
VAC0387 | |||||||
VAC0169 | |||||||
VAC0918 | PRP-D-Hib-Impfstoff, nicht spezifiziert | PRP-D Hib vaccine, unspecified | Εμβόλιο PRP-D Hib, απροσδιόριστο | PRP-D Hib vakcīna, neprecizēta | Szczepionka PRP-D Hib, nieokreślona | Vacina PRP-D Hib, não especificada | |
VAL203 | PCV-22F | PCV-22F | VPC-22F | PCV-22F | PCV-22F | PCV-22F | PCV-22F |
VAL336 | RVF | RVF | FVR | RVF | RVF | RVF | FVR |
VAL421 | Junin | Junin | |||||
VAC1234 | 15-valent unconjugated pneumococcal vaccine, unspecified | ||||||
VAC1367 | |||||||
VAC1101 | |||||||
VAC1016 | |||||||
VAC1149 | Oral live attenuated cholera vaccine, unspecified | ||||||
VAC0472 | |||||||
VAL118 | MenB | MenB | MenB | MenB | MenB | MenB | MenB |
VAC0690 | |||||||
VAC0255 | |||||||
VAC0388 | |||||||
VAC0919 | Hib-hbOC-Impfstoff, nicht spezifiziert | Hib hbOC vaccine, unspecified | Εμβόλιο Hib hbOC, απροσδιόριστο | Hib hbOC vakcīna, neprecizēta | Szczepionka Hib hbOC, nieokreślona | Vacina Hib hbOC, não especificada | |
VAC0037 | |||||||
VAL204 | PCV-23F | PCV-23F | VPC-23F | PCV-23F | PCV-23F | PCV-23F | PCV-23F |
VAL422 | Yp | Yp | |||||
VAC1102 | |||||||
VAC1235 | RIX4414 monovalent rotavirus vaccine, unspecified | ||||||
VAC1320 | |||||||
VAC1368 | |||||||
VAC1017 | |||||||
VAC0473 | |||||||
VAC0691 | |||||||
VAL119 | MPV-mono | MPV-mono | MPV-mono | MPV-mono | MPV-mono | MPV-mono | MPV-mono |
VAL337 | Pocken-Ig | POX-Ig | POX-Ig | Ευλογιά-Ig | Bakas-Ig | Ospa-Ig | Varíola-Ig |
VAC0212 | |||||||
VAC0345 | Hib PRP-T conjugated vaccine, unspecified | Hib PRP-T conjugated vaccine, unspecified | Hib PRP-T conjugated vaccine, unspecified | Hib PRP-T conjugated vaccine, unspecified | Hib PRP-T conjugated vaccine, unspecified | Hib PRP-T conjugated vaccine, unspecified | |
VAC0127 | |||||||
VAC0478 | |||||||
VAC1410 | COVID-19 mRNA vaccine, Omicron JN.1 subvariant, 25 micrograms per dose, multidose vial | ||||||
VAC0563 | |||||||
VAC0696 | |||||||
VAC1107 | Whole inactivated Cholera vaccine, unspecified | ||||||
VAC0781 | |||||||
VAC0430 | |||||||
VAL209 | PPSV-04 | PPSV-04 | VPP-04 | PPSV-04 | PPSV-04 | PPSV-04 | PPSV-04 |
VAC1325 | |||||||
VAC0213 | |||||||
VAC0346 | |||||||
VAC0128 | |||||||
VAC0479 | |||||||
VAC0697 | |||||||
VAC1411 | COVID-19 mRNA vaccine, subvariant Omicron JN.1, 30 micrograms, adult dose (+ 12 years) | ||||||
VAC1326 | |||||||
VAC0431 | |||||||
VAC0782 | |||||||
VAC1108 | COVID-19 bivalent mRNA vaccine, original virus + Omicron BA.1 variant, unspecified | ||||||
VAC0210 | |||||||
VAC0343 | |||||||
VAC0258 | |||||||
VAC0125 | |||||||
VAC1323 | |||||||
VAC0476 | |||||||
VAC1238 | Vaccine against hepatitis B and malaria, unspecified | ||||||
VAC0694 | |||||||
VAC0561 | |||||||
VAC1105 | |||||||
VAL207 | PPSV-02 | PPSV-02 | VPP-02 | PPSV-02 | PPSV-02 | PPSV-02 | PPSV-02 |
VAC0211 | |||||||
VAC0344 | PRP-OMP Hib vaccine, unspecified | PRP-OMP Hib vaccine, unspecified | PRP-OMP Hib vaccine, unspecified | PRP-OMP Hib vaccine, unspecified | PRP-OMP Hib vaccine, unspecified | PRP-OMP Hib vaccine, unspecified | |
VAC0126 | |||||||
VAC0259 | |||||||
VAC0477 | |||||||
VAC0695 | |||||||
VAC1106 | COVID-19 VLP vaccine, unspecified | ||||||
VAC1239 | Konjugierter Pneumokokken-Impfstoff, 15-valent, nicht näher bezeichnet | 15-valent Pneumococcus conjugate vaccine, unspecified | Πνευμονιοκοκκικό 15-δύναμο συζευγμένο εμβόλιο, απροσδιόριστο | Pneimokoku 15-valenta konjugētā vakcīna, neprecizēta | 15-walentna skoniugowana szczepionka przeciw pneumokokom, nieokreślona | Vacina pneumocócica conjugada 15-valente, não especificada | |
VAC0562 | |||||||
VAC1324 | |||||||
VAL208 | PPSV-03 | PPSV-03 | VPP-03 | PPSV-03 | PPSV-03 | PPSV-03 | PPSV-03 |
VAC0780 | |||||||
VAC0030 | |||||||
VAC0163 | Whole-cell inactivated pertussis vaccine, unspecified | Whole-cell inactivated pertussis vaccine, unspecified | Whole-cell inactivated pertussis vaccine, unspecified | Whole-cell inactivated pertussis vaccine, unspecified | Whole-cell inactivated pertussis vaccine, unspecified | Whole-cell inactivated pertussis vaccine, unspecified | |
VAC0296 | |||||||
VAC0078 | |||||||
VAL071 | Ty-I | Ty-I | Ty-I | Ty-I | Ty-I | Ty-I | Ty-I |
VAC0827 | MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified | MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified | MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified | MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified | MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified | MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified | |
VAC0911 | Hepatitis-A-Totimpfstoff, monovalent, pädiatrische Dosis, nicht spezifiziert | Hepatitis A whole inactivated vaccine, monovalent, pediatric dose, unspecified | Ολόκληρο αδρανοποιημένο εμβόλιο ηπατίτιδας Α, μονοσθενές, παιδιατρική δόση, απροσδιόριστο | A hepatīta vesela inaktivēta vakcīna, monovalenta, pediatriskā deva, neprecizēta | Wirusowe zapalenie wątroby Szczepionka cała inaktywowana, jednoważna, dawka pediatryczna, nieokreślona | Vacina totalmente inativada contra hepatite A, monovalente, dose pediátrica, não especificada | |
VAC1361 | |||||||
VAC1010 | |||||||
VAC1143 | COVID-19 vaccine with non-replicating viral vector, adenovirus encoding the spike protein of SARS-CoV-2, unspecified | ||||||
VAC1058 | |||||||
VAC1276 | |||||||
VAC0382 | Tetanus diphtheria vaccine, unspecified | Tetanus diphtheria vaccine, unspecified | Tetanus diphtheria vaccine, unspecified | Tetanus diphtheria vaccine, unspecified | Tetanus diphtheria vaccine, unspecified | Tetanus diphtheria vaccine, unspecified | |
VAC0031 | |||||||
VAC0164 | |||||||
VAC0297 | |||||||
VAC0079 | |||||||
VAL072 | MenB-fHbpAB | MenB-fHbpAB | MenB-fHbpAB | MenB-fHbpAB | MenB-fHbpAB | MenB-fHbpAB | MenB-fHbpAB |
VAL290 | COVID-mRNA-S-30 | COVID-mRNA-S-ORI-30 | Covid-ARNm-S-ORI-30 | COVID-mRNA-S-ORI-30 | COVID-mRNA-S-ORI-30 | COVID-mRNA-S-ORI-30 | COVID-mRNA-S-ORI-30 |
VAC0828 | Rotavirus pentavalent vaccine, unspecified | Rotavirus pentavalent vaccine, unspecified | Rotavirus pentavalent vaccine, unspecified | Rotavirus pentavalent vaccine, unspecified | Rotavirus pentavalent vaccine, unspecified | Rotavirus pentavalent vaccine, unspecified | |
VAC1011 | |||||||
VAC0912 | Hepatitis-A-Impfstoff, pädiatrische Dosis, nicht spezifiziert | Hepatitis A vaccine, pediatric dose, unspecified | Εμβόλιο ηπατίτιδας Α, παιδιατρική δόση, απροσδιόριστη | Vakcīna pret A hepatītu, pediatriskā deva, neprecizēta | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu A, dawka pediatryczna, nieokreślona | Vacina contra hepatite A, dose pediátrica, não especificada | |
VAC1362 | |||||||
VAC1059 | |||||||
DIS080 | Meningokokken X | Meningococcal X | Μηνιγγιτιδόκοκκος X | Meningokoks X | Meningokok X | Meningococo X | |
VAC1144 | COVID-19 protein subunit vaccine, recombinant SARS-CoV-2 spike protein, S-2P and CpG1018, unspecified | ||||||
VAC1277 | Impfstoff gegen Chikungunya, ohne nähere Angaben | Vaccine against chikungunya, unspecified | Εμβόλιο κατά του chikungunya, απροσδιόριστο | Vakcīna pret čikungunju, neprecizēta | Szczepionka przeciwko chikungunya, nieokreślona | ||
VAC0161 | |||||||
VAC0294 | |||||||
VAC0076 | |||||||
VAC0958 | |||||||
VAC1274 | |||||||
VAC0957 | |||||||
VAC0824 | Hepatitis A virosome vaccine, unspecified | Hepatitis A virosome vaccine, unspecified | Hepatitis A virosome vaccine, unspecified | Hepatitis A virosome vaccine, unspecified | Hepatitis A virosome vaccine, unspecified | Hepatitis A virosome vaccine, unspecified | |
VAC1141 | Bird Flu H5N8 Vaccine, unspecified | ||||||
VAC1056 | |||||||
VAC1189 | Non-replicating vector COVID-19 vaccine, modified Ankara vaccine encoding the SARS-CoV-2 spike protein, unspecified | ||||||
VAC0162 | Brucellosis vaccine, unspecified | Brucellosis vaccine, unspecified | Brucellosis vaccine, unspecified | Brucellosis vaccine, unspecified | Brucellosis vaccine, unspecified | Brucellosis vaccine, unspecified | |
VAC0295 | |||||||
VAC0077 | |||||||
VAC0959 | |||||||
VAL070 | COVID-VVnr-S-Ad | COVID-VVnr-S-Ad | Covid-VVnr-S-Ad | COVID-VVnr-S-Ad | COVID-VVnr-S-Ad | COVID-VVnr-S-Ad | COVID-VVnr-S-Ad |
VAC0826 | |||||||
VAC1142 | COVID-19 vaccine, non-replicating vector, antigen-presenting cells, unspecified | ||||||
VAC0910 | Inaktivierter Hepatitis-A-Impfstoff, Erwachsenendosis, nicht spezifiziert | Inactivated hepatitis A vaccine, adult dose, unspecified | Αδρανοποιημένο εμβόλιο ηπατίτιδας Α, δόση για ενήλικες, μη καθορισμένη | Inaktivēta A hepatīta vakcīna, pieaugušo deva, neprecizēta | Inaktywowana szczepionka przeciwko wirusowemu zapaleniu wątroby typu A, dawka dla dorosłych, nieokreślona | Vacina inativada contra hepatite A, dose para adultos, não especificada | |
VAC1275 | |||||||
VAC1360 | |||||||
VAC0825 | Combined hepatitis A and hepatitis B vaccine, unspecified | Combined hepatitis A and hepatitis B vaccine, unspecified | Combined hepatitis A and hepatitis B vaccine, unspecified | Combined hepatitis A and hepatitis B vaccine, unspecified | Combined hepatitis A and hepatitis B vaccine, unspecified | Combined hepatitis A and hepatitis B vaccine, unspecified | |
VAC1057 | |||||||
VAC0380 | T.Polio, unspecified | T.Polio, unspecified | T.Polio, unspecified | T.Polio, unspecified | T.Polio, unspecified | T.Polio, unspecified | |
VAC0252 | |||||||
VAC0385 | |||||||
VAC0034 | |||||||
VAL075 | Lepto-wI | Lepto-wI | Lepto-eI | Lepto-wI | Lepto-wI | Lepto-wI | Lepto-wI |
VAL293 | Anthrax-Ig | Anthrax-Ig | Charbon-Ig | Anthrax-Ig | Anthrax-Ig | Anthrax-Ig | Anthrax-Ig |
VAL160 | Shingles | Shingles | Zona | Shingles | Shingles | Shingles | Shingles |
VAC0916 | Hepatitis-B-Impfstoff, monovalent, Dosierung für Dialysepatienten, nicht spezifiziert | Hepatitis B vaccine, monovalent, dialysis patient dosage, unspecified | Εμβόλιο ηπατίτιδας Β, μονοσθενές, δοσολογία ασθενούς σε αιμοκάθαρση, απροσδιόριστη | B hepatīta vakcīna, monovalenta, dialīzes pacienta deva, neprecizēta | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu B, monowalentna, dawka dla pacjentów dializowanych, nieokreślona | Vacina contra hepatite B, monovalente, dosagem para pacientes em diálise, não especificada | |
VAC1365 | |||||||
VAC1014 | |||||||
VAC1147 | Human monoclonal antibody against respiratory syncytial virus (RSV), nirsevimab, unspecified | ||||||
VAC1232 | Acellular pertussis vaccine, reduced dose, unspecified | ||||||
VAC0470 | |||||||
VAC0120 | |||||||
VAC0253 | |||||||
VAC0386 | |||||||
VAC0168 | |||||||
VAC0035 | |||||||
VAL294 | Pox-1G | POX-1G | POX-1G | Pox-1G | Pox-1G | Pox-1G | Pox-1G |
VAL161 | MenB-mc | MenB-mc | MenB-mc | MenB-mc | MenB-mc | MenB-mc | MenB-mc |
VAC0917 | Hepatitis-E-Impfstoff, nicht näher bezeichnet | Hepatitis E vaccine, unspecified | Εμβόλιο ηπατίτιδας Ε, απροσδιόριστο | Vakcīna pret E hepatītu, neprecizēta | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu E, nieokreślona | Vacina contra hepatite E, não especificada | |
VAC1015 | |||||||
VAC1100 | |||||||
VAL076 | COVID-19-Impfstoff, inaktiviertes Vollvirus, nicht spezifiziert | COVID-IV | Covid-VI | Εμβόλιο COVID-19, αδρανοποιημένο με ολόκληρο τον ιό, απροσδιόριστο | COVID-19 vakcīna, inaktivēta ar veselu vīrionu, neprecizēta | Szczepionka COVID-19, inaktywowana całymi wirusami, nieokreślona | Vacina COVID-19, virião inteiro inactivado, não especificada |
VAC1233 | 10-valenter konjugierter Pneumokokken-Impfstoff, nicht näher bezeichnet | 10-valent Pneumococcus conjugate vaccine, unspecified | Πνευμονιοκοκκικό 10-δύναμο συζευγμένο εμβόλιο, απροσδιόριστο | Pneimokoku 10-valentā konjugētā vakcīna, neprecizēta | 10-walentna skoniugowana szczepionka przeciw pneumokokom, nieokreślona | Vacina pneumocócica conjugada 10-valente, não especificada | |
VAC1366 | |||||||
VAC1148 | Haemophilus influenzae type b vaccine, unconjugated polysaccharide, unspecified | ||||||
VAC0471 | |||||||
VAC0383 | |||||||
VAC0032 | |||||||
VAC0165 | |||||||
VAC0298 | |||||||
VAL073 | COVID-VVr+APC | COVID-VVr+APC | Covid-VVr+APC | COVID-VVr+APC | COVID-VVr+APC | COVID-VVr+APC | COVID-VVr+APC |
VAL291 | HepB-r-3Ag | HBs-r-3Ag | HBs-r-3Ag | HepB-r-3Ag | HepB-r-3Ag | HepB-r-3Ag | HepB-r-3Ag |
VAC0914 | Hepatitis-B-Impfstoff, monovalent, pädiatrische Dosis, nicht spezifiziert | Hepatitis B vaccine, monovalent, pediatric dose, unspecified | Εμβόλιο ηπατίτιδας Β, μονοσθενές, παιδιατρική δόση, απροσδιόριστο | B hepatīta vakcīna, monovalenta, pediatriskā deva, neprecizēta | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu B, monowalentna, dawka pediatryczna, nieokreślona | Vacina contra hepatite B, monovalente, dose pediátrica, não especificada | |
VAC0829 | Rubella-Mumps vaccine, unspecified | Rubella-Mumps vaccine, unspecified | Rubella-Mumps vaccine, unspecified | Rubella-Mumps vaccine, unspecified | Rubella-Mumps vaccine, unspecified | Rubella-Mumps vaccine, unspecified | |
VAC1230 | Meningococcal C and anti-Haemophilus influenzae type b vaccine, conjugated with tetanus toxoid, unspecified | ||||||
VAC0913 | |||||||
VAC1363 | |||||||
VAC1278 | |||||||
VAC1012 | |||||||
VAC1145 | Recombinant hepatitis B vaccine, three antigens, unspecified | ||||||
VAC0251 | |||||||
VAC0384 | |||||||
VAC0166 | |||||||
VAC0033 | |||||||
VAC0299 | |||||||
VAL074 | Vierwertiger inaktivierter Influenza-Impfstoff, Split oder Subunit, hochdosiert | INF-SUhd4 | Inf-SUhd4 | Τετραδύναμο αδρανοποιημένο εμβόλιο γρίπης, διαιρεμένο ή υπομονάδα, υψηλής δόσης | Četrivalenta inaktivēta gripas vakcīna, sadalīta vai subvienota, lielas devas | Inaktywowana czterowalentna szczepionka przeciwko grypie, podzielona lub podjednostkowa, wysokodawkowa | Vacina quadrivalente contra a gripe inactivada, fenda ou subunidade, dose alta |
VAL292 | Covid-VVnr-S-Ad26-CT | COVID-VVnr-S-Ad26-CT | Covid-VVnr-S-Ad26-CT | Covid-VVnr-S-Ad26-CT | Covid-VVnr-S-Ad26-CT | Covid-VVnr-S-Ad26-CT | Covid-VVnr-S-Ad26-CT |
VAC0915 | Hepatitis-B-Impfstoff, monovalent, Dosierung für Erwachsene, nicht spezifiziert | Hepatitis B vaccine, monovalent, adult dose, unspecified | Εμβόλιο ηπατίτιδας Β, μονοσθενές, δόση για ενήλικες, απροσδιόριστο | B hepatīta vakcīna, monovalenta, pieaugušo deva, nav precizēta | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu B, monowalentna, dawka dla dorosłych, nieokreślona | Vacina contra hepatite B, monovalente, dosagem para adultos, não especificada | |
VAC1231 | Pentavalent vaccine DTPaHibHepB- Diphtheria-Tetanus-Pertussis-Hib PRP-Hepatitis B 10μg, unspecified | ||||||
VAC1146 | Inactivated quadrivalent influenza vaccine, high dose, unspecified | ||||||
VAC1279 | Adjuvanted adsorbed anthrax vaccine | ||||||
VAC1364 | |||||||
VAC1013 | |||||||
VAL031 | TBE | TBE | TBE | TBE | TBE | TBE | TBE |
VAL382 | COVID-PS-rSnp-JN.1 | Covid-SP-rSnp-JN.1 | |||||
VAC1292 | |||||||
VAC0539 | |||||||
DIS041 | Brucellose | Brucellosis | Βρουκέλλωση | Bruceloze | Bruceloza | Brucelose | |
DIS003 | Keuchhusten | Pertussis | Κοκκίτης | Gara klepus | Krztusiec | Tosse convulsa | |
VAC0624 | |||||||
VAC0757 | |||||||
VAC1074 | |||||||
VAL079 | Rub-LAV | Rub-LA | Rub-VVA | Rub-LAV | Rub-LAV | Rub-LAV | Rub-LAV |
VAC0975 | |||||||
VAL164 | COVID-non-live | COVID-non-live | Covid-non-vivant | COVID-non-live | COVID-non-live | COVID-non-live | COVID-non-live |
VAC0842 | |||||||
VAL297 | MenA | MenA | MenA | MenA | MenA | MenA | MenA |
VAC0094 | |||||||
VAC0095 | |||||||
VAL250 | JE-I-mb | JE-I-mb | EJ-I-cm | JE-I-mb | JE-I-mb | JE-I-mb | JE-I-mb |
VAL383 | mRSV | mRSV | mVRS | mRSV | mRSV | mRSV | mRSV |
VAC1160 | 2nd generation live smallpox vaccine, unspecified | ||||||
VAC1293 | |||||||
VAC0408 | |||||||
DIS040 | Malaria | Malaria | Ελονοσία | Malārija | Malaria | Malária | |
VAC0407 | |||||||
VAC0758 | |||||||
DIS004 | Poliomyelitis | Poliomyelitis | Πολιομυελίτις | Poliomielīts | Polio / Choroba Heinego-Medina | Poliomielite | |
VAC0976 | |||||||
VAC1075 | Azellulärer Anthrax-Impfstoff, nicht näher bezeichnet | Acellular anthrax vaccine, unspecified | Ακυτταρικό εμβόλιο άνθρακα, απροσδιόριστο | Acelulārā Sibīrijas mēra vakcīna, neprecizēta | Bezkomórkowa szczepionka przeciwko wąglikowi, nieokreślona | Vacina acelular contra antraz, não especificada | |
VAC0625 | |||||||
VAC0710 | |||||||
VAL298 | MenC | MenC | MenC | MenC | MenC | MenC | MenC |
VAL165 | COVID-live | COVID-live | Covid-vivant | COVID-live | COVID-live | COVID-live | COVID-live |
VAC0843 | |||||||
VAL032 | Ty-ViPS | Ty-ViPS | Ty-ViPS | Ty-ViPS | Ty-ViPS | Ty-ViPS | Ty-ViPS |
VAC0180 | |||||||
VAL162 | COVID-VVr | COVID-VVr | Covid-VVr | COVID-VVr | COVID-VVr | COVID-VVr | COVID-VVr |
VAL295 | Pox-2G | POX-2G | POX-2G | Pox-2G | Pox-2G | Pox-2G | Pox-2G |
VAL380 | COVID-mRNA-S-OMI-JN.1-10 | Covid-ARNm-S-OMI-JN.1-10 | |||||
VAC1072 | COVID-19-mRNA-Impfstoff, Originalvirus, 25 µg, nicht spezifiziert | COVID-19 mRNA vaccine, original virus, 25 µg, unspecified | Εμβόλιο mRNA COVID-19, αρχικός ιός, 25 μg, απροσδιόριστο | Covid-19 mRNS vakcīna, oriģināls vīruss, 25 µg, neprecizēts | Szczepionka mRNA przeciwko COVID-19, wirus oryginalny, 25 µg, nieokreślony | Vacina de mRNA contra COVID-19, vírus original, 25 µg, não especificado | |
VAC1290 | |||||||
VAC0319 | |||||||
DIS005 | Haemophilus influenzae b-Infektion | Haemophilus influenzae b | Haemophilus influenzae β | Pfeifera nūjiņa | Haemophilus influenzae typu b | Haemophilus influenzae b | |
VAC0888 | |||||||
VAC0404 | |||||||
VAC0622 | |||||||
VAC0973 | |||||||
VAC0755 | |||||||
VAC0840 | |||||||
VAL077 | Mumps-LAV | MUMPS-LA | Or-VVA | Mumps-LAV | Mumps-LAV | Mumps-LAV | Mumps-LAV |
VAC0092 | |||||||
VAL163 | COVID-VVnr | COVID-VVnr | Covid-VVnr | COVID-VVnr | COVID-VVnr | COVID-VVnr | COVID-VVnr |
VAL030 | Lyme-OspA | Lyme-OspA | Lyme-OspA | Lyme-OspA | Lyme-OspA | Lyme-OspA | Lyme-OspA |
VAL381 | COVID-mRNA-S-OMI-JN.1-3 | Covid-ARNm-S-OMI-JN.1-3 | |||||
VAC1073 | Impfstoff gegen Lyme-Borreliose, nicht näher bezeichnet | Lyme disease vaccine, unspecified | Εμβόλιο για τη νόσο του Lyme, απροσδιόριστο | Vakcīna pret Laima slimību, neprecizēta | Szczepionka na boreliozę, nieokreślona | Vacina contra a doença de Lyme, não especificada | |
VAC1291 | |||||||
VAC0889 | |||||||
VAC0538 | |||||||
VAC0405 | |||||||
VAC0756 | |||||||
VAC0841 | |||||||
VAL078 | MCV-Y | MCV-Y | MCV-Y | MCV-Y | MCV-Y | MCV-Y | MCV-Y |
VAC0623 | Measles-mumps vaccine, unspecified | Measles-mumps vaccine, unspecified | Measles-mumps vaccine, unspecified | Measles-mumps vaccine, unspecified | Measles-mumps vaccine, unspecified | Measles-mumps vaccine, unspecified | |
VAL296 | Pox-3G-MVA | POX-3G-MVA | POX-3G-MVA | Pox-3G-MVA | Pox-3G-MVA | Pox-3G-MVA | Pox-3G-MVA |
VAC0974 | |||||||
DIS006 | Hepatitis B | Hepatitis B | Ηπατίτιδα Β | B hepatīts | Wirusowe Zapalenie Wątroby typu B | Hepatite B | |
VAC0093 | |||||||
VAC0183 | |||||||
VAC0098 | |||||||
VAC1381 | |||||||
VAC1296 | |||||||
VAC0979 | |||||||
VAC0713 | Typhoid polysaccharide vaccine, unspecified | Typhoid polysaccharide vaccine, unspecified | Typhoid polysaccharide vaccine, unspecified | Typhoid polysaccharide vaccine, unspecified | Typhoid polysaccharide vaccine, unspecified | Typhoid polysaccharide vaccine, unspecified | |
VAL168 | COVID-RNA | COVID-mRNA | Covid-ARN | COVID-RNA | COVID-RNA | COVID-RNA | COVID-RNA |
VAC0846 | |||||||
VAC1030 | |||||||
VAC1163 | 20-valenter konjugierter Pneumokokken-Impfstoff, nicht näher bezeichnet | 20-valent Pneumococcus conjugate vaccine, unspecified | 20-δύναμο πνευμονιοκοκκικό συζευγμένο εμβόλιο, απροσδιόριστο | 20-valenta pneimokoku konjugētā vakcīna, neprecizēta | 20-walentna skoniugowana szczepionka przeciw pneumokokom, nieokreślona | Vacina pneumocócica conjugada 20-valente, não especificada | |
VAL035 | COVID-DNA-S | COVID-DNA-S | Covid-ADN-S | COVID-DNA-S | COVID-DNA-S | COVID-DNA-S | COVID-DNA-S |
VAL386 | AH5 | AH5 | AH5 | AH5 | AH5 | AH5 | AH5 |
VAC0931 | |||||||
VAL253 | eRIG | eRIG | eRIG | eRIG | eRIG | eRIG | eRIG |
VAL120 | MPV-poly | MPV-poly | MPV-poly | MPV-poly | MPV-poly | MPV-poly | MPV-poly |
VAC1078 | |||||||
VAC0050 | |||||||
VAC0051 | |||||||
VAC0184 | |||||||
VAC0099 | |||||||
VAC0848 | |||||||
VAC0714 | |||||||
VAC1164 | Quadrivalent DTPaHib- Diphtheria-Tetanus-Pertussis-Hib PRP vaccine, unspecified | ||||||
VAC0932 | Quadrivalenter rekombinanter Influenza-Impfstoff, nicht spezifiziert | Quadrivalent recombinant influenza vaccine, unspecified | Τετραδύναμο ανασυνδυασμένο εμβόλιο γρίπης, απροσδιόριστο | Kvadrivalentā rekombinantā gripas vakcīna, neprecizēta | Czterowalentna rekombinowana szczepionka przeciw grypie, nieokreślona | Vacina quadrivalente recombinante contra influenza, não especificada | |
VAC1297 | |||||||
VAC1382 | |||||||
VAC0847 | |||||||
VAL169 | COVID-mRNA-SAM | COVID-mRNA-SAM | Covid-ARNm-AAA | COVID-mRNA-SAM | COVID-mRNA-SAM | COVID-mRNA-SAM | COVID-mRNA-SAM |
VAC1031 | |||||||
VAL036 | HPV-09-valent | HPV-09-valent | VPH-09-valent | HPV-09-valent | HPV-09-valent | HPV-09-valent | HPV-09-valent |
VAL254 | Rab-I-Semple | Rab-I-Semple | Rab-I-Semple | Rab-I-Semple | Rab-I-Semple | Rab-I-Semple | Rab-I-Semple |
VAL387 | COVID-mRNA-S-OMI-JN.1-25 | Covid-ARNm-S-OMI-JN.1-25 | Covid-ARNm-S-OMI-JN.1-25 | ||||
VAL121 | POLIO-I-O | IPV-O | VPI-0 | POLIO-I-O | POLIO-I-O | POLIO-I-O | POLIO-I-O |
VAC1079 | |||||||
VAC0096 | |||||||
VAL251 | JE-I-Vero | JE-I-Vero | EJ-I-Vero | JE-I-Vero | JE-I-Vero | JE-I-Vero | JE-I-Vero |
DIS001 | Diphtherie | Diphtheria | Διφθερίτιδα | Difterija | Błonica | Difteria | |
VAC1161 | Quadrivalent DTPeP vaccine - Diphtheria-Tetanus-Pertussis-Hib PRP, unspecified | ||||||
VAC0409 | |||||||
VAC0977 | |||||||
VAC0626 | |||||||
VAC0759 | |||||||
VAC0844 | |||||||
VAC1076 | |||||||
VAC1294 | |||||||
VAL166 | INF-SUped3 | Inf-SUped3 | |||||
VAC0711 | Typhoid conjugate vaccine, unspecified | Typhoid conjugate vaccine, unspecified | Typhoid conjugate vaccine, unspecified | Typhoid conjugate vaccine, unspecified | Typhoid conjugate vaccine, unspecified | Typhoid conjugate vaccine, unspecified | |
VAL299 | MenY | MenY | MenY | MenY | MenY | MenY | MenY |
VAL033 | mOPV2 | mOPV2 | mVPO2 | mOPV2 | mOPV2 | mOPV2 | mOPV2 |
VAL384 | LEP | LEP | Lep | LEP | LEP | LEP | LEP |
VAC0097 | |||||||
VAC0628 | |||||||
VAC1380 | |||||||
VAC0845 | |||||||
VAC1077 | |||||||
VAC0627 | |||||||
VAC0712 | Typhoid-hepatitis A vaccine, unspecified | Typhoid-hepatitis A vaccine, unspecified | Typhoid-hepatitis A vaccine, unspecified | Typhoid-hepatitis A vaccine, unspecified | Typhoid-hepatitis A vaccine, unspecified | Typhoid-hepatitis A vaccine, unspecified | |
VAC1162 | COVID-19 mRNA vaccine, bivalent, original virus and Omicron BA.1 variant, 15 micrograms, unspecified | ||||||
DIS002 | Tetanus | Tetanus | Τέτανος | Stingumkrampji | Tężec | Tétano | |
VAC0978 | |||||||
VAC1295 | |||||||
VAL167 | COVID-VVnr+APC | COVID-VVnr+APC | Covid-VVnr+APC | COVID-VVnr+APC | COVID-VVnr+APC | COVID-VVnr+APC | COVID-VVnr+APC |
VAL034 | d | d | d | d | d | d | d |
VAL252 | RIG-hu | RIG-hu | hRIG | RIG-hu | RIG-hu | RIG-hu | RIG-hu |
VAC0930 | |||||||
VAL385 | AH5N8 | AH5N8 | |||||
VAC0182 | |||||||
VAC0313 | |||||||
VAC0228 | |||||||
VAL039 | COVID-VLP-rS | COVID-VLP-rS | Covid-VLP-rS | COVID-VLP-rS | COVID-VLP-rS | COVID-VLP-rS | COVID-VLP-rS |
VAL124 | Chol-L | CHOL-LA | Chol-V | Chol-L | Chol-L | Chol-L | Chol-L |
VAL257 | Rab-I-CC | Rab-I-CC | Rab-I-CC | Rab-I-CC | Rab-I-CC | Rab-I-CC | Rab-I-CC |
VAC0579 | |||||||
VAL342 | Kpn | Kpn | Kpn | Kpn | Kpn | Kpn | Kpn |
VAC0446 | |||||||
VAC0664 | |||||||
VAC0797 | Diph-T-aP/ap, unspecified | Diph-T-aP/ap, unspecified | Diph-T-aP/ap, unspecified | Diph-T-aP/ap, unspecified | Diph-T-aP/ap, unspecified | Diph-T-aP/ap, unspecified | |
VAC0531 | |||||||
VAC1426 | Bivalent recombinant vaccine against human papillomavirus (types 16 and 18) (Pichia pastoris) | ||||||
VAC0882 | |||||||
VAC1208 | Quadrivalent DTPeHepB vaccine - Diphtheria-Tetanus-Pertussis-HepatitisB 10µg, unspecified | ||||||
VAC0229 | |||||||
VAL258 | Rab-I-HDCV | Rab-I-HDCV | Rab-I-HDCV | Rab-I-HDCV | Rab-I-HDCV | Rab-I-HDCV | Rab-I-HDCV |
VAL125 | HepA-I | HepA-I | HepA-I | HepA-I | HepA-I | HepA-I | HepA-I |
VAC0447 | |||||||
VAC0798 | Hib-MeningoC vaccine, unspecified | Hib-MeningoC vaccine, unspecified | Hib-MeningoC vaccine, unspecified | Hib-MeningoC vaccine, unspecified | Hib-MeningoC vaccine, unspecified | Hib-MeningoC vaccine, unspecified | |
VAL210 | PPSV-05 | PPSV-05 | VPP-05 | PPSV-05 | PPSV-05 | PPSV-05 | PPSV-05 |
VAL343 | Efa | Efa | Efa | Efa | Efa | Efa | Efa |
VAC0532 | |||||||
VAC0665 | |||||||
VAC0883 | |||||||
VAC1209 | Measles vaccine, whole inactivated, unspecified | ||||||
VAC1427 | Whole inactivated Japanese encephalitis vaccine, prepared in Vero cells, 6 micrograms | ||||||
VAC0311 | |||||||
DIS048 | Meningokokken | Méningocoque | Μηνιγγιτιδόκοκκος | Meningokoku | Meningokok | Meningococo | |
VAC0226 | |||||||
VAC0359 | |||||||
VAC0008 | |||||||
VAL037 | MPV-A | MPV-A | MPV-A | MPV-A | MPV-A | MPV-A | MPV-A |
VAL388 | COVID-mRNA-S-OMI-JN.1-50 | Covid-ARNm-S-OMI-JN.1-50 | Covid-ARNm-S-OMI-JN.1-50 | ||||
VAL255 | Rab-I-Fuenzalida | Rab-I-Fuenzalida | Rab-I-Fuenzalida | Rab-I-Fuenzalida | Rab-I-Fuenzalida | Rab-I-Fuenzalida | Rab-I-Fuenzalida |
VAL122 | INF-SUNA3 | Inf-SUNA3 | |||||
VAC0577 | |||||||
VAL340 | Milzbrand | Anthrax | Charbon | Άνθρακας | Sibīrijas mēris | Wąglik | Antraz |
VAC0444 | |||||||
VAC0662 | |||||||
VAC1424 | 10-valent pneumococcal polysaccharide conjugate vaccine, serotypes 1, 5, 6A, 6B, 7F, 9V, 14, 19A, 19F and 23F | ||||||
VAC0880 | Pentavalenter Diphtherie-Tetanus-Pertussis-Hib-Polio-Impfstoff (DTPerHibIPV), nicht spezifiziert | Pentavalent Diphtheria-Tetanus-Pertussis-Hib-Polio (DTPerHibIPV) vaccine, unspecified | Πενταδύναμο εμβόλιο διφθερίτιδας-τετάνου-κοκκύτη-Hib-πολυομυελίτιδας (DTPerHibIPV), μη καθορισμένο | Pentavalentā difterijas-stingumkrampju-garā klepus-Hib-polio (DTPerHibIPV) vakcīna, neprecizēta | Pentawalentna szczepionka przeciwko błonicy, tężcowi, krztuścowi, Hib-Polio (DTPerHibIPV), nieokreślona | Vacina pentavalente contra difteria-tétano-coqueluche-Hib-poliomielite (DTPerHibIPV), não especificada | |
VAC0795 | Acellular pertussis vaccine, unspecified | Acellular pertussis vaccine, unspecified | Acellular pertussis vaccine, unspecified | Acellular pertussis vaccine, unspecified | Acellular pertussis vaccine, unspecified | Acellular pertussis vaccine, unspecified | |
VAC1206 | COVID-19 vaccine with self-amplifying mRNA, unspecified | ||||||
VAC1339 | |||||||
VAC0312 | |||||||
VAC0227 | |||||||
VAC0009 | |||||||
DIS047 | Meningokokken Y | Meningococcal Y | Μηνιγγιτιδόκοκκος Υ | Meningokoks Y | Meningokok Y | Meningococo Y | |
VAL038 | COVID-VVr-S-Meas | COVID-VVr-S-Meas | Covid-VVr-S-Roug | COVID-VVr-S-Meas | COVID-VVr-S-Meas | COVID-VVr-S-Meas | COVID-VVr-S-Meas |
VAL256 | Rab-I-NervousTissue | Rab-I-NervousTissue | Rab-I-TissuNerveux | Rab-I-NervousTissue | Rab-I-NervousTissue | Rab-I-NervousTissue | Rab-I-NervousTissue |
VAL389 | PAER7 | PAER7 | PAER7 | PAER7 | PAER7 | PAER7 | PAER7 |
VAL123 | Rota5-L | Rota5-L | Rota5-V | Rota5-L | Rota5-L | Rota5-L | Rota5-L |
VAC0578 | |||||||
VAC0796 | Pertussis vaccine, unspecified | Pertussis vaccine, unspecified | Pertussis vaccine, unspecified | Pertussis vaccine, unspecified | Pertussis vaccine, unspecified | Pertussis vaccine, unspecified | |
VAC0445 | |||||||
VAL341 | Eco | Eco | Eco | Eco | Eco | Eco | Eco |
VAC0881 | Abgeschwächter Lebendimpfstoff gegen Japanische Enzephalitis, nicht näher bezeichnet | Live attenuated Japanese Encephalitis vaccine, unspecified | Ζωντανό εξασθενημένο εμβόλιο Ιαπωνικής Εγκεφαλίτιδας, απροσδιόριστο | Dzīva novājināta Japānas encefalīta vakcīna, neprecizēta | Żywa, atenuowana szczepionka przeciwko japońskiemu zapaleniu mózgu, nieokreślona | Vacina viva atenuada contra encefalite japonesa, não especificada | |
VAC0663 | |||||||
VAC0530 | |||||||
VAC1425 | Typhoid vaccine, Vi antigen conjugated to CRM197 protein | ||||||
VAC1207 | COVID-19 vaccine with replicative viral vector, Newcastle disease virus encoding the SARS-CoV-2 spike protein, unspecified | ||||||
VAC0317 | |||||||
DIS046 | Meningokokken W | Meningococcal W | Μηνιγγιτιδόκοκκος W | Meningokoku W | Meningokok W | Meningococo W | |
VAC1070 | |||||||
VAL346 | EV71 | EV71 | |||||
VAL213 | PPSV-08 | PPSV-08 | VPP-08 | PPSV-08 | PPSV-08 | PPSV-08 | PPSV-08 |
VAC0668 | |||||||
VAC0535 | |||||||
VAC0620 | |||||||
VAC0753 | |||||||
VAC0886 | |||||||
VAC0971 | |||||||
VAC0090 | |||||||
VAL128 | Inf | INF | Inf | Inf | Inf | Inf | Inf |
DIS045 | Meningokokken B | Meningococcal B | Μηνιγγιτιδόκοκκος Β | Meningokoks B | Meningokok B | Meningococo B | |
VAC0318 | |||||||
VAC1071 | RSV-antistof eller -vaccine, uspecificeret | RSV antibody or vaccine, unspecified | Αντίσωμα ή εμβόλιο RSV, απροσδιόριστο | RSV antiviela vai vakcīna, neprecizēta | Przeciwciało lub szczepionka przeciwko wirusowi RSV, nieokreślone | Anticorpo ou vacina contra RSV, não especificado | |
VAL214 | PPSV-09N | PPSV-09N | VPP-09N | PPSV-09N | PPSV-09N | PPSV-09N | PPSV-09N |
VAL347 | Lepto-ca | Lepto-ca | |||||
VAC0669 | |||||||
VAC0754 | |||||||
VAC0403 | |||||||
VAC0972 | |||||||
DIS008 | Masern | Measles | Ιλαρά | Masalas | Odra | Sarampo | |
VAC0887 | |||||||
VAC0621 | |||||||
VAC0091 | |||||||
VAL129 | HSV | HSV | HSV | HSV | HSV | HSV | HSV |
VAC0315 | |||||||
DIS044 | Meningokokken A | Meningococcal A | Μηνιγγιτιδόκοκκος Α | Meningokoks A | Meningokok A | Meningococo A | |
VAL259 | Rab-I-PCEC | Rab-I-PCEC | Rab-I-PCEC | Rab-I-PCEC | Rab-I-PCEC | Rab-I-PCEC | Rab-I-PCEC |
VAL126 | Ebola | Ebola | Ebola | Ebola | Ebola | Ebola | Ebola |
VAL344 | Pvu | Pvu | Pvu | Pvu | Pvu | Pvu | Pvu |
VAC0448 | |||||||
DIS043 | Meningococcus C | Meningococcal C | Μηνιγγιτιδόκοκκος C | Meningokoks C | Meningokoki C | Meningococo C | |
VAC0666 | |||||||
DIS009 | Mumps | Mumps | Παρωτίτιδα | Epidēmiskais parotīts | Świnka | Parotidite epidémica | |
VAL211 | PPSV-06B | PPSV-06B | VPP-06B | PPSV-06B | PPSV-06B | PPSV-06B | PPSV-06B |
VAC0884 | |||||||
VAC0799 | DT-Hib vaccine, unspecified | DT-Hib vaccine, unspecified | DT-Hib vaccine, unspecified | DT-Hib vaccine, unspecified | DT-Hib vaccine, unspecified | DT-Hib vaccine, unspecified | |
VAC0400 | |||||||
VAC1428 | COVID-19 vaccine, protein subunit, recombinant homodimeric RBD protein, Omicron variant XBB.1.16, with adjuvant (SQBA) | ||||||
VAL127 | INF-SUimsc4 | Inf-SUimsc4 | |||||
VAC0449 | |||||||
DIS042 | Exanthematischer Typhus | Exanthematous typhus | Εξανθηματώδης τύφος | Eksantēmisks tīfs | Tyfus wysypkowy | tifo exantematoso | |
VAL212 | PPSV-07F | PPSV-07F | VPP-07F | PPSV-07F | PPSV-07F | PPSV-07F | PPSV-07F |
VAL345 | UTI | UTI | UTI | UTI | UTI | UTI | UTI |
VAC0885 | |||||||
VAC0534 | |||||||
VAC0667 | |||||||
VAC0401 | |||||||
VAC0752 | |||||||
VAC0970 | |||||||
VAC1429 | |||||||
VAC0220 | |||||||
VAC0353 | |||||||
VAC0135 | Polio vaccine, unspecified | Polio vaccine, unspecified | Polio vaccine, unspecified | Polio vaccine, unspecified | Polio vaccine, unspecified | Polio vaccine, unspecified | |
VAC0002 | |||||||
VAC0268 | |||||||
VAL302 | Covid-mRNA-S-50 | COVID-mRNA-S-ORI-50 | Covid-ARNm-S-ORI-50 | COVID-mRNA-S-ORI-50 | Covid-mRNA-S-50 | Covid-mRNA-S-50 | Covid-mRNA-S-50 |
VAC1333 | |||||||
VAC1200 | Quadrivalent influenza vaccine, on cell culture, unspecified | ||||||
VAC0486 | |||||||
VAC1115 | Pentavalent vaccine DTPaHibP - Diphtheria-Tetanus-Pertussis-Hib PRP-Polio, unspecified | ||||||
VAC1248 | Influenza/Covid 19 mRNA vaccine, unspecified | ||||||
VAL217 | PPSV-11A | PPSV-11A | VPP-11A | PPSV-11A | PPSV-11A | PPSV-11A | PPSV-11A |
VAC0003 | |||||||
VAC0354 | |||||||
VAC0136 | DTwP - Diphtheria-Tetanus-Pertussis, unspecified | DTwP - Diphtheria-Tetanus-Pertussis, unspecified | DTwP - Diphtheria-Tetanus-Pertussis, unspecified | DTwP - Diphtheria-Tetanus-Pertussis, unspecified | DTwP - Diphtheria-Tetanus-Pertussis, unspecified | DTwP - Diphtheria-Tetanus-Pertussis, unspecified | |
VAL303 | Covid-ARNm-S-ORI | COVID-mRNA-S-ORI | Covid-ARNm-S-ORI | COVID-mRNA-S-ORI | COVID-mRNA-S-ORI | COVID-mRNA-S-ORI | COVID-mRNA-S-ORI |
VAC1201 | Tetravalent Dengue vaccine, live attenuated chimeric recombinant based on 17D yellow fever vaccine, unspecified | ||||||
VAC1334 | |||||||
VAC0487 | |||||||
VAC1249 | Flu vaccine, trivalent inactivated, high dose, intradermal use, unspecified | ||||||
VAC1116 | Rabies vaccine, whole inactivated, prepared in Vero cell culture, unspecified | ||||||
VAC0790 | Diphtheria-Tetanus-Hepatitis B vaccine, unspecified | Diphtheria-Tetanus-Hepatitis B vaccine, unspecified | Diphtheria-Tetanus-Hepatitis B vaccine, unspecified | Diphtheria-Tetanus-Hepatitis B vaccine, unspecified | Diphtheria-Tetanus-Hepatitis B vaccine, unspecified | Diphtheria-Tetanus-Hepatitis B vaccine, unspecified | |
VAL218 | PPSV-12F | PPSV-12F | VPP-12F | PPSV-12F | PPSV-12F | PPSV-12F | PPSV-12F |
VAC0351 | |||||||
VAC0133 | Smallpox vaccine, unspecified | Smallpox vaccine, unspecified | Smallpox vaccine, unspecified | Smallpox vaccine, unspecified | Smallpox vaccine, unspecified | Smallpox vaccine, unspecified | |
VAC0266 | |||||||
VAC0399 | |||||||
VAC0048 | |||||||
VAL215 | PPSV-09V | PPSV-09V | VPP-09V | PPSV-09V | PPSV-09V | PPSV-09V | PPSV-09V |
VAL300 | MenW | MenW | MenW | MenW | MenW | MenW | MenW |
VAC1113 | COVID-19 protein subunit vaccine, recombinant spike protein, unspecified | ||||||
VAC1246 | |||||||
VAC1331 | |||||||
VAC1379 | |||||||
VAC1028 | |||||||
VAC0484 | |||||||
VAL348 | Lepto-po | Lepto-po | |||||
VAC0352 | |||||||
VAC0001 | |||||||
VAC0134 | BCG vaccine, unspecified | BCG vaccine, unspecified | BCG vaccine, unspecified | BCG vaccine, unspecified | BCG vaccine, unspecified | BCG vaccine, unspecified | |
VAC0267 | |||||||
VAC0049 | |||||||
VAL301 | Rekombinanter trivalenter Impfstoff gegen Influenza | INF-R3 | Inf-R3 | Ανασυνδυασμένο τρισθενές εμβόλιο γρίπης | Rekombinantā trivalentā gripas vakcīna | Rekombinowana trójwartościowa szczepionka przeciw grypie | Vacina trivalente contra a gripe recombinante |
VAC1114 | Vaccine against typhoid fever and hepatitis A, unspecified | ||||||
VAC1332 | |||||||
VAC1029 | |||||||
VAC0485 | |||||||
VAC1247 | Hepatitis-A-Impfstoff, nicht näher bezeichnet | Hepatitis A vaccine, unspecified | |||||
VAC0570 | |||||||
VAL216 | PPSV-10A | PPSV-10A | VPP-10A | PPSV-10A | PPSV-10A | PPSV-10A | PPSV-10A |
VAL349 | INF-SUAnd3 | Inf-SUAnd3 | |||||
VAC0224 | |||||||
VAC0357 | |||||||
VAC0139 | |||||||
VAC0006 | |||||||
VAC1422 | COVID-19 protein subunit vaccine, recombinant N protein | ||||||
VAC0575 | |||||||
VAC1337 | |||||||
VAC0442 | |||||||
VAC0660 | |||||||
VAC0793 | |||||||
VAC1204 | COVID-19 protein subunit vaccine, recombinant spike protein, with adjuvant, unspecified | ||||||
VAL306 | Covid-ARNm-S-ORI-3 | COVID-mRNA-S-ORI-3 | Covid-ARNm-S-ORI-3 | COVID-mRNA-S-ORI-3 | COVID-mRNA-S-ORI-3 | COVID-mRNA-S-ORI-3 | COVID-mRNA-S-ORI-3 |
VAC1119 | COVID-19 inactivated vaccine, whole virus, authorized, unspecified | ||||||
VAC0310 | |||||||
VAC0225 | |||||||
VAC0007 | |||||||
VAC0358 | Rabies immunoglobulin human origin, unspecified | Rabies immunoglobulin human origin, unspecified | Rabies immunoglobulin human origin, unspecified | Rabies immunoglobulin human origin, unspecified | Rabies immunoglobulin human origin, unspecified | Rabies immunoglobulin human origin, unspecified | |
VAL080 | Rab-I | Rab-I | Rab-I | Rab-I | Rab-I | Rab-I | Rab-I |
VAC0576 | |||||||
VAC0443 | |||||||
VAC0794 | T-igT, unspecified | T-igT, unspecified | T-igT, unspecified | T-igT, unspecified | T-igT, unspecified | T-igT, unspecified | |
VAC1205 | Ebola virus vaccine, recombinant live non-replicating viral vector Ad26.ZEBOV, unspecified | ||||||
VAC1338 | |||||||
VAC1423 | Live attenuated influenza A(H1N1)pdm09 pandemic vaccine | ||||||
VAC0661 | |||||||
VAL307 | Covid-ARNm-S-OMI-BA.4/5-15 | COVID-mRNA-S-OMI-BA.4/5-15 | Covid-ARNm-S-OMI-BA.4/5-15 | COVID-mRNA-S-OMI-BA.4/5-15 | COVID-mRNA-S-OMI-BA.4/5-15 | COVID-mRNA-S-OMI-BA.4/5-15 | COVID-mRNA-S-OMI-BA.4/5-15 |
VAC0222 | |||||||
VAC0355 | |||||||
VAC0137 | DT vaccine, unspecified | DT vaccine, unspecified | DT vaccine, unspecified | DT vaccine, unspecified | DT vaccine, unspecified | DT vaccine, unspecified | |
VAC0004 | |||||||
VAC1420 | Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation | ||||||
VAC1202 | COVID-19 vaccine with live attenuated virus, unspecified | ||||||
VAC0488 | |||||||
VAC1117 | COVID-19 bivalent mRNA vaccine against the original virus and the Omicron BA.4/5 variant, 5 micrograms, unspecified | ||||||
VAC0573 | |||||||
VAC1335 | |||||||
VAL219 | PPSV-14 | PPSV-14 | VPP-14 | PPSV-14 | PPSV-14 | PPSV-14 | PPSV-14 |
VAC0791 | Hexavalenter Diphtherie-Tetanus-Pertussis-Polio-Hib-Hepatitis B-Impfstoff, nicht spezifiziert | Hexavalent vaccine DTPerHibPHepB - Diphtheria-Tetanus-Pertussis-Polio-Hib-Hepatitis B vaccine, unspecified | Εξασθενές εμβόλιο διφθερίτιδας-τετάνου-κοκκύτη-πολιο-χιμπ-ηπατίτιδας Β, ακαθόριστο | Heksavalentā difterijas-Tetanus-Pertuss-Polio-Hib-Hepatīta B vakcīna, neprecizēta | Hexavalent Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B-Hib vaccine, unspecified | Hexavalent Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B-Hib vaccine, unspecified | |
VAL304 | Covid-ARNm-S-ORI-15 | COVID-mRNA-S-ORI-15 | Covid-ARNm-S-ORI-15 | Covid-ARNm-S-ORI-15 | Covid-ARNm-S-ORI-15 | Covid-ARNm-S-ORI-15 | Covid-ARNm-S-ORI-15 |
VAC0223 | |||||||
VAC0356 | |||||||
VAC0005 | |||||||
VAC0138 | Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified | |
VAC0489 | |||||||
VAC1421 | COVID-19 vaccine, mRNA encoding the SARS-CoV-2 spike protein, original virus | ||||||
VAC0574 | |||||||
VAC1118 | Enterovirus A71 vaccine, unspecified | ||||||
VAC0792 | Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine, unspecified | |
VAC0441 | |||||||
VAC1203 | Brucellosis vaccine, protein (P.I. antigen) | ||||||
VAC1336 | |||||||
VAL305 | Covid-ARNm-S-OMI-BA.1-15 | COVID-mRNA-S-OMI-BA.1-15 | Covid-ARNm-S-OMI-BA.1-15 | COVID-mRNA-S-OMI-BA.1-15 | COVID-mRNA-S-OMI-BA.1-15 | Covid-ARNm-S-OMI-BA.1-15 | Covid-ARNm-S-OMI-BA.1-15 |
VAC0260 | |||||||
VAC0393 | |||||||
VAC0175 | |||||||
VAC0042 | |||||||
VAL083 | D-d | D-d | D-d | D-d | D-d | D-d | D-d |
VAC0706 | |||||||
VAC0839 | Inactivated whole-cell brucella vaccine, unspecified | Inactivated whole-cell brucella vaccine, unspecified | Inactivated whole-cell brucella vaccine, unspecified | Inactivated whole-cell brucella vaccine, unspecified | Inactivated whole-cell brucella vaccine, unspecified | Inactivated whole-cell brucella vaccine, unspecified | |
VAC1022 | |||||||
VAC0923 | Monoklonaler Antikörper gegen das Respiratory Syncytial Virus, nicht spezifiziert | Respiratory Syncytial Virus monoclonal antibody, unspecified | Μονόκλωνο αντίσωμα αναπνευστικού συγκυτιακού ιού, απροσδιόριστο | Elpceļu sincitiālā vīrusa monoklonāla antiviela, neprecizēta | Przeciwciało monoklonalne przeciwko wirusowi syncytialnemu układu oddechowego, nieokreślone | Anticorpo monoclonal do vírus sincicial respiratório, não especificado | |
VAC1240 | 4-component meningococcal B vaccine, unspecified | ||||||
VAC1373 | |||||||
VAC1155 | Plasma hepatitis B vaccine, unspecified | ||||||
VAC1288 | |||||||
VAC0261 | |||||||
VAC0394 | |||||||
VAC0043 | |||||||
VAC0176 | |||||||
VAL084 | COVID-VVr-S-VSV | COVID-VVr-S-VSV | Covid-VVr-S-VSV | COVID-VVr-S-VSV | COVID-VVr-S-VSV | COVID-VVr-S-VSV | COVID-VVr-S-VSV |
VAC0707 | |||||||
VAC0925 | Trivalenter inaktivierter Grippeimpfstoff, nicht näher bezeichnet | Trivalent inactivated influenza vaccine, unspecified | Τριδύναμο αδρανοποιημένο εμβόλιο γρίπης, απροσδιόριστο | Trīsvērtīgā inaktivēta gripas vakcīna, neprecizēta | Trójwalentna inaktywowana szczepionka przeciw grypie, nieokreślona | Vacina trivalente inativada contra influenza, não especificada | |
VAC1241 | Shingles vaccine, varicella-zoster virus (VZV) surface glycoprotein E (gE), unspecified | ||||||
VAC0924 | |||||||
VAC1374 | |||||||
VAC1289 | |||||||
VAC1023 | |||||||
VAC1156 | Immunoglobulin against botulism, unspecified | ||||||
VAC0040 | |||||||
VAC0173 | |||||||
VAC0088 | DTIPV vaccine, unspecified | DTIPV vaccine, unspecified | DTIPV vaccine, unspecified | DTIPV vaccine, unspecified | DTIPV vaccine, unspecified | DTIPV vaccine, unspecified | |
VAL081 | Chol | CHOL | Chol | Chol | Chol | Chol | Chol |
VAC0837 | |||||||
VAC0703 | |||||||
VAC1153 | Quadrivalent meningococcal ACWY vaccine, diphtheria toxoid conjugate, unspecified | ||||||
VAC0921 | Impfstoff gegen Japanische Enzephalitis, nicht näher bezeichnet | Japanese encephalitis vaccine, unspecified | Ιαπωνικό εμβόλιο εγκεφαλίτιδας, απροσδιόριστο | Japānas encefalīta vakcīna, neprecizēta | Szczepionka przeciwko japońskiemu zapaleniu mózgu, nieokreślona | Vacina contra encefalite japonesa, não especificada | |
VAC1286 | |||||||
VAC1371 | |||||||
VAC0836 | |||||||
VAC1020 | |||||||
VAC1068 | Impfstoff gegen Rift-Valley-Fieber, nicht näher bezeichnet | Rift Valley fever vaccine, unspecified | Εμβόλιο κατά του πυρετού Rift Valley, απροσδιόριστο | Rifta ielejas drudža vakcīna, neprecizēta | Szczepionka na gorączkę Doliny Rift, nieokreślona | Vacina contra a febre do Vale do Rift, não especificada | |
VAL308 | Covid-ARNm-S-OMI-BA.4/5-25 | COVID-mRNA-S-OMI-BA.4/5-25 | Covid-ARNm-S-OMI-BA.4/5-25 | COVID-mRNA-S-OMI-BA.4/5-25 | COVID-mRNA-S-OMI-BA.4/5-25 | COVID-mRNA-S-OMI-BA.4/5-25 | COVID-mRNA-S-OMI-BA.4/5-25 |
VAC0391 | |||||||
VAC0392 | |||||||
VAC0041 | |||||||
VAC0174 | |||||||
VAL082 | HPV | HPV | VPH | HPV | HPV | HPV | HPV |
VAC0838 | |||||||
VAC0705 | |||||||
VAC0922 | Abgeschwächter Adenovirus-Lebendimpfstoff, Typ 4 und Typ 7, oral | Live attenuated adenovirus vaccine, type 4 and type 7, oral | Εμβόλιο ζωντανού εξασθενημένου αδενοϊού, τύπου 4 και τύπου 7, από του στόματος | Dzīva novājināta adenovīrusa vakcīna, 4. un 7. tipa, perorāla | Żywa, atenuowana szczepionka adenowirusowa typu 4 i typu 7, doustna | Vacina de adenovírus vivo atenuado, tipo 4 e tipo 7, oral | |
VAC1372 | |||||||
VAC1021 | |||||||
VAC1154 | Whole inactivated mumps vaccine, unspecified | ||||||
VAC1069 | Vaccinia immune globulin | Vaccinia immune globulin | Vaccinia immune globulin | Vaccinia immune globulin | Vaccinia immune globulin | Vaccinia immune globulin | |
VAC1287 | |||||||
VAL309 | Covid-ARNm-S-OMI-BA.4/5-5 | COVID-mRNA-S-OMI-BA.4/5-5 | Covid-ARNm-S-OMI-BA.4/5-5 | Covid-ARNm-S-OMI-BA.4/5-5 | Covid-ARNm-S-OMI-BA.4/5-5 | Covid-ARNm-S-OMI-BA.4/5-5 | Covid-ARNm-S-OMI-BA.4/5-5 |
VAC0131 | Rabies vaccine, unspecified | Rabies vaccine, unspecified | Rabies vaccine, unspecified | Rabies vaccine, unspecified | Rabies vaccine, unspecified | Rabies vaccine, unspecified | |
VAC0264 | |||||||
VAC0397 | |||||||
VAC0046 | |||||||
VAC0179 | |||||||
VAL172 | Cbur | Cbur | Cbur | Cbur | Cbur | Cbur | Cbur |
VAL390 | CHIK | CHIK | CHIK | CHIK | CHIK | CHIK | CHIK |
VAC0928 | Lebendimpfstoff gegen Hepatitis A, nicht näher bezeichnet | Live attenuated Hepatitis A vaccine, unspecified | Ζωντανό εξασθενημένο εμβόλιο ηπατίτιδας Α, απροσδιόριστο | Dzīva novājināta A hepatīta vakcīna, neprecizēta | Żywa, atenuowana szczepionka przeciwko wirusowemu zapaleniu wątroby typu A, nieokreślona | Vacina viva atenuada contra hepatite A, não especificada | |
VAC1026 | |||||||
VAC1111 | Japanese Encephalitis Vaccine, whole inactivated, prepared on Vero cells, unspecified | ||||||
VAL087 | CYD-TDV | CYD-TDV | CYD-TDV | CYD-TDV | CYD-TDV | CYD-TDV | CYD-TDV |
VAC1244 | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron XBB.1.5 variant, 30 micrograms | ||||||
VAC1377 | |||||||
VAC1159 | Recombinant trivalent influenza vaccine, unspecified | ||||||
VAC0482 | |||||||
VAC0350 | |||||||
VAC0265 | |||||||
VAC0132 | Tetanus vaccine, unspecified | Tetanus vaccine, unspecified | Tetanus vaccine, unspecified | Tetanus vaccine, unspecified | Tetanus vaccine, unspecified | Tetanus vaccine, unspecified | |
VAC0398 | |||||||
VAC0047 | |||||||
VAC0929 | Quadrivalenter inaktivierter Influenza-Impfstoff, pädiatrische Dosis, nicht spezifiziert | Influenza quadrivalent inactivated vaccine, pediatric dose, unspecified | Τετραδύναμο αδρανοποιημένο εμβόλιο κατά της γρίπης, παιδιατρική δόση, απροσδιόριστη | Gripas četrvērtīgā inaktivētā vakcīna, pediatriskā deva, neprecizēta | Czterowalentna inaktywowana szczepionka przeciw grypie, dawka pediatryczna, nieokreślona | Vacina influenza quadrivalente inativada, dose pediátrica, não especificada | |
VAL173 | Junin-LAV | Junin-LA | Junin-VVA | Junin-LAV | Junin-LAV | Junin-LAV | Junin-LAV |
VAL040 | INF-SUnd4 | Inf-SUnd4 | |||||
VAL391 | Chik-VLP | Chik-VLP | Chik-VLP | Chik-VLP | Chik-VLP | Chik-VLP | Chik-VLP |
VAC1330 | |||||||
VAC1245 | ABCWY meningococcal vaccine, unspecified | ||||||
VAL088 | VZV-Ig | VZV-Ig | VZV-Ig | VZV-Ig | VZV-Ig | VZV-Ig | VZV-Ig |
VAC1378 | |||||||
VAC1112 | Live attenuated quadrivalent influenza vaccine, unspecified | ||||||
VAC1027 | |||||||
VAC0483 | |||||||
VAC0262 | |||||||
VAC0395 | |||||||
VAC0044 | |||||||
VAC0177 | |||||||
VAL085 | mOPV3 | mOPV3 | mVPO3 | mOPV3 | mOPV3 | mOPV3 | mOPV3 |
VAL170 | rHepB-05 | rHepB-05 | rAgHBs-05 | rHepB-05 | rHepB-05 | rHepB-05 | rHepB-05 |
VAC0926 | |||||||
VAC0708 | |||||||
VAC1242 | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron XBB.1.5 variant, 25 micrograms | ||||||
VAC1157 | 3rd generation smallpox vaccine, modified Ankara vaccinia virus, unspecified | ||||||
VAC1375 | |||||||
VAC1024 | |||||||
VAC0480 | |||||||
VAC0263 | |||||||
VAC0130 | MMR vaccine, unspecified | MMR vaccine, live attenuated, unspecified | MMR vaccine, unspecified | MMR vaccine, unspecified | MMR vaccine, unspecified | MMR vaccine, unspecified | |
VAC0045 | |||||||
VAC0396 | |||||||
VAC0178 | |||||||
VAL086 | COVID-LA | COVID-LA | Covid-VA | COVID-LA | COVID-LA | COVID-LA | COVID-LA |
VAC0709 | |||||||
VAL171 | VEE | VEE | VEE | VEE | VEE | VEE | VEE |
VAC0927 | COVID-19-mRNA-Impfstoff, pädiatrische Dosis, nicht spezifiziert | COVID-19 mRNA vaccine, paediatric dose, unspecified | Εμβόλιο mRNA COVID-19, παιδιατρική δόση, απροσδιόριστη | Covid-19 mRNS vakcīna, pediatriskā deva, nav precizēta | Szczepionka mRNA przeciwko COVID-19, dawka pediatryczna, nieokreślona | Vacina de mRNA contra a COVID-19, dose pediátrica, não especificada | |
VAC1110 | Meningococcal C vaccine unconjugated, unspecified | ||||||
VAC1376 | |||||||
VAC1025 | |||||||
VAC1158 | COVID-19 mRNA vaccine against the Omicron XBB.1.5 variant, 3 micrograms, unspecified | ||||||
VAC1243 | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron XBB.1.5 variant, 50 micrograms | ||||||
VAC0481 | |||||||
VAL261 | Rab-I-PHKCV | Rab-I-PHKCV | Rab-I-PHKCV | Rab-I-PHKCV | Rab-I-PHKCV | Rab-I-PHKCV | Rab-I-PHKCV |
VAL394 | COVID-mRNA-S-OMI-BA.4/5 | Covid-ARNm-S-OMI-BA.4/5 | |||||
VAC1171 | Inactivated trivalent influenza vaccine, high dose, unspecified | ||||||
VAC0419 | |||||||
VAC0769 | |||||||
VAC0418 | |||||||
VAC0987 | |||||||
DIS053 | Lyme-borreliose | Lyme disease | Η νόσος του Lyme | Laima slimība | Borelioza | Doença de lyme | |
VAC1086 | |||||||
VAC0503 | Rabies immunoglobulin equine origin, unspecified | Rabies immunoglobulin equine origin, unspecified | Rabies immunoglobulin equine origin, unspecified | Rabies immunoglobulin equine origin, unspecified | Rabies immunoglobulin equine origin, unspecified | Rabies immunoglobulin equine origin, unspecified | |
VAC0636 | |||||||
VAC0721 | |||||||
VAL176 | HPIVs | HPIVs | VPIH | HPIVs | HPIVs | HPIVs | HPIVs |
VAC0854 | mOPV3 Sabin monovalenter oraler Polioimpfstoff Typ 3, nicht spezifiziert | mOPV3 Sabin monovalent oral polio vaccine type 3, unspecified | mOPV3 Sabin μονοσθενές από του στόματος εμβόλιο πολιομυελίτιδας τύπου 3, απροσδιόριστο | mOPV3 Sabin monovalentā perorālā poliomielīta vakcīna, 3. tips, neprecizēta | mOPV3 Sabin, monowalentna doustna szczepionka przeciw polio typu 3, nieokreślona | Vacina monovalente oral contra poliomielite mOPV3 Sabin tipo 3, não especificada | |
VAL043 | COVID-mRNA-S | COVID-mRNA-S | Covid-ARNm-S | COVID-mRNA-S | COVID-mRNA-S | COVID-mRNA-S | COVID-mRNA-S |
VAC0191 | |||||||
VAL262 | Rab-I-EEV | Rab-I-EEV | Rab-I-VOE | Rab-I-EEV | Rab-I-EEV | Rab-I-EEV | Rab-I-EEV |
VAC1390 | |||||||
VAC1172 | Diphtheria toxoid, reduced dose, unspecified | ||||||
VAC0988 | |||||||
VAC0637 | |||||||
VAC0855 | Diphtherie-Tetanus-Polio-Impfstoff, nicht näher bezeichnet | Diphtheria-Tetanus-Polio vaccine, unspecified | Εμβόλιο διφθερίτιδας-τετάνου-πολυομυελίτιδας, απροσδιόριστο | Difterijas-stingumkrampju-poliomielīta vakcīna, neprecizēta | Szczepionka przeciw błonicy, tężcowi i polio, nieokreślona | Vacina contra difteria, tétano e poliomielite, não especificada | |
DIS052 | Botulismus | Botulism | Δηλητηρίαση από ακάθαρτη τροφή | Botulisms | Zatrucie jadem kiełbasianym | Botulismo | |
VAC1087 | |||||||
VAC0504 | |||||||
VAC0940 | |||||||
VAC0722 | |||||||
VAL177 | Hib | Hib | Hib | Hib | Hib | Hib | Hib |
VAL044 | VZV-LAV | VZV-LA | VZV-VVA | VZV-LAV | VZV-LAV | VZV-LAV | VZV-LAV |
VAL395 | COVID-mRNA-S-OMI-JN.1 | Covid-ARNm-S-OMI-JN.1 | |||||
VAC0192 | |||||||
VAL174 | HAN | HAN | HAN | HAN | HAN | HAN | HAN |
VAL041 | MCV-A | MCV-A | MCV-A | MCV-A | MCV-A | MCV-A | MCV-A |
VAL392 | AH5N1-RNA | AH5N1-RNA | AH5N1-ARN | AH5N1-RNA | AH5N1-RNA | AH5N1-RNA | AH5N1-RNA |
VAC1084 | |||||||
DIS051 | Milzbrand | Anthrax | Ανθρακας | Sibīrijas mēris | Wąglik | Carbúnculo | |
VAC0549 | dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified | dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified | dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified | dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified | dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified | dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified | |
VAC0416 | |||||||
VAC0767 | |||||||
VAC0852 | mOPV2 Sabin monovalenter oraler Polioimpfstoff Typ 2, nicht spezifiziert | mOPV2 Sabin monovalent oral polio vaccine type 2, unspecified | mOPV2 Sabin μονοσθενές από του στόματος εμβόλιο πολιομυελίτιδας τύπου 2, απροσδιόριστο | mOPV2 Sabin monovalentā perorālā poliomielīta vakcīna, 2. tips, neprecizēta | mOPV2 Sabin, monowalentna doustna szczepionka przeciw polio typu 2, nieokreślona | Vacina monovalente oral contra poliomielite mOPV2 Sabin tipo 2, não especificada | |
VAL089 | JE-I | JE-I | EJ-I | JE-I | JE-I | JE-I | JE-I |
VAC0634 | |||||||
VAC0501 | |||||||
VAC0985 | |||||||
VAL042 | POLIO | POLIO | POLIO | POLIO | POLIO | POLIO | POLIO |
VAL393 | COVID-mRNA-S-OMI-BA.1 | Covid-ARNm-S-OMI-BA.1 | |||||
VAL260 | Rab-I-PVRV | Rab-I-PVRV | Rab-I-PVRV | Rab-I-PVRV | Rab-I-PVRV | Rab-I-PVRV | Rab-I-PVRV |
VAC1170 | Non-replicating viral vector COVID-19 vaccine, chimpanzee adenovirus ChadOx1 encoding the SARS-CoV-2 spike protein | ||||||
VAC0417 | |||||||
VAC0635 | |||||||
VAC0768 | |||||||
VAC1085 | |||||||
VAC0502 | Rabies immunoglobulin, unspecified | Rabies immunoglobulin, unspecified | Rabies immunoglobulin, unspecified | Rabies immunoglobulin, unspecified | Rabies immunoglobulin, unspecified | Rabies immunoglobulin, unspecified | |
VAC0986 | |||||||
VAL175 | Leish | Leish | Leish | Leish | Leish | Leish | Leish |
DIS050 | Geflügelpest | Avian influenza | Γρίπη των πτηνών | Putnu gripa | Ptasia grypa | Gripe aviária | |
VAC0853 | mOPV1 Sabin monovalenter oraler Polioimpfstoff Typ 1, nicht spezifiziert | mOPV1 Sabin monovalent oral polio vaccine type 1, unspecified | mOPV1 Sabin μονοσθενές από του στόματος εμβόλιο πολιομυελίτιδας τύπου 1, απροσδιόριστο | mOPV1 Sabin monovalentā perorālā poliomielīta vakcīna, 1. tips, neprecizēta | mOPV1 Sabin, monowalentna doustna szczepionka przeciw polio typu 1, nieokreślona | Vacina monovalente oral contra poliomielite mOPV1 Sabin tipo 1, não especificada | |
VAC0720 | |||||||
VAC0190 | |||||||
VAC0195 | |||||||
VAC0062 | |||||||
VAL350 | INF-SUAnd4 | Inf-SUAnd4 | |||||
VAC0859 | Vierwertiger HPV-Impfstoff, nicht näher bezeichnet | HPV vaccine quadrivalent, unspecified | Εμβόλιο HPV τετραδύναμο, απροσδιόριστο | HPV vakcīnas četrvērtīgā, neprecizēta | Szczepionka przeciwko HPV czterowalentna, nieokreślona | Vacina contra HPV quadrivalente, não especificada | |
VAC1260 | |||||||
VAC0508 | |||||||
VAC0725 | |||||||
VAC1175 | Inactivated trivalent influenza vaccine cell culture, normal dose, unspecified | ||||||
VAC0943 | Diploide Zellen des Tollwutimpfstoffs, nicht näher bezeichnet | Rabies vaccine diploid cells, unspecified | Διπλοειδή κύτταρα αντιλυσσικού εμβολίου, απροσδιόριστα | Trakumsērgas vakcīnas diploīdās šūnas, neprecizētas | RabKomórki diploidalne szczepionki przeciw wściekliźnie, nieokreślone | Células diplóides da vacina contra a raiva, não especificadas | |
VAC1393 | |||||||
VAC0858 | Bivalenter HPV-Impfstoff, nicht spezifiziert | HPV vaccine bivalent, unspecified | Εμβόλιο HPV δισθενές, απροσδιόριστο | HPV vakcīna divvērtīgā, neprecizēta | Szczepionka przeciw HPV dwuwalentna, nieokreślona | Vacina contra HPV bivalente, não especificada | |
VAC1042 | COVID-19-Impfstoff, nicht replizierender viraler Vektor, nicht spezifiziert | COVID-19 vaccine, non-replicating viral vector, unspecified | Εμβόλιο COVID-19, μη αναπαραγόμενος ιικός φορέας, απροσδιόριστος | Covid-19 vakcīna, nereplicējošs vīrusu vektors, nav precizēts | Szczepionka przeciwko COVID-19, niereplikujący wektor wirusowy, nieokreślony | Vacina contra a COVID-19, vetor viral não replicante, não especificado | |
VAL047 | IgHepB | IgHepB | IgHepB | IgHepB | IgHepB | IgHepB | IgHepB |
VAL265 | COVID-IV-CT | COVID-IV-CT | Covid-VI-CT | COVID-IV-CT | COVID-IV-CT | COVID-IV-CT | COVID-IV-CT |
VAL398 | COVID-VVr-S | Covid-VVr-S | |||||
VAL132 | mOPV1 | mOPV1 | mVPO1 | mOPV1 | mOPV1 | mOPV1 | mOPV1 |
VAC0810 | Meningococcal polyvalent polysaccharide vaccine, unspecified | Meningococcal polyvalent polysaccharide vaccine, unspecified | Meningococcal polyvalent polysaccharide vaccine, unspecified | Meningococcal polyvalent polysaccharide vaccine, unspecified | Meningococcal polyvalent polysaccharide vaccine, unspecified | Meningococcal polyvalent polysaccharide vaccine, unspecified | |
VAC0280 | |||||||
VAC0063 | |||||||
VAC0196 | |||||||
VAC0509 | |||||||
VAC0727 | |||||||
VAC0944 | Inaktivierter oraler Cholera-Virionimpfstoff, nicht spezifiziert | Inactivated whole virion oral cholera vaccine, unspecified | Απενεργοποιημένο από του στόματος εμβόλιο χολέρας ολόκληρου ιού, απροσδιόριστο | Inaktivēta visa viriona perorālā holēras vakcīna, neprecizēta | Inaktywowana doustna szczepionka przeciw cholerze z całym wirionem, nieokreślona | Vacina oral contra cólera com virion inteiro inativado, não especificada | |
VAC1394 | |||||||
VAC0726 | |||||||
VAC0811 | Meningococcal B vaccine, unspecified | Meningococcal B vaccine, unspecified | Meningococcal B vaccine, unspecified | Meningococcal B vaccine, unspecified | Meningococcal B vaccine, unspecified | Meningococcal B vaccine, unspecified | |
VAC1043 | COVID-19-Impfstoff, Proteinuntereinheit, nicht spezifiziert | COVID-19 vaccine, protein subunit, unspecified | Εμβόλιο COVID-19, υπομονάδα πρωτεΐνης, απροσδιόριστο | Covid-19 vakcīna, proteīna apakšvienība, neprecizēta | Szczepionka przeciwko COVID-19, podjednostka białka, nieokreślona | Vacina contra COVID-19, subunidade proteica, não especificada | |
VAC1176 | COVID-19 vaccine with non-replicating viral vector, adenovirus 5 encoding the S and N proteins of SARS-CoV-2, unspecified | ||||||
VAL048 | Or-I | MUMPS-I | Or-I | Or-I | Or-I | Or-I | Or-I |
VAC1261 | |||||||
VAL399 | Ty-ViC-T | Ty-ViC-T | |||||
VAL133 | mOPV | mOPV | mVPO | mOPV | mOPV | mOPV | mOPV |
VAL266 | MCV-C-T | MCV-C-T | MCV-C-T | MCV-C-T | MCV-C-T | MCV-C-T | MCV-C-T |
VAL351 | INF-V3 | Inf-V3 | |||||
VAC0281 | |||||||
VAL130 | HepA-VLP | HepA-VLP | HepA-VLP | HepA-VLP | HepA-VLP | HepA-VLP | HepA-VLP |
VAC1040 | |||||||
VAC0639 | |||||||
VAC1391 | |||||||
VAC0856 | DTaPHib-Impfstoff, nicht spezifiziert | DTaPHib vaccine, unspecified | Εμβόλιο DTaPHib, απροσδιόριστο | DTaPHib vakcīna, neprecizēta | Szczepionka DTaPHib, nieokreślona | Vacina DTaPHib, não especificada | |
VAC1088 | |||||||
VAC0638 | |||||||
VAC0505 | |||||||
VAC0723 | |||||||
VAC1173 | COVID-19 vaccine with replicative viral vector, influenza virus encoding the spike protein of SARS-CoV-2, unspecified | ||||||
VAC0989 | |||||||
VAL178 | Covid-mRNA-S-OMI-25 | COVID-mRNA-S-OMI-BA.1-25 | Covid-ARNm-S-OMI-BA.1-25 | COVID-mRNA-S-OMI-BA.1-25 | COVID-mRNA-S-OMI-BA.1-25 | COVID-mRNA-S-OMI-BA.1-25 | COVID-mRNA-S-OMI-BA.1-25 |
VAL045 | pTy-I | pTy-I | pTy-I | pTy-I | pTy-I | pTy-I | pTy-I |
VAL263 | Rab-I-PDEV | Rab-I-PDEV | Rab-I-PDEV | Rab-I-PDEV | Rab-I-PDEV | Rab-I-PDEV | Rab-I-PDEV |
VAC0941 | Immunglobulin gegen Milzbrand, nicht näher bezeichnet | Immunoglobulin against anthrax, unspecified | Ανοσοσφαιρίνη κατά του άνθρακα, απροσδιόριστη | Imūnglobulīns pret Sibīrijas mēri, neprecizēts | Immunoglobulina przeciw wąglikowi, nieokreślona | Imunoglobulina contra antraz, não especificada | |
VAL396 | COVID-mRNA-S-OMI-XBB.1.5 | Covid-ARNm-S-OMI-XBB.1.5 | |||||
VAC0193 | |||||||
VAC0060 | |||||||
VAC0194 | |||||||
VAC1392 | |||||||
VAC0507 | |||||||
VAC0506 | Pentavalent DTaPHibIPV vaccine, unspecified | Pentavalent DTaPHibIPV vaccine, unspecified | Pentavalent DTaPHibIPV vaccine, unspecified | Pentavalent DTaPHibIPV vaccine, unspecified | Pentavalent DTaPHibIPV vaccine, unspecified | Pentavalent DTaPHibIPV vaccine, unspecified | |
VAC0857 | Diphtherie-Tetanus-Pertussis-Hepatitis-B-Impfstoff, nicht näher bezeichnet | Diphtheria-Tetanus-Pertussis-Hepatitis B vaccine, unspecified | Εμβόλιο διφθερίτιδας-τετάνου-κοκκύτη-Ηπατίτιδας Β, απροσδιόριστο | Difterijas-stingumkrampju-garā klepus-B hepatīta vakcīna, neprecizēta | Szczepionka przeciw błonicy, tężcowi, krztuścowi i wirusowemu zapaleniu wątroby typu B, nieokreślona | Vacina contra difteria-tétano-coqueluche-hepatite B, não especificada | |
VAL179 | MCV-mono | MCV-mono | MCV-mono | MCV-mono | MCV-mono | MCV-mono | MCV-mono |
VAC0724 | |||||||
VAC1041 | COVID-19-RNA-Impfstoff, nicht spezifiziert | COVID-19 mRNA vaccine, unspecified | Εμβόλιο RNA COVID-19, απροσδιόριστο | Covid-19 RNS vakcīna, neprecizēta | Szczepionka RNA przeciwko Covid-19, nieokreślona | Vacina de RNA COVID-19, não especificada | |
VAC1174 | Pentavalent DTPaPHepB vaccine - Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B 10µg, unspecified | ||||||
VAL046 | Typhus | Typhus | Typhus | Typhus | Typhus | Typhus | Typhus |
VAL397 | COVID-VVnr-S | Covid-VVnr-S | |||||
VAC0942 | Tollwutimpfstoff gegen Hühnerembryonen, nicht näher bezeichnet | Chicken embryo rabies vaccine, unspecified | Εμβόλιο λύσσας εμβρύου κοτόπουλου, απροσδιόριστο | Vistas embrija trakumsērgas vakcīna, neprecizēta | Szczepionka przeciwko wściekliźnie zarodków kurcząt, nieokreślona | Vacina anti-rábica de embrião de galinha, não especificada | |
VAL264 | COVID-IV | COVID-IV-Auth | Covid-VI-Aut | COVID-IV-Auth | COVID-IV-Auth | COVID-IV-Auth | COVID-IV-Auth |
VAL131 | Yp-I | Yp-I | Yp-I | Yp-I | Yp-I | Yp-I | Yp-I |
VAC1089 | |||||||
VAC0061 | |||||||
VAC0325 | |||||||
VAC0107 | |||||||
DIS014 | Tuberkulose | Tuberculosis | Φυματίωση | Tuberkuloze | Gruźlica | Tuberculose | |
VAL269 | MCV-A-CRM | MCV-A-CRM | MCV-A-CRM | MCV-A-CRM | MCV-A-CRM | MCV-A-CRM | MCV-A-CRM |
VAL136 | MCV-W | MCV-W | MCV-W | MCV-W | MCV-W | MCV-W | MCV-W |
VAL003 | Per | Per | Coq | Per | Per | Per | Per |
VAL221 | PPSV-15F | PPSV-15F | VPP-15F | PPSV-15F | PPSV-15F | PPSV-15F | PPSV-15F |
VAC0458 | |||||||
VAL354 | PCV-9N | VPC-09N | |||||
VAC0543 | |||||||
VAC0676 | |||||||
VAC0410 | |||||||
VAC0761 | |||||||
VAC1305 | |||||||
VAC0894 | Adenovirus vaccine, unspecified | Adenovirus vaccine, unspecified | Adenovirus vaccine, unspecified | Adenovirus vaccine, unspecified | Adenovirus vaccine, unspecified | Adenovirus vaccine, unspecified | |
VAC1438 | Influenza vaccine, trivalent, inactivated, fractionated or subunit, adjuvanted | ||||||
VAC0326 | |||||||
VAC0108 | |||||||
VAL137 | MPV-C | MPV-C | MPV-C | MPV-C | MPV-C | MPV-C | MPV-C |
VAL004 | I-Chol-I | CHOL-I-I | I-Chol-I | I-Chol-I | I-Chol-I | I-Chol-I | I-Chol-I |
VAL355 | PCV-17F | VPC-17F | |||||
VAC0459 | |||||||
VAC0677 | |||||||
VAL222 | PPSV-17F | PPSV-17F | VPP-17F | PPSV-17F | PPSV-17F | PPSV-17F | PPSV-17F |
VAC0895 | Impfstoff gegen Venezolanische Pferdeenzephalitis, nicht spezifiziert | Venezuelan Equine Encephalitis Vaccine, Unspecified | Εμβόλιο εγκεφαλίτιδας ιπποειδών της Βενεζουέλας, απροσδιόριστο | Venecuēlas zirgu encefalīta vakcīna, neprecizēta | Wenezuelska szczepionka przeciwko zapaleniu mózgu koni, nieokreślona | Vacina venezuelana contra encefalite equina, não especificada | |
VAC0544 | |||||||
VAC0411 | |||||||
VAC0980 | |||||||
VAC0762 | |||||||
VAC1439 | Meningococcal vaccine, polyvalent, conjugate polysaccharide | ||||||
VAC1306 | |||||||
VAC0323 | |||||||
VAC0105 | |||||||
VAC0238 | |||||||
VAL049 | Hib-PS | Hib-PS | Hib-PS | Hib-PS | Hib-PS | Hib-PS | Hib-PS |
VAL267 | MCV-C-D | MCV-C-D | MCV-C-D | MCV-C-D | MCV-C-D | MCV-C-D | MCV-C-D |
VAL134 | INF-SUid4 | Inf-SUid4 | |||||
VAL001 | Inf-L3 | INF-L3 | Inf-L3 | Inf-L3 | Inf-L3 | Inf-L3 | Inf-L3 |
VAC0456 | |||||||
VAL352 | INF-V4 | Inf-V4 | |||||
VAC0892 | |||||||
VAC0541 | |||||||
VAC0674 | |||||||
VAC1303 | |||||||
VAC1436 | |||||||
VAC1218 | Meningococcal A polysaccharide vaccine conjugated to tetanus toxoid, unspecified | ||||||
DIS059 | Pest | Plague | Πανούκλα | Mēris | Plaga | Praga | |
VAC0324 | Pneumococcal conjugate vaccine, 7 valent, unspecified | Pneumococcal conjugate vaccine, 7 valent, unspecified | Pneumococcal conjugate vaccine, 7 valent, unspecified | Pneumococcal conjugate vaccine, 7 valent, unspecified | Pneumococcal conjugate vaccine, 7 valent, unspecified | Pneumococcal conjugate vaccine, 7 valent, unspecified | |
VAC0106 | |||||||
DIS011 | Windpocken | Chickenpox | Ανεμοβλογιά | Vējbakas | Ospa wietrzna | Varicela | |
VAL135 | Covid-ARNm-S-CT | COVID-mRNA-S-CT | Covid-ARNm-S-CT | Covid-ARNm-S-CT | Covid-ARNm-S-CT | Covid-ARNm-S-CT | Covid-ARNm-S-CT |
DIS010 | Röteln | Rubella | Ερυθρά | Masaliņas | Różyczka | Rubéola | |
VAL268 | MCV-C-CRM | MCV-C-CRM | MCV-C-CRM | MCV-C-CRM | MCV-C-CRM | MCV-C-CRM | MCV-C-CRM |
VAL002 | Ty-ViC | Ty-ViC | Ty-ViC | Ty-ViC | Ty-ViC | Ty-ViC | Ty-ViC |
VAL353 | PCV-02 | VPC-02 | |||||
VAC0457 | |||||||
VAC0675 | |||||||
VAL220 | PPSV-15B | PPSV-15B | VPP-15B | PPSV-15B | PPSV-15B | PPSV-15B | PPSV-15B |
VAC0542 | |||||||
VAC1304 | |||||||
VAC1437 | Meningococcal vaccine, monovalent, conjugate | ||||||
VAC0893 | |||||||
VAC0760 | |||||||
VAC1219 | Hexavalent vaccine DTPeHibMCV-A-C-T - Diphtheria-Tetanus-Pertussis-Hib PRP-Meningococcus A and C, conjugated with tetanus toxoid, unspecified | ||||||
VAC1082 | |||||||
DIS058 | Respiratorisches Syncytial-Virus | Human Respiratory Syncytial Virus | Αναπνευστικός συγκυτιακός ιός | Respiratori sinicitāls vīruss | Syncytialny wirus oddechowy | Vírus sincicial respiratório | |
VAL225 | PPSV-19F | PPSV-19F | VPP-19F | PPSV-19F | PPSV-19F | PPSV-19F | PPSV-19F |
VAL358 | BIG | BIG | |||||
VAC0414 | |||||||
VAC0765 | |||||||
VAC0983 | |||||||
VAL310 | Covid-mRNA-S-ORI-5 | COVID-mRNA-S-ORI-5 | Covid-ARNm-S-ORI-5 | Covid-mRNA-S-ORI-5 | Covid-mRNA-S-ORI-5 | Covid-mRNA-S-ORI-5 | Covid-mRNA-S-ORI-5 |
VAC0898 | Leishmaniose-Impfstoff, nicht näher bezeichnet | Leishmaniasis vaccine, unspecified | Εμβόλιο λεϊσμανίασης, απροσδιόριστο | Leishmaniozes vakcīna, neprecizēta | Szczepionka na leiszmaniozę, nieokreślona | Vacina contra leishmaniose, não especificada | |
VAC0632 | |||||||
VAC0850 | |||||||
VAC1309 | |||||||
VAL007 | rVSVdG-ZEBOV-GP | rVSVdG-ZEBOV-GP | rVSVdG-ZEBOV-GP | rVSVdG-ZEBOV-GP | rVSVdG-ZEBOV-GP | rVSVdG-ZEBOV-GP | rVSVdG-ZEBOV-GP |
VAC1083 | |||||||
DIS057 | COVID-19 | COVID-19 | COVID-19 | COVID-19 | COVID-19 | COVID-19 | |
VAL226 | PPSV-20 | PPSV-20 | VPP-20 | PPSV-20 | PPSV-20 | PPSV-20 | PPSV-20 |
VAC0899 | Impfstoff gegen humanes Parainfluenzavirus, nicht spezifiziert | Human Parainfluenza Virus Vaccine, unspecified | Εμβόλιο για τον ιό της ανθρώπινης παραγρίπης, απροσδιόριστο | Cilvēka paragripas vīrusa vakcīna, neprecizēta | Szczepionka przeciwko ludzkiemu wirusowi paragrypy, nieokreślona | Vacina contra o vírus da parainfluenza humana, não especificada | |
VAL311 | R21/Matrix-M | R21/Matrix-M | R21/Matrix-M | R21/Matrix-M | R21/Matrix-M | R21/Matrix-M | R21/Matrix-M |
VAC0415 | |||||||
VAC0633 | |||||||
VAC0984 | |||||||
VAC0851 | |||||||
VAC0766 | |||||||
VAC0500 | |||||||
VAL008 | aP | aP | Ca | aP | aP | aP | aP |
VAL359 | Inaktivierte Ganzzell-Cholera-Valenz, ohne Spezifikation | CHOL-I | Chol-I | Αδρανοποιημένη ολόκληρη χολερική βαλεντία, χωρίς διευκρίνιση | Inaktivēta visa holēras valence, bez precizējuma | Wartość całkowicie inaktywowana przeciwko cholerze, bez określenia | Valência colérica inteira inativada, sem especificação |
VAC1080 | |||||||
VAC0327 | |||||||
DIS056 | Chikungunyafieber | Chikungunya | Τσικουνγκούνια | Čikungunja | Chikungunia | Chicungunha | |
VAC0109 | |||||||
VAL138 | MPV-W | MPV-W | MPV-W | MPV-W | MPV-W | MPV-W | MPV-W |
VAL005 | Meas-LAV | MEAS-LA | Roug-VVA | Meas-LAV | Meas-LAV | Meas-LAV | Meas-LAV |
VAL223 | PPSV-18C | PPSV-18C | VPP-18C | PPSV-18C | PPSV-18C | PPSV-18C | PPSV-18C |
VAL356 | PCV-20 | VPC-20 | |||||
VAC0896 | Q-Fieber-Impfstoff, nicht näher bezeichnet | Q fever vaccine, unspecified | Q-Fieber-Impfstoff, nicht näher bezeichnet | Q drudža vakcīna, neprecizēta | Szczepionka na gorączkę Q, nieokreślona | Vacina contra febre Q, não especificada | |
VAC0545 | |||||||
VAC0678 | |||||||
VAC0412 | |||||||
VAC0763 | |||||||
VAC0981 | |||||||
VAC1307 | |||||||
DIS055 | Ebolafieber | Ebola | Έμπολα | Ebolas vīrusslimība | Ebola | Ébola | |
VAC0328 | |||||||
VAC1081 | |||||||
VAL006 | Bruc | Bruc | Bruc | Bruc | Bruc | Bruc | Bruc |
VAL357 | CHOL-LA-O | O-Chol-V | |||||
VAC0679 | |||||||
VAL224 | PPSV-19A | PPSV-19A | VPP-19A | PPSV-19A | PPSV-19A | PPSV-19A | PPSV-19A |
DIS054 | Hepatitis E | Hepatitis E | Ηπατίτιδα Ε | E hepatīts | Wirusowe Zapalenie Wątroby typu E | Hepatite E | |
VAC0546 | |||||||
VAC0413 | |||||||
VAC0631 | |||||||
VAC0764 | |||||||
VAC0897 | Hantavirus-Impfstoff, nicht näher bezeichnet | Hantavirus vaccine, unspecified | Εμβόλιο Hantavirus, απροσδιόριστο | Hantavīrusa vakcīna, neprecizēta | Szczepionka hantawirusowa, nieokreślona | Vacina contra hantavírus, não especificada | |
VAC0982 | |||||||
VAC1308 | |||||||
VAL139 | MPV-Y | MPV-Y | MPV-Y | MPV-Y | MPV-Y | MPV-Y | MPV-Y |
VAC0232 | |||||||
VAC0014 | |||||||
VAC0365 | |||||||
VAC0147 | Influenza A(H1N1)2009 vaccine, unspecified | Influenza A(H1N1)2009 vaccine, unspecified | Influenza A(H1N1)2009 vaccine, unspecified | Influenza A(H1N1)2009 vaccine, unspecified | Influenza A(H1N1)2009 vaccine, unspecified | Influenza A(H1N1)2009 vaccine, unspecified | |
VAL314 | TBE-Neudorfl-ADU | TBE-Neudorfl-ADU | TBE-Neudorfl-ADU | TBE-Neudorfl-ADU | TBE-Neudorfl-ADU | TBE-Neudorfl-ADU | TBE-Neudorfl-ADU |
VAC1212 | Trivalent Poliomyelitis vaccine, whole inactivated oral, unspecified | ||||||
VAC1345 | |||||||
VAC1430 | COVID-19 bivalent mRNA vaccine against the original virus and the Omicron BA.4/5 variant, 50 micrograms, unspecified | ||||||
VAC0498 | |||||||
VAC1127 | Immunoglobulin against hepatitis A, measles, chickenpox and rubella, unspecified | ||||||
VAL229 | PPSV-33F | PPSV-33F | VPP-33F | PPSV-33F | PPSV-33F | PPSV-33F | PPSV-33F |
VAC0450 | |||||||
VAC0233 | |||||||
VAC0366 | |||||||
VAC0148 | Leptospirosis vaccine, unspecified | Leptospirosis vaccine, unspecified | Leptospirosis vaccine, unspecified | Leptospirosis vaccine, unspecified | Leptospirosis vaccine, unspecified | Leptospirosis vaccine, unspecified | |
VAC0015 | |||||||
VAL400 | Ty-ViC-CRM | Ty-ViC-CRM | |||||
VAC1431 | RSV vaccine, unspecified | ||||||
VAC1213 | Cholera vaccine containing recombinant cholera toxin B subunit and inactivated whole V. cholerae O1 bacteria, unspecified | ||||||
VAC0499 | |||||||
VAC1128 | COVID-19 plasmid DNA vaccine, unspecified | ||||||
VAC1346 | |||||||
VAC0451 | |||||||
VAL315 | TBE-Neudorfl-PED | TBE-Neudorfl-PED | TBE-Neudorfl-PED | TBE-Neudorfl-PED | TBE-Neudorfl-PED | TBE-Neudorfl-PED | TBE-Neudorfl-PED |
VAC0230 | |||||||
VAC0012 | |||||||
VAC0363 | |||||||
VAC0145 | Tick-borne encephalitis vaccine, unspecified | Tick-borne encephalitis vaccine, unspecified | Tick-borne encephalitis vaccine, unspecified | Tick-borne encephalitis vaccine, unspecified | Tick-borne encephalitis vaccine, unspecified | Tick-borne encephalitis vaccine, unspecified | |
VAC0278 | |||||||
VAC0809 | Meningococcal monovalent polysaccharide vaccine, unspecified | Meningococcal monovalent polysaccharide vaccine, unspecified | Meningococcal monovalent polysaccharide vaccine, unspecified | Meningococcal monovalent polysaccharide vaccine, unspecified | Meningococcal monovalent polysaccharide vaccine, unspecified | Meningococcal monovalent polysaccharide vaccine, unspecified | |
VAL312 | TBE-K23 | TBE-K23 | TBE-K23 | TBE-K23 | TBE-K23 | TBE-K23 | TBE-K23 |
VAC1125 | Hepatitis B vaccine, unspecified | ||||||
VAC1210 | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, original virus, 100 micrograms, unspecified | ||||||
VAC1343 | |||||||
VAC0496 | |||||||
VAC1258 | |||||||
VAL009 | Mala-SPO | Mala-SPO | Palu-SPO | Mala-SPO | Mala-SPO | Mala-SPO | Mala-SPO |
VAL227 | PPSV-22F | PPSV-22F | VPP-22F | PPSV-22F | PPSV-22F | PPSV-22F | PPSV-22F |
VAC0231 | |||||||
VAC0364 | |||||||
VAC0146 | Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified | Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified | Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified | Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified | Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified | Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified | |
VAC0013 | |||||||
VAL313 | TBE-Neudorfl | TBE-Neudorfl | TBE-Neudorfl | TBE-Neudorfl | TBE-Neudorfl | TBE-Neudorfl | TBE-Neudorfl |
VAC1344 | |||||||
VAC1211 | Meningococcal C polysaccharide vaccine conjugated to CRM197 protein, unspecified | ||||||
VAC0497 | Tetanus immunoglobulin, unspecified | Tetanus immunoglobulin, unspecified | Tetanus immunoglobulin, unspecified | Tetanus immunoglobulin, unspecified | Tetanus immunoglobulin, unspecified | Tetanus immunoglobulin, unspecified | |
VAC1126 | Pentavalent DTP Hib vaccine - Diphtheria-Tetanus-Pertussis-Hib PRP-Polio, unspecified | ||||||
VAC1259 | |||||||
VAC0582 | |||||||
VAL228 | PPSV-23F | PPSV-23F | VPP-23F | PPSV-23F | PPSV-23F | PPSV-23F | PPSV-23F |
VAC0321 | |||||||
VAC0103 | |||||||
VAC0236 | |||||||
VAC0018 | |||||||
VAC0369 | |||||||
DIS018 | Typhus | Typhoid | Τυφοειδής | Vēdertīfs | Dur brzuszny | Febre tifoide | |
VAL091 | Ty-LA | Ty-LA-O | Ty-VA | Ty-LA | Ty-LA | Ty-LA | Ty-LA |
VAC1301 | |||||||
VAC0454 | |||||||
VAC1216 | Quadrivalent DTPaHepB vaccine - Diphtheria-Tetanus-Pertussis-Hepatitis B 10µg, unspecified | ||||||
VAC1349 | |||||||
VAC1434 | Meningococcal A vaccine, unspecified | ||||||
VAC0672 | |||||||
VAL318 | RSV-V | RSV-V | VRS-V | RSV-V | RSV-V | RSV-V | RSV-V |
VAC0890 | |||||||
VAL403 | MenX | MenX | |||||
VAC0322 | |||||||
VAC0104 | |||||||
DIS017 | Gelbfieber | Yellow fever | Κίτρινος πυρετός | Dzeltenais drudzis | Żółta gorączka | Febre amarela | |
VAC0019 | |||||||
VAL092 | YF | YF | YF | YF | YF | YF | YF |
VAC0673 | |||||||
VAC1435 | Rabies vaccine, inactivated, whole virion, cell culture-based, unspecified | ||||||
VAC0891 | |||||||
VAC1217 | Vaccine against hepatitis B and Haemophilus influenzae type b, unspecified | ||||||
VAC0540 | |||||||
VAL319 | COVID-19-Impfstoff, nicht-replizierender adenoviraler Vektor, der für das SARS-CoV-2-Spike-Protein kodiert, Inhalationsimpfstoff, nicht spezifiziert | COVID-VVnr-S-INH | Covid-VVnr-S-INH | ||||
VAC1302 | |||||||
VAL404 | MCV-X | MCV-X | |||||
VAC0234 | |||||||
VAC0101 | Hepatitis-B-Impfstoff, rekombinant, ohne nähere Angaben | Hepatitis B vaccine, recombinant, unspecified | Εμβόλιο ανασυνδυασμένης ηπατίτιδας Β, απροσδιόριστο | Rekombinantā B hepatīta vakcīna, neprecizēta | Rekombinowana szczepionka przeciw wirusowemu zapaleniu wątroby typu B, nieokreślona | Vacina recombinante contra a hepatite B, não especificada | |
VAC0367 | |||||||
VAC0016 | |||||||
DIS016 | Hepatitis A | Hepatitis A | Ηπατίτιδα Α | A hepatīts | Wirusowe Zapalenie Wątroby typu A | Hepatite A | |
VAC0149 | Meningococcal B:14:P1.7,16 vaccine, unspecified | Meningococcal B:14:P1.7,16 vaccine, unspecified | Meningococcal B:14:P1.7,16 vaccine, unspecified | Meningococcal B:14:P1.7,16 vaccine, unspecified | Meningococcal B:14:P1.7,16 vaccine, unspecified | Meningococcal B:14:P1.7,16 vaccine, unspecified | |
VAL401 | EJ-I-Vero-3 | EJ-I-Vero-3 | |||||
VAC1432 | Argentine hemorrhagic fever vaccine, Junin virus, unspecified | ||||||
VAC0585 | TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified | TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified | TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified | TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified | TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified | TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified | |
VAC1129 | COVID-19 protein subunit vaccine, recombinant spike protein in nanoparticles, unspecified | ||||||
VAC0452 | |||||||
VAC1214 | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, against the Omicron XBB.1.5 variant, 10µg, unspecified | ||||||
VAC1347 | |||||||
VAC0670 | |||||||
VAL316 | RSV-PreF3 | RSV-PreF3 | VRS-PreF3 | RSV-PreF3 | RSV-PreF3 | RSV-PreF3 | RSV-PreF3 |
VAC0320 | OPV 1-2-3, unspecified | OPV 1-2-3, unspecified | OPV 1-2-3, unspecified | OPV 1-2-3, unspecified | OPV 1-2-3, unspecified | OPV 1-2-3, unspecified | |
VAC0102 | Inaktivierter Hepatitis-A-Impfstoff, nicht näher bezeichnet | Inactivated hepatitis A vaccine, unspecified | Αδρανοποιημένο εμβόλιο ηπατίτιδας Α, απροσδιόριστο | Nespecificēta inaktivēta A hepatīta vakcīna | Inaktywowana szczepionka przeciw wirusowemu zapaleniu wątroby typu A, nieokreślona | Vacina inactivada contra a hepatite A, não especificada | |
VAC0235 | |||||||
DIS015 | Influenza | Influenza | εποχική γρίπη | Gripa | Grypa sezonowa | Gripe | |
VAC0368 | |||||||
VAC0017 | |||||||
VAL090 | rHBsAg | rHBsAg | rAgHBs | rHBsAg | rHBsAg | rHBsAg | rHBsAg |
VAL402 | EJ-I-Vero-6 | EJ-I-Vero-6 | |||||
VAC1300 | |||||||
VAC1433 | Plague vaccine, unspecified | ||||||
VAC0586 | |||||||
VAC1348 | |||||||
VAC0453 | |||||||
VAC0671 | |||||||
VAC1215 | Hexavalent vaccine DTPaHibPHepB - Diphtheria-Tetanus-Pertussis-Hib OMP-Polio-Hepatitis B 10µg, unspecified | ||||||
VAL317 | RSV-Ab | RSV-Ab | VRS-Ab | RSV-Ab | RSV-Ab | RSV-Ab | RSV-Ab |
VAC0490 | |||||||
VAC0272 | |||||||
VAC0054 | |||||||
VAC0187 | |||||||
VAL095 | COVID-VVr-S-Nv | COVID-VVr-S-Nv | Covid-VVr-S-Nv | COVID-VVr-S-Nv | COVID-VVr-S-Nv | COVID-VVr-S-Nv | COVID-VVr-S-Nv |
VAC0718 | |||||||
VAC0936 | |||||||
VAL180 | Covid-mRNA-S-100 | COVID-mRNA-S-ORI-100 | Covid-ARNm-S-ORI-100 | COVID-mRNA-S-ORI-100 | COVID-mRNA-S-ORI-100 | COVID-mRNA-S-ORI-100 | COVID-mRNA-S-ORI-100 |
VAC1252 | |||||||
VAC0935 | |||||||
VAC1385 | |||||||
VAC0802 | Monovalent oral polio vaccine - type unknown, unspecified | Monovalent oral polio vaccine - type unknown, unspecified | Monovalent oral polio vaccine - type unknown, unspecified | Monovalent oral polio vaccine - type unknown, unspecified | Monovalent oral polio vaccine - type unknown, unspecified | Monovalent oral polio vaccine - type unknown, unspecified | |
VAC1034 | |||||||
VAC1167 | Acellular Pertussis Vaccine, unspecified | ||||||
VAL407 | COVID-mRNA-S-OMI-KP.2-3 | Covid-ARNm-S-OMI-KP.2-3 | |||||
VAC0140 | |||||||
VAC0273 | |||||||
VAC0188 | |||||||
VAL096 | BCG | BCG | BCG | BCG | BCG | BCG | BCG |
VAL181 | Covid-mRNA-S-ORI-25 | COVID-mRNA-S-ORI-25 | Covid-ARNm-S-ORI-25 | Covid-mRNA-S-ORI-25 | Covid-mRNA-S-ORI-25 | Covid-mRNA-S-ORI-25 | Covid-mRNA-S-ORI-25 |
VAC0937 | Botulismus-Impfstoff, nicht näher bezeichnet | Botulism vaccine, unspecified | Εμβόλιο αλλαντίασης, απροσδιόριστο | Botulisma vakcīna, neprecizēta | Szczepionka na botulizm, nieokreślona | Vacina contra botulismo, não especificada | |
VAC0804 | Anthrax vaccine, unspecified | Anthrax vaccine, unspecified | Anthrax vaccine, unspecified | Anthrax vaccine, unspecified | Anthrax vaccine, unspecified | Anthrax vaccine, unspecified | |
VAC0719 | |||||||
VAC1120 | Trivalent leptospirosis vaccine, unspecified | ||||||
VAC1253 | |||||||
VAC0803 | |||||||
VAC1168 | Quadrivalent DTPeHib- Diphtheria-Tetanus-Pertussis-Hib OC vaccine, unspecified | ||||||
VAC1386 | |||||||
VAC1035 | |||||||
VAL408 | COVID-mRNA-S-OMI-KP.2-10 | Covid-ARNm-S-OMI-KP.2-10 | |||||
VAC0491 | |||||||
VAC0052 | |||||||
VAC0185 | |||||||
VAL093 | Meas-I | MEAS-I | Roug-I | Meas-I | Meas-I | Meas-I | Meas-I |
VAC0849 | Tularämie-Impfstoff, nicht näher bezeichnet | Tularemia vaccine, unspecified | Εμβόλιο για την τουλαραιμία, απροσδιόριστο | Vakcīna pret tularēmiju, neprecizēta | Szczepionka na tularemię, nieokreślona | Vacina contra tularemia, não especificada | |
VAC0716 | |||||||
VAC0933 | |||||||
VAC1383 | |||||||
VAC0800 | Diphtheria-tetanus-pertussis-Hib vaccine, unspecified | Diphtheria-tetanus-pertussis-Hib vaccine, unspecified | Diphtheria-tetanus-pertussis-Hib vaccine, unspecified | Diphtheria-tetanus-pertussis-Hib vaccine, unspecified | Diphtheria-tetanus-pertussis-Hib vaccine, unspecified | Diphtheria-tetanus-pertussis-Hib vaccine, unspecified | |
VAC0715 | |||||||
VAC1032 | |||||||
VAC1165 | Diphtheria toxoid, standard dose, unspecified | ||||||
VAC1250 | |||||||
VAC1298 | |||||||
VAL405 | INF-pdm09-V | Inf-pdm09-V | |||||
VAC0270 | Inactivated Polio vaccine, unspecified | Inactivated Polio vaccine, unspecified | Inactivated Polio vaccine, unspecified | Inactivated Polio vaccine, unspecified | Inactivated Polio vaccine, unspecified | Inactivated Polio vaccine, unspecified | |
VAC0271 | |||||||
VAC0186 | |||||||
VAC0053 | |||||||
VAL094 | INF-SUhd3 | Inf-SUhd3 | |||||
VAC0717 | |||||||
VAC0801 | HepB-Hib, unspecified | HepB-Hib, unspecified | HepB-Hib, unspecified | HepB-Hib, unspecified | HepB-Hib, unspecified | HepB-Hib, unspecified | |
VAC1033 | |||||||
VAC0934 | |||||||
VAC1251 | |||||||
VAC1384 | |||||||
VAC1166 | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, currently in clinical trial, unspecified | ||||||
VAC1299 | |||||||
VAL406 | COVID-mRNA-S-OMI-KP.2 | Covid-ARNm-S-OMI-KP.2 | |||||
VAC0361 | |||||||
VAC0010 | |||||||
VAC0276 | |||||||
VAC0143 | Haemophilus influenzae B (or Hib) vaccine, unspecified | Haemophilus influenzae B (or Hib) vaccine, unspecified | Haemophilus influenzae B (or Hib) vaccine, unspecified | Haemophilus influenzae B (or Hib) vaccine, unspecified | Haemophilus influenzae B (or Hib) vaccine, unspecified | Haemophilus influenzae B (or Hib) vaccine, unspecified | |
VAC0058 | |||||||
VAL184 | PCV | PCV | VPC | PCV | PCV | PCV | PCV |
VAL051 | AH5N1 | AH5N1 | AH5N1 | AH5N1 | AH5N1 | AH5N1 | AH5N1 |
VAC0807 | Cholera-Typhoid inactivated vaccine, unspecified | Cholera-Typhoid inactivated vaccine, unspecified | Cholera-Typhoid inactivated vaccine, unspecified | Cholera-Typhoid inactivated vaccine, unspecified | Cholera-Typhoid inactivated vaccine, unspecified | Cholera-Typhoid inactivated vaccine, unspecified | |
VAC1341 | SPIKEVAX BA.4-5 0,1 mg/mL dose 50 µg | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron XBB.1.5 variant, unspecified dose | SPIKEVAX BA.4-5 0,1 mg/mL dose 50 µg | SPIKEVAX BA.4-5 0,1 mg/mL dose 50 µg | SPIKEVAX BA.4-5 0,1 mg/mL dose 50 µg | SPIKEVAX BA.4-5 0,1 mg/mL dose 50 µg | |
VAC1256 | Hexavalent vaccine DTwPHibPHepB - Diphtheria-Tetanus-Pertussis-Hib-Polio-Hepatitis B 15µg, unspecified | ||||||
VAL099 | Inf-pdm09 | INF-pdm09 | Inf-pdm09 | Inf-pdm09 | Inf-pdm09 | Inf-pdm09 | Inf-pdm09 |
VAC1389 | |||||||
VAC1123 | Live attenuated trivalent influenza vaccine, unspecified | ||||||
VAC1038 | Impfstoff gegen Zeckenenzephalitis, Stamm Neudörfl, Erwachsenendosis, nicht spezifiziert | Tick-borne encephalitis vaccine, Neudörfl strain, adult dose, unspecified | Εμβόλιο εγκεφαλίτιδας που μεταδίδεται από κρότωνες, στέλεχος Neudörfl, δόση ενηλίκων, μη καθορισμένη | Vakcīna pret ērču encefalītu, Neudörfl celms, pieaugušo deva, neprecizēta | Szczepionka na kleszczowe zapalenie mózgu, szczep Neudörfl, dawka dla dorosłych, nieokreślona | Vacina contra encefalite transmitida por carrapatos, cepa Neudörfl, dose para adultos, não especificada | |
VAC0494 | |||||||
VAC0362 | |||||||
VAC0144 | Cholera vaccine, unspecified | Cholera vaccine, unspecified | Cholera vaccine, unspecified | Cholera vaccine, unspecified | Cholera vaccine, unspecified | Cholera vaccine, unspecified | |
VAC0011 | |||||||
VAC0277 | |||||||
VAL185 | PPSV | PPSV | VPP | PPSV | PPSV | PPSV | PPSV |
VAC0808 | Hib-MenCY, unspecified | Hib-MenCY, unspecified | Hib-MenCY, unspecified | Hib-MenCY, unspecified | Hib-MenCY, unspecified | Hib-MenCY, unspecified | |
VAC0059 | |||||||
VAL052 | HPV-04-valent | HPV-04-valent | VPH-04-valent | HPV-04-valent | HPV-04-valent | HPV-04-valent | HPV-04-valent |
VAL270 | MCV-A-D | MCV-A-D | MCV-A-D | MCV-A-D | MCV-A-D | MCV-A-D | MCV-A-D |
VAC1124 | Inactivated whole virus COVID-19 vaccine, in clinical trial, unspecified | ||||||
VAC1257 | Cholera vaccine, whole inactivated oral, bivalent containing the whole inactivated V. cholerae O1 and O139 bacteria, unspecified | ||||||
VAC1342 | |||||||
VAC1039 | COVID-19-mRNA-Impfstoff, Originalvirus, 50 µg, nicht spezifiziert | COVID-19 mRNA vaccine, original virus, 50 µg, unspecified | Εμβόλιο mRNA COVID-19, αρχικός ιός, 50 μg, απροσδιόριστο | Covid-19 mRNS vakcīna, oriģināls vīruss, 50 µg, neprecizēts | Szczepionka mRNA przeciwko COVID-19, wirus oryginalny, 50 µg, nieokreślony | Vacina de mRNA contra COVID-19, vírus original, 50 µg, não especificado | |
VAC0495 | |||||||
VAC0580 | |||||||
VAC0141 | |||||||
VAC0274 | |||||||
VAC0056 | |||||||
VAC0189 | |||||||
VAL097 | D | D | D | D | D | D | D |
VAL182 | Meas | MEAS | Roug | Meas | Meas | Meas | Meas |
VAC0805 | Whole-cell inactivated cholera vaccine, unspecified | Whole-cell inactivated cholera vaccine, unspecified | Whole-cell inactivated cholera vaccine, unspecified | Whole-cell inactivated cholera vaccine, unspecified | Whole-cell inactivated cholera vaccine, unspecified | Whole-cell inactivated cholera vaccine, unspecified | |
VAC0938 | Quadrivalenter Grippeimpfstoff, nicht näher bezeichnet | Quadrivalent influenza vaccine, unspecified | Τετραδύναμο εμβόλιο γρίπης, απροσδιόριστο | Neprecizēta četrvērtīgā gripas vakcīna | Czterowalentna szczepionka przeciw grypie, nieokreślona | Vacina quadrivalente contra influenza, não especificada | |
VAC1121 | Hexavalent vaccine DTPaHibPHepB - Diphtheria-Tetanus-Pertussis-Hib-Polio-Hepatitis B 10µg, unspecified | ||||||
VAC1387 | |||||||
VAC1036 | |||||||
VAC1169 | COVID-19 Bivalent mRNA vaccine, original virus + Omicron BA.4/5 variant, 15 micrograms, unspecified | ||||||
VAC1254 | |||||||
VAL409 | COVID-mRNA-S-OMI-KP.2-30 | Covid-ARNm-S-OMI-KP.2-30 | |||||
VAC0492 | |||||||
VAC0360 | |||||||
VAC0275 | |||||||
VAC0057 | |||||||
VAL183 | Mumps | MUMPS | Oreillons | Mumps | Mumps | Mumps | Mumps |
VAL050 | COVID-VVnr-S-Ad5 | COVID-VVnr-S-Ad5 | Covid-VVnr-S-Ad5 | COVID-VVnr-S-Ad5 | COVID-VVnr-S-Ad5 | COVID-VVnr-S-Ad5 | COVID-VVnr-S-Ad5 |
VAC0939 | |||||||
VAC0806 | Live attenuated cholera vaccine, unspecified | Live attenuated cholera vaccine, unspecified | Live attenuated cholera vaccine, unspecified | Live attenuated cholera vaccine, unspecified | Live attenuated cholera vaccine, unspecified | Live attenuated cholera vaccine, unspecified | |
VAC1340 | |||||||
VAC1037 | Impfstoff gegen Zeckenenzephalitis, Stamm Neudörfl, pädiatrische Dosis, nicht spezifiziert | Tick-borne encephalitis vaccine, Neudörfl strain, paediatric dose, unspecified | Εμβόλιο εγκεφαλίτιδας από κρότωνες, στέλεχος Neudörfl, παιδιατρική δόση, μη καθορισμένη | Vakcīna pret ērču encefalītu, Neudörfl celms, pediatriskā deva, neprecizēta | Szczepionka na kleszczowe zapalenie mózgu, szczep Neudörfl, dawka pediatryczna, nieokreślona | Vacina contra encefalite transmitida por carrapatos, cepa Neudörfl, dose pediátrica, não especificada | |
VAC1122 | 1st generation live smallpox vaccine, unspecified | ||||||
VAL098 | 4CMenB | 4CMenB | 4CMenB | 4CMenB | 4CMenB | 4CMenB | 4CMenB |
VAC1255 | |||||||
VAC1388 | |||||||
VAL273 | MCV-W-D | MCV-W-D | MCV-W-D | MCV-W-D | MCV-W-D | MCV-W-D | MCV-W-D |
VAL140 | Inf-L | INF-L | Inf-L | Inf-L | Inf-L | Inf-L | Inf-L |
DIS066 | Hantavirus | Hantavirus | Χανταϊός | Hantavīruss | Hantawirus | Hantavírus | |
VAC1050 | |||||||
VAC1183 | Non-replicating viral vector Ebola vaccine, unspecified | ||||||
VAC0648 | COVID-19 vaccine, unspecified | COVID-19 vaccine, unspecified | COVID-19 vaccine, unspecified | COVID-19 vaccine, unspecified | COVID-19 vaccine, unspecified | COVID-19 vaccine, unspecified | |
VAC0999 | |||||||
VAC0866 | Meningokokken-Konjugatimpfstoff A, nicht näher bezeichnet | Meningococcal conjugate vaccine A, unspecified | Μηνιγγιτιδοκοκκικό συζευγμένο εμβόλιο Α, απροσδιόριστο | Meningokoku konjugētā vakcīna A, neprecizēta | Szczepionka skoniugowana przeciwko meningokokom A, nieokreślona | Vacina meningocócica conjugada A, não especificada | |
VAC1098 | |||||||
VAC0515 | |||||||
DIS065 | Q-Fieber | Q fever | Q πυρετός | Q drudzis | Gorączka Q | febre Q | |
VAC0951 | |||||||
VAC0600 | OPV bivalent 1-3, unspecified | OPV bivalent 1-3, unspecified | OPV bivalent 1-3, unspecified | OPV bivalent 1-3, unspecified | OPV bivalent 1-3, unspecified | OPV bivalent 1-3, unspecified | |
VAL188 | PCV-04 | PCV-04 | VPC-04 | PCV-04 | PCV-04 | PCV-04 | PCV-04 |
VAC0733 | |||||||
VAL055 | Ig-Measles | MEAS-Ig | Ig-Rougeole | Ig-Measles | Ig-Measles | Ig-Measles | Ig-Measles |
VAC0070 | |||||||
VAL141 | Rota-mv-RIX4414 | ROTA-LA-mv-RIX4414 | Rota-mv-RIX4414 | Rota-mv-RIX4414 | Rota-mv-RIX4414 | Rota-mv-RIX4414 | Rota-mv-RIX4414 |
VAC1051 | |||||||
VAC0867 | Diphtherie-Antitoxin, nicht näher bezeichnet | Diphtheria antitoxin, unspecified | Αντιτοξίνη διφθερίτιδας, μη καθορισμένη | Difterijas antitoksīns, neprecizēts | Antytoksyna błonicza, nieokreślona | Antitoxina diftérica, não especificada | |
VAC1099 | |||||||
VAC0649 | |||||||
VAC0516 | |||||||
VAC0734 | |||||||
DIS064 | Venezolanische Pferdeenzephalitis | Venezuelan equine encephalitis | Βενεζουελανική εγκεφαλίτιδα ιπποειδών | Venecuēlas zirgu encefalīts | Wenezuelskie zapalenie mózgu koni | Encefalite equina venezuelana | |
VAC1184 | Meningococcal C polysaccharide vaccine conjugated to tetanus toxoid, unspecified | ||||||
VAL189 | PCV-05 | PCV-05 | VPC-05 | PCV-05 | PCV-05 | PCV-05 | PCV-05 |
VAL056 | POLIO-I | IPV | VPI | POLIO-I | POLIO-I | POLIO-I | POLIO-I |
VAC0601 | DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified | DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified | DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified | DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified | DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified | DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified | |
VAL274 | MCV-W-CRM | MCV-W-CRM | MCV-W-CRM | MCV-W-CRM | MCV-W-CRM | MCV-W-CRM | MCV-W-CRM |
VAC0952 | |||||||
VAC0071 | |||||||
VAC1409 | COVID-19 mRNA vaccine, Omicron JN.1 subvariant, 50 micrograms per dose, multidose vial | ||||||
VAL053 | COVID-PS | COVID-PS | Covid-SP | COVID-PS | COVID-PS | COVID-PS | COVID-PS |
VAL271 | MCV-A-T | MCV-A-T | MCV-A-T | MCV-A-T | MCV-A-T | MCV-A-T | MCV-A-T |
VAC1181 | Pentavalent vaccine DTPeHibHepB - Diphtheria-Tetanus-Pertussis-Hib PRP-HepatitisB 10µg, unspecified | ||||||
VAC0428 | |||||||
DIS063 | Adenovirus | Adenovirus | Αδενοϊός | Adenovīruss | Adenowirus | Adenovírus | |
VAC0646 | |||||||
VAC0779 | |||||||
VAC1096 | |||||||
VAC0513 | |||||||
VAC0997 | 13-valenter Konjugatimpfstoff gegen Pneumokokken, nicht näher bezeichnet | Pneumococcal 13-valent conjugate vaccine, unspecified | Πνευμονιόκοκκο 13-δύναμο συζευγμένο εμβόλιο, απροσδιόριστο | 13-valentā konjugāta pneimokoku vakcīna, neprecizēta | 13-walentna szczepionka skoniugowana przeciwko pneumokokom, nieokreślona | Vacina pneumocócica conjugada 13-valente, não especificada | |
VAL186 | PCV-01 | PCV-01 | VPC-01 | PCV-01 | PCV-01 | PCV-01 | PCV-01 |
VAC0864 | Varizella-Zoster-Immunglobulin, nicht näher bezeichnet | Varicella-Zoster immunoglobulin, unspecified | Ανοσοσφαιρίνη ανεμευλογιάς-ζωστήρα, μη καθορισμένη | Varicella-Zoster imūnglobulīns, neprecizēts | Immunoglobulina przeciwko ospie wietrznej i półpaścu, nieokreślona | Imunoglobulina varicela-zoster, não especificada | |
VAC0731 | |||||||
VAC1408 | |||||||
VAL272 | MCV-W-T | MCV-W-T | MCV-W-T | MCV-W-T | MCV-W-T | MCV-W-T | MCV-W-T |
VAC1182 | Meningococcal ACWY polysaccharide vaccine conjugated to tetanus toxoid, unspecified | ||||||
VAC0429 | |||||||
DIS062 | Argentinisches hämorrhagisches Fieber | Argentine hemorrhagic fever | Αργεντινός αιμορραγικός πυρετός | Argentīnas hemorāģiskais drudzis | Argentyńska gorączka krwotoczna | febre hemorrágica argentina | |
VAC0998 | |||||||
VAC1097 | |||||||
VAC0647 | |||||||
VAC0514 | |||||||
VAC0732 | |||||||
VAC0950 | |||||||
VAL187 | PCV-03 | PCV-03 | VPC-03 | PCV-03 | PCV-03 | PCV-03 | PCV-03 |
VAC0865 | Polysaccharid-Meningokokken-A-Impfstoff, nicht spezifiziert | Polysaccharide meningococcal A vaccine, unspecified | Εμβόλιο πολυσακχαρίτη μηνιγγιτιδοκοκκικού Α, απροσδιόριστο | Polisaharīdu meningokoku A vakcīna, neprecizēta | Szczepionka polisacharydowa przeciwko meningokokom typu A, nieokreślona | Vacina polissacarídica meningocócica A, não especificada | |
VAL054 | COVID-VVnr-S-MVA | COVID-VVnr-S-MVA | Covid-VVnr-S-MVA | COVID-VVnr-S-MVA | COVID-VVnr-S-MVA | COVID-VVnr-S-MVA | COVID-VVnr-S-MVA |
VAC0074 | |||||||
VAC0955 | |||||||
VAC0737 | |||||||
VAC0822 | Influenza vaccine, live attenuated, unspecified | Influenza vaccine, live attenuated, unspecified | Influenza vaccine, live attenuated, unspecified | Influenza vaccine, live attenuated, unspecified | Influenza vaccine, live attenuated, unspecified | Influenza vaccine, live attenuated, unspecified | |
VAC1054 | |||||||
VAC1187 | COVID-19 vaccine with replicative viral vector, measles virus encoding the SARS-CoV-2 spike protein, unspecified | ||||||
VAL059 | Quadrivalente lebend-attenuierte Influenza-Valenz, normale Dosis | INF-L4 | Inf-L4 | Τετρασθενής ζωντανή εξασθενημένη βαλεντία της γρίπης, κανονική δόση | Četrvalenta dzīva novājināta gripas valence, normāla deva | Czterowalentna żywa atenuowana wartość przeciwko grypie, normalna dawka | Valência vacinal tetravalente viva atenuada contra a gripe, dose normal |
VAC1272 | |||||||
VAL277 | MCV-Y-D | MCV-Y-D | MCV-Y-D | MCV-Y-D | MCV-Y-D | MCV-Y-D | MCV-Y-D |
VAL144 | HepA-mv-ADU | HepA-mv-ADU | HepA-mv-ADU | HepA-mv-ADU | HepA-mv-ADU | HepA-mv-ADU | HepA-mv-ADU |
VAL011 | COVID-PS-rRBD | COVID-PS-rRBD | Covid-SP-rRBD | COVID-PS-rRBD | COVID-PS-rRBD | COVID-PS-rRBD | COVID-PS-rRBD |
VAL362 | INF-V | Inf-V | |||||
DIS061 | Tularämie | Tularemia | Τουλαραιμία | Tularēmija | Tularemia | Tularemia | |
VAC0292 | |||||||
VAC0293 | |||||||
VAC0739 | |||||||
VAC0823 | VLP influenza vaccine, unspecified | VLP influenza vaccine, unspecified | VLP influenza vaccine, unspecified | VLP influenza vaccine, unspecified | VLP influenza vaccine, unspecified | VLP influenza vaccine, unspecified | |
VAC1055 | |||||||
VAL278 | Adeno-LAV | AD-LA | Adeno-VVA | Adeno-LAV | Adeno-LAV | Adeno-LAV | Adeno-LAV |
VAC1140 | COVID-19 bivalent mRNA vaccine against the original virus and the Omicron BA.4/5 variant, 25 micrograms, unspecified | ||||||
VAC0956 | |||||||
VAC1273 | |||||||
VAL145 | HepA-bv-ADU | HepA-bv-ADU | HepA-bv-ADU | HepA-bv-ADU | HepA-bv-ADU | HepA-bv-ADU | HepA-bv-ADU |
VAL012 | rHBsAg-40 | rHBsAg-40 | rAgHBs-40 | rHBsAg-40 | rHBsAg-40 | rHBsAg-40 | rHBsAg-40 |
VAL230 | Quadrivalente inaktivierte Influenza-Valenz, Spalt- oder Untereinheit, ohne Spezifikation | INF-SU4 | Inf-SU4 | Τετρασθενής αδρανοποιημένη βαλεντία της γρίπης, κλασματοποιημένη ή υπομονάδα, χωρίς διευκρίνιση | Četrvalenta inaktivēta gripas valence, frakcionēta vai apakšvienība, bez precizējuma | Czterowalentna inaktywowana wartość przeciwko grypie, dzielona lub podjednostkowa, bez określenia | Valência vacinal tetravalente inativada da gripe, fracionada ou de subunidade, sem especificação |
DIS060 | Herpes | Herpes | Ερπης | Herpes | Opryszczka | Herpes | |
VAC1188 | COVID-19 mRNA vaccine encoding the spike protein of SARS-CoV-2, original virus, 3 micrograms, unspecified | ||||||
VAL363 | INF-VLP3 | Inf-VLP3 | |||||
VAC0160 | Live attenuated shingles vaccine, unspecified | Live attenuated shingles vaccine, unspecified | Live attenuated shingles vaccine, unspecified | Live attenuated shingles vaccine, unspecified | Live attenuated shingles vaccine, unspecified | Live attenuated shingles vaccine, unspecified | |
VAL360 | Inaktivierte Influenza-Valenz aus Zellkultur, spalt- oder untereinheitlich, normale Dosis, ohne Spezifikation | INF-CC | Inf-CC | Αδρανοποιημένη βαλεντία της γρίπης που προέρχεται από κυτταροκαλλιέργεια, κλασματοποιημένη ή υπομονάδα, κανονική δόση, χωρίς διευκρίνιση | Inaktivēta gripas valence, iegūta no šūnu kultūras, frakcionēta vai apakšvienība, normāla deva, bez precizējuma | Wartość inaktywowana przeciwko grypie uzyskana z hodowli komórkowej, dzielona lub podjednostkowa, normalna dawka, bez określenia | Valência vacinal inativada da gripe obtida por cultura celular, fracionada ou de subunidade, dose normal, sem especificação |
VAC1270 | |||||||
VAC0518 | |||||||
VAC0517 | |||||||
VAC0602 | DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified | DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified | DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified | DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified | DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified | DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified | |
VAC0735 | |||||||
VAC0868 | |||||||
VAC1052 | |||||||
VAC1185 | COVID-19 vaccine with non-replicating viral vector, adenovirus 26 encoding the spike protein of SARS-CoV-2, unspecified | ||||||
VAL057 | MCV-C | MCV-C | MCV-C | MCV-C | MCV-C | MCV-C | MCV-C |
VAC0953 | |||||||
VAL142 | HepA-mv-PED | HepA-mv-PED | HepA-mv-PED | HepA-mv-PED | HepA-mv-PED | HepA-mv-PED | HepA-mv-PED |
VAC0820 | Inactivated whole influenza vaccine, unspecified | Inactivated whole influenza vaccine, unspecified | Inactivated whole influenza vaccine, unspecified | Inactivated whole influenza vaccine, unspecified | Inactivated whole influenza vaccine, unspecified | Inactivated whole influenza vaccine, unspecified | |
VAL275 | MCV-Y-CRM | MCV-Y-CRM | MCV-Y-CRM | MCV-Y-CRM | MCV-Y-CRM | MCV-Y-CRM | MCV-Y-CRM |
VAC0290 | |||||||
VAC0072 | |||||||
VAC0073 | |||||||
VAL361 | Rekombinante Influenza-Valenz, ohne Spezifikation | INF-R | Inf-R | Aνασυνδυασμένη βαλεντία της γρίπης, χωρίς διευκρίνιση | Rekombinanta gripas valence, bez precizējuma | Rekombinowana wartość przeciwko grypie, bez określenia | Valência vacinal recombinante da gripe, sem especificação |
VAC1271 | |||||||
VAC0736 | |||||||
VAC1186 | COVID-19 vaccine with replicative viral vector with antigen-presenting cells, unspecified | ||||||
VAC0954 | |||||||
VAC0869 | |||||||
VAC1053 | |||||||
VAL058 | Inaktivierte Influenza-Valenz, Spalt- oder Untereinheit, ohne Spezifikation | INF-SU | Inf-SU | Αδρανοποιημένη βαλεντία της γρίπης, κλασματοποιημένη ή υπομονάδα, χωρίς διευκρίνιση | Inaktivēta gripas valence, frakcionēta vai apakšvienība, bez precizējuma | Inaktywowana wartość przeciwko grypie, dzielona lub podjednostkowa, bez określenia | Valência vacinal inativada da gripe, fracionada ou de subunidade, sem especificação |
VAC0603 | |||||||
VAL276 | MCV-Y-T | MCV-Y-T | MCV-Y-T | MCV-Y-T | MCV-Y-T | MCV-Y-T | MCV-Y-T |
VAL143 | HepA-bv-PED | HepA-bv-PED | HepA-bv-PED | HepA-bv-PED | HepA-bv-PED | HepA-bv-PED | HepA-bv-PED |
VAC0821 | Inactivated influenza vaccine, split or subunit, unspecified | Inactivated influenza vaccine, split or subunit, unspecified | Inactivated influenza vaccine, split or subunit, unspecified | Inactivated influenza vaccine, split or subunit, unspecified | Inactivated influenza vaccine, split or subunit, unspecified | Inactivated influenza vaccine, split or subunit, unspecified | |
VAL010 | wP | wP | Ce | wP | wP | wP | wP |
VAC0291 | |||||||
VAC1090 | |||||||
VAC0204 | |||||||
VAC0337 | |||||||
VAL148 | RSV-IG | RSV-IG | VRS-Ig | RSV-IG | RSV-IG | RSV-IG | RSV-IG |
VAL015 | INF-SUnd3 | Inf-SUnd3 | |||||
VAL366 | RNA-basierte Influenza-Valenz, ohne Spezifikation | INF-RNA | INF-ARN | Βαλεντία της γρίπης με βάση το RNA, χωρίς διευκρίνιση | RNS bāzes gripas valence, bez precizējuma | Wartość przeciwko grypie oparta na RNA, bez określenia | Valência vacinal de RNA contra a gripe, sem especificação |
VAC0688 | |||||||
VAL100 | JE-LAV-14-14-2 | JE-LA-14-14-2 | EJ-VVA-14-14-2 | JE-LAV-14-14-2 | JE-LAV-14-14-2 | JE-LAV-14-14-2 | JE-LAV-14-14-2 |
VAL233 | PPSV-25 | PPSV-25 | VPP-25 | PPSV-25 | PPSV-25 | PPSV-25 | PPSV-25 |
VAC0555 | |||||||
VAC0991 | |||||||
VAC0640 | |||||||
VAC1402 | |||||||
VAC0773 | |||||||
VAC1317 | |||||||
VAC1091 | |||||||
VAC0205 | |||||||
VAC0338 | |||||||
DIS025 | Pneumokokken | Pneumococcus | Πνευμονιόκοκκος | Pneimokoku | Pneumokoki | Pneumococo | |
VAL149 | Covid-mRNA-S-25 | COVID-mRNA-S-OMI | Covid-ARNm-S-OMI | Covid-mRNA-S-25 | Covid-mRNA-S-25 | Covid-mRNA-S-25 | Covid-mRNA-S-25 |
VAL016 | RIG | RIG | RIG | RIG | RIG | RIG | RIG |
VAL234 | Men | Men | Men | Men | Men | Men | Men |
VAL367 | CHOL-I-O1-O | O-Chol-O1-I | |||||
VAL101 | COVID-VVnr-S-Nv | COVID-VVnr-S-Nv | Covid-VVnr-S-Nv | COVID-VVnr-S-Nv | COVID-VVnr-S-Nv | COVID-VVnr-S-Nv | COVID-VVnr-S-Nv |
VAC0556 | |||||||
VAC0689 | |||||||
VAC0774 | |||||||
VAC0423 | |||||||
VAC0641 | |||||||
VAC0992 | |||||||
VAC1403 | |||||||
VAC1318 | |||||||
VAC0202 | |||||||
VAC0335 | |||||||
VAL146 | Bruc-I | Bruc-I | Bruc-I | Bruc-I | Bruc-I | Bruc-I | Bruc-I |
VAL279 | INF-SUped4 | Inf-SUped4 | |||||
VAL013 | Shingles-gE | Shingles-gE | Zona-gE | Shingles-gE | Shingles-gE | Shingles-gE | Shingles-gE |
VAL364 | Nicht-lebende Influenza-Valenz, ohne Spezifikation | INF-NL | Inf-NL | Μη ζωντανή βαλεντία της γρίπης, χωρίς διευκρίνιση | Nedzīva gripas valence, bez precizējuma | Nieżywa wartość przeciwko grypie, bez określenia | Valência vacinal não viva da gripe, sem especificação |
VAC0468 | |||||||
VAC0686 | |||||||
VAC1400 | |||||||
VAL231 | INF-SUimsc3 | Inf-SUimsc3 | |||||
VAC0553 | Pentavalent DTwPHibIPV vaccine, unspecified | Pentavalent DTwPHibIPV vaccine, unspecified | Pentavalent DTwPHibIPV vaccine, unspecified | Pentavalent DTwPHibIPV vaccine, unspecified | Pentavalent DTwPHibIPV vaccine, unspecified | Pentavalent DTwPHibIPV vaccine, unspecified | |
VAC1315 | |||||||
VAC0420 | |||||||
VAC0771 | |||||||
VAC0203 | |||||||
VAC0336 | |||||||
VAL147 | Bruc-IP | Bruc-IP | Bruc-PI | Bruc-IP | Bruc-IP | Bruc-IP | Bruc-IP |
VAL014 | Ty | Ty | Ty | Ty | Ty | Ty | Ty |
VAC0469 | |||||||
VAL232 | PPSV-06A | PPSV-06A | VPP-06A | PPSV-06A | PPSV-06A | PPSV-06A | PPSV-06A |
VAL365 | Nicht-lebende Influenza-Valenz aus Eikultur, ohne Spezifikation | INF-E | Inf-E | Μη ζωντανή βαλεντία της γρίπης που προέρχεται από καλλιέργεια σε αυγά, χωρίς διευκρίνιση | Nedzīva gripas valence, iegūta no olu kultūras, bez precizējuma | Nieżywa wartość przeciwko grypie uzyskana z hodowli na jajach, bez określenia | Valência vacinal não viva da gripe obtida por cultura em ovos, sem especificação |
VAC0554 | |||||||
VAC0687 | |||||||
VAC0421 | |||||||
VAC0772 | |||||||
VAC0990 | |||||||
VAC1316 | |||||||
VAC1401 | |||||||
VAC1094 | |||||||
VAC0208 | |||||||
VAL237 | HPV-poly | HPV-poly | VPH-poly | HPV-poly | HPV-poly | HPV-poly | HPV-poly |
VAL104 | COVID-PS-rS | COVID-PS-rS | Covid-SP-rS | COVID-PS-rS | COVID-PS-rS | COVID-PS-rS | COVID-PS-rS |
VAL322 | RSV-PreFAB | RSV-PreFAB | VRS-PreFAB | RSV-PreFAB | RSV-PreFAB | RSV-PreFAB | RSV-PreFAB |
VAC0426 | |||||||
VAC0644 | |||||||
VAC0995 | |||||||
VAC0862 | Masern-Immunglobulin, nicht näher bezeichnet | Measles immunoglobulin, unspecified | Ανοσοσφαιρίνη ιλαράς, απροσδιόριστη | Masalu imūnglobulīns, neprecizēts | Immunoglobulina odry, nieokreślona | Imunoglobulina contra o sarampo, não especificada | |
VAC0777 | |||||||
VAC0511 | |||||||
VAC1406 | |||||||
VAL019 | DATx | DATx | DATx | DATx | DATx | DATx | DATx |
VAC1095 | |||||||
VAC1180 | Recombinant Lyme disease vaccine, unspecified | ||||||
VAC0209 | |||||||
VAL105 | Pneumo | Pneumo | Pneumo | Pneumo | Pneumo | Pneumo | Pneumo |
VAC0778 | |||||||
VAC0427 | |||||||
VAL323 | COVID-mRNA-S-OMI-XBB.1.5-30 | Covid-ARNm-S-OMI-XBB.1.5-30 | |||||
VAC0863 | Hepatitis-B-Immunglobulin, nicht näher bezeichnet | Hepatitis B immunoglobulin, unspecified | Ανοσοσφαιρίνη ηπατίτιδας Β, μη καθορισμένη | B hepatīta imūnglobulīns, neprecizēts | Immunoglobulina przeciw wirusowi zapalenia wątroby typu B, nieokreślona | Imunoglobulina contra hepatite B, não especificada | |
VAC0512 | Typhus vaccine, unspecified | Typhus vaccine, unspecified | Typhus vaccine, unspecified | Typhus vaccine, unspecified | Typhus vaccine, unspecified | Typhus vaccine, unspecified | |
VAC0645 | |||||||
VAC0730 | |||||||
VAC0996 | |||||||
VAL238 | HPV-06 | HPV-06 | VPH-06 | HPV-06 | HPV-06 | HPV-06 | HPV-06 |
VAC1407 | |||||||
VAC0206 | |||||||
VAC0339 | Pneumococcal polysaccharide vaccine 23-valent, unspecified | Pneumococcal polysaccharide vaccine 23-valent, unspecified | Pneumococcal polysaccharide vaccine 23-valent, unspecified | Pneumococcal polysaccharide vaccine 23-valent, unspecified | Pneumococcal polysaccharide vaccine 23-valent, unspecified | Pneumococcal polysaccharide vaccine 23-valent, unspecified | |
DIS068 | Menschliche Parainfluenza-Viren | Human parainfluenza viruses | Ανθρώπινοι ιοί παραγρίπης | Cilvēka paragripas vīrusi | Wirusy paragrypy ludzkiej | Vírus da parainfluenza humana | |
VAC1092 | |||||||
VAL017 | ap | ap | ca | ap | ap | ap | ap |
VAL368 | CHOL-I-O139-O | O-Chol-O139-I | |||||
VAL235 | MCV-poly | MCV-poly | MCV-poly | MCV-poly | MCV-poly | MCV-poly | MCV-poly |
VAL102 | HepE | HepE | HepE | HepE | HepE | HepE | HepE |
VAL320 | RSV-mAb | VRS-mAb | |||||
VAC0424 | Live attenuated oral typhoid vaccine, unspecified | Live attenuated oral typhoid vaccine, unspecified | Live attenuated oral typhoid vaccine, unspecified | Live attenuated oral typhoid vaccine, unspecified | Live attenuated oral typhoid vaccine, unspecified | Live attenuated oral typhoid vaccine, unspecified | |
VAC0642 | |||||||
VAC0775 | DTwPHib, unspecified | DTwPHib, unspecified | DTwPHib, unspecified | DTwPHib, unspecified | DTwPHib, unspecified | DTwPHib, unspecified | |
VAC0993 | |||||||
VAC1404 | |||||||
VAC0860 | Nonavalenter HPV-Impfstoff, nicht spezifiziert | HPV vaccine nonavalent, unspecified | Εμβόλιο HPV μη δυναμικό, απροσδιόριστο | HPV vakcīna nevalenta, neprecizēta | Szczepionka przeciwko HPV nieważna, nieokreślona | Vacina contra HPV nonavalente, não especificada | |
VAC1319 | |||||||
VAC0207 | |||||||
DIS067 | Leishmaniose | Leishmaniasis | Λεϊσμανίαση | Leišmanioze | Leiszmanioza | Leishmaniose | |
VAC1093 | |||||||
VAL236 | HPV-mono | HPV-mono | VPH-mono | HPV-mono | HPV-mono | HPV-mono | HPV-mono |
VAL369 | PCV-15A | VPC-15A | |||||
VAL103 | Hib-C | Hib-C | Hib-C | Hib-C | Hib-C | Hib-C | Hib-C |
VAC0776 | |||||||
VAC0425 | |||||||
VAC0994 | |||||||
VAL321 | VRS-mAb-nir | VRS-mAb-nir | VRS-mAb-nir | VRS-mAb-nir | VRS-mAb-nir | VRS-mAb-nir | VRS-mAb-nir |
VAC0510 | |||||||
VAC0643 | Meningococcal ACWY conjugate vaccine, unspecified | Meningococcal ACWY conjugate vaccine, unspecified | Meningococcal ACWY conjugate vaccine, unspecified | Meningococcal ACWY conjugate vaccine, unspecified | Meningococcal ACWY conjugate vaccine, unspecified | Meningococcal ACWY conjugate vaccine, unspecified | |
VAC0861 | Mehrkomponenten-Meningokokken-B-Impfstoff, nicht näher bezeichnet | Multicomponent meningococcal B vaccine, unspecified | Πολυσυστατικό εμβόλιο μηνιγγιτιδοκοκκικού Β, απροσδιόριστο | Daudzkomponentu meningokoku B vakcīna, neprecizēta | Wieloskładnikowa szczepionka przeciw meningokokom typu B, nieokreślona | Vacina meningocócica B multicomponente, não especificada | |
VAC1405 | |||||||
VAL018 | Pox-3G-LC16 | POX-3G-LC16 | POX-3G-LC16 | Pox-3G-LC16 | Pox-3G-LC16 | Pox-3G-LC16 | Pox-3G-LC16 |
VAC0111 | Yellow fever vaccine, unspecified | Yellow fever vaccine, unspecified | Yellow fever vaccine, unspecified | Yellow fever vaccine, unspecified | Yellow fever vaccine, unspecified | Yellow fever vaccine, unspecified | |
VAC0244 | |||||||
VAC0377 | |||||||
VAC0908 | Impfstoff gegen Adenovirus Typ 7, nicht spezifiziert | Vaccine against adenovirus type 7, unspecified | Εμβόλιο κατά του αδενοϊού τύπου 7, απροσδιόριστο | Vakcīna pret 7. tipa adenovīrusu, neprecizēts | Szczepionka przeciwko adenowirusowi typu 7, nieokreślona | Vacina contra adenovírus tipo 7, não especificada | |
VAC0159 | Chickenpox vaccine, unspecified | Chickenpox vaccine, unspecified | Chickenpox vaccine, unspecified | Chickenpox vaccine, unspecified | Chickenpox vaccine, unspecified | Chickenpox vaccine, unspecified | |
VAC0026 | |||||||
VAL411 | COVID-mRNA-S-OMI-BA.4/5-50 | COVID-mRNA-S-OMI-BA.4/5-50 | Covid-ARNm-S-OMI-BA.4/5-50 | COVID-mRNA-S-OMI-BA.4/5-50 | COVID-mRNA-S-OMI-BA.4/5-50 | COVID-mRNA-S-OMI-BA.4/5-50 | COVID-mRNA-S-OMI-BA.4/5-50 |
VAC1442 | Influenza vaccine, quadrivalent, virosomal, unspecified | ||||||
VAC1224 | Respiratory syncytial virus (RSV) vaccine, recombinant, F-glycoprotein (prefusion) RSV subtypes A and B, unspecified | ||||||
VAC1139 | COVID-19 vaccine, non-replicating vector, Newcastle disease virus encoding the SARS-CoV-2 spike protein, unspecified | ||||||
VAC0595 | |||||||
VAC1006 | |||||||
VAC1357 | |||||||
VAC0462 | |||||||
VAC0680 | |||||||
VAL108 | ZebovVRnrAd26 | ZebovVRnrAd26 | ZebovVRnrAd26 | ZebovVRnrAd26 | ZebovVRnrAd26 | ZebovVRnrAd26 | ZebovVRnrAd26 |
VAL326 | COVID-mRNA-S-OMI-BA.4/5-1.5 | COVID-mRNA-S-OMI-BA.4/5-1.5 | Covid-ARNm-S-OMI-BA.4/5-1,5 | COVID-mRNA-S-OMI-BA.4/5-1.5 | COVID-mRNA-S-OMI-BA.4/5-1.5 | COVID-mRNA-S-OMI-BA.4/5-1.5 | COVID-mRNA-S-OMI-BA.4/5-1.5 |
VAC0330 | |||||||
VAC0245 | |||||||
VAC0112 | Typhoid vaccine, unspecified | Typhoid vaccine, unspecified | Typhoid vaccine, unspecified | Typhoid vaccine, unspecified | Typhoid vaccine, unspecified | Typhoid vaccine, unspecified | |
VAC0027 | |||||||
VAC0378 | |||||||
VAC0909 | Botulinum-Antitoxin | Botulinum antitoxin | Αντιτοξίνη αλλαντίασης | Botulīna antitoksīns | Antytoksyna botulinowa | Antitoxina botulínica | |
VAL412 | Covid-ARNm-S-OMI-BA.1-50 | COVID-mRNA-S-OMI-BA.1-50 | Covid-ARNm-S-OMI-BA.1-50 | Covid-ARNm-S-OMI-BA.1-50 | Covid-ARNm-S-OMI-BA.1-50 | Covid-ARNm-S-OMI-BA.1-50 | Covid-ARNm-S-OMI-BA.1-50 |
VAC1310 | |||||||
VAC1443 | Influenza vaccine, trivalent, virosomal, unspecified | ||||||
VAC0596 | DTaPHibHepB pentavalent vaccine, unspecified | DTaPHibHepB pentavalent vaccine, unspecified | DTaPHibHepB pentavalent vaccine, unspecified | DTaPHibHepB pentavalent vaccine, unspecified | DTaPHibHepB pentavalent vaccine, unspecified | DTaPHibHepB pentavalent vaccine, unspecified | |
VAC1007 | |||||||
VAC0463 | |||||||
VAC1225 | Diphtheria, tetanus, typhoid and paratypoid A and B vaccines, unspecified | ||||||
VAC1358 | |||||||
VAL109 | Ebola-MVA-BN-Filo | Ebola-MVA-BN-Filo | Ebola-MVA-BN-Filo | Ebola-MVA-BN-Filo | Ebola-MVA-BN-Filo | Ebola-MVA-BN-Filo | Ebola-MVA-BN-Filo |
VAC0681 | |||||||
VAL327 | COVID-mRNA-S-ORI-1.5 | COVID-mRNA-S-ORI-1.5 | Covid-ARNm-S-ORI-1,5 | COVID-mRNA-S-ORI-1.5 | COVID-mRNA-S-ORI-1.5 | COVID-mRNA-S-ORI-1.5 | COVID-mRNA-S-ORI-1.5 |
VAC0242 | |||||||
VAC0375 | |||||||
VAC0157 | Pneumococcal vaccine, unspecified | Pneumococcal vaccine, unspecified | Pneumococcal vaccine, unspecified | Pneumococcal vaccine, unspecified | Pneumococcal vaccine, unspecified | Pneumococcal vaccine, unspecified | |
VAC0024 | |||||||
VAC0906 | Gürtelrose-Impfstoff, nicht näher bezeichnet | Shingles vaccine, unspecified | Εμβόλιο κατά του έρπητα ζωστήρα, απροσδιόριστο | Vakcīna pret jostas rozi, neprecizēta | Szczepionka na półpasiec, nieokreślona | Vacina contra herpes zoster, não especificada | |
VAL324 | COVID-mRNA-S-OMI-XBB.1.5-10 | Covid-ARNm-S-OMI-XBB.1.5-10 | |||||
VAC1440 | Influenza vaccine, quadrivalent, inactivated, fractionated or subunit, adjuvanted, normal dose | ||||||
VAC1004 | |||||||
VAC1355 | |||||||
VAC1222 | Human monoclonal antibody against respiratory syncytial virus (RSV), palivizumab, unspecified | ||||||
VAC1137 | Whole inactivated tick-borne encephalitis vaccine, strain K23, unspecified | ||||||
VAC0593 | |||||||
VAC0460 | |||||||
VAL239 | HVP-11 | HPV-11 | VPH-11 | HVP-11 | HVP-11 | HVP-11 | HVP-11 |
VAL106 | Rota | ROTA-LA | Rota | Rota | Rota | Rota | Rota |
VAC0110 | Influenza vaccine, unspecified | Influenza vaccine, unspecified | Influenza vaccine, unspecified | Influenza vaccine, unspecified | Influenza vaccine, unspecified | Influenza vaccine, unspecified | |
VAC0243 | |||||||
VAC0025 | |||||||
VAC0376 | |||||||
VAC0907 | Impfstoff gegen Adenovirus Typ 4, nicht spezifiziert | Vaccine against adenovirus type 4, unspecified | Εμβόλιο κατά του αδενοϊού τύπου 4, απροσδιόριστο | Vakcīna pret 4. tipa adenovīrusu, neprecizēts | Szczepionka przeciwko adenowirusowi typu 4, nieokreślona | Vacina contra adenovírus tipo 4, não especificada | |
VAC0158 | Rotavirus vaccine, unspecified | Rotavirus vaccine, unspecified | Rotavirus vaccine, unspecified | Rotavirus vaccine, unspecified | Rotavirus vaccine, unspecified | Rotavirus vaccine, unspecified | |
VAL325 | COVID-mRNA-S-OMI-XBB.1.5-3 | Covid-ARNm-S-OMI-XBB.1.5-3 | |||||
VAL410 | COVID-PS-rN | Covid-SP-rN | |||||
VAC1223 | Immunoglobulin against respiratory syncytial virus (RSV), unspecified | ||||||
VAC1356 | |||||||
VAC1441 | Influenza vaccine, quadrivalent, inactivated, split or subunit, intradermal route, unspecified | ||||||
VAC0594 | |||||||
VAC1005 | |||||||
VAC1138 | COVID-19 recombinant protein subunit vaccine | ||||||
VAC0461 | |||||||
VAL107 | COVID-19-Impfstoff, Protein-Untereinheit, rekombinante Spike-Protein-Nanopartikel | COVID-PS-rSnp | Covid-SP-rSnp | Εμβόλιο COVID-19, πρωτεϊνική υπομονάδα, ανασυνδυασμένα νανοσωματίδια πρωτεΐνης αιχμής | COVID-19 vakcīna, proteīna apakšvienība, rekombinantās smaiļveida proteīna nanodaļiņas | Szczepionka COVID-19, podjednostka białkowa, rekombinowane nanocząstki białka kolczastego | Vacina COVID-19, subunidade de proteína, nanopartículas de proteína recombinante de espigão |
VAC0200 | |||||||
VAC0333 | |||||||
VAC0115 | |||||||
VAC0248 | |||||||
VAC0599 | DTPerHibHepB pentavalent vaccine, unspecified | DTPerHibHepB pentavalent vaccine, unspecified | DTPerHibHepB pentavalent vaccine, unspecified | DTPerHibHepB pentavalent vaccine, unspecified | DTPerHibHepB pentavalent vaccine, unspecified | DTPerHibHepB pentavalent vaccine, unspecified | |
VAC0466 | |||||||
VAC0684 | |||||||
VAC1446 | Japanese encephalitis vaccine, inactivated, whole-virus, derived from Vero cells, 3 micrograms | ||||||
VAC1228 | Respiratory syncytial virus (RSV) vaccine, recombinant, F protein-derived RSVPreF3 antigen, unspecified | ||||||
VAC0551 | DTaPIPV vaccine, standard dose, unspecified | DTaPIPV vaccine, standard dose, unspecified | DTaPIPV vaccine, standard dose, unspecified | DTaPIPV vaccine, standard dose, unspecified | DTaPIPV vaccine, standard dose, unspecified | DTaPIPV vaccine, standard dose, unspecified | |
VAC1313 | |||||||
VAL415 | BantAdj | BantAdj | BantAdj | BantAdj | BantAdj | BantAdj | BantAdj |
VAC0201 | |||||||
VAC0334 | |||||||
VAC0249 | |||||||
DIS029 | Pocken-Monkeypox | Smallpox-Monkeypox | Ευλογιά-Μαϊμουδοπανώλη | Bakas-Monkeypox | Ospa-Monkeypox | Varíola-Monkeypox | |
VAC0116 | |||||||
VAC0467 | |||||||
VAC0552 | DTPCaHibHepB hexavalenter Impfstoff - Diphtherie-Tetanus-Polio-zelluläre Keuchhusten-Hib-HepB, nicht spezifiziert | Hexavalent vaccine DTPCaHibHepB - Diphtheria-Tetanus-Polio-Acellular Pertussis-Hib-HepB, unspecified | DTaPHibHepBIPV hexavalent vaccine, unspecified | DTaPHibHepBIPV hexavalent vaccine, unspecified | DTaPHibHepBIPV hexavalent vaccine, unspecified | DTaPHibHepBIPV hexavalent vaccine, unspecified | |
VAC0685 | |||||||
VAC0770 | |||||||
VAC1314 | |||||||
VAL416 | COVID-PS-rS-A | Covid-SP-rS-A | |||||
VAC1229 | Vaccine against meningococcal serogroups B (outer membrane vesicle proteins) and C | ||||||
VAC0113 | Rubella vaccine, unspecified | Rubella vaccine, live attenuated, unspecified | Rubella vaccine, unspecified | Rubella vaccine, unspecified | Rubella vaccine, unspecified | Rubella vaccine, unspecified | |
VAC0246 | |||||||
VAC0379 | |||||||
DIS028 | Japanische enzephalitis | Japanese encephalitis | Ιαπωνική εγκεφαλίτιδα | Japāņu encefalīts | Japońskie zapalenie mózgu | Encefalite japonesa | |
VAC0028 | |||||||
VAL413 | Covid-SP-rRBD-XBB.1.16 | COVID-PS-rRBD-XBB.1.16 | Covid-SP-rRBD-XBB.1.16 | Covid-SP-rRBD-XBB.1.16 | Covid-SP-rRBD-XBB.1.16 | Covid-SP-rRBD-XBB.1.16 | Covid-SP-rRBD-XBB.1.16 |
VAC1311 | Meningococcal ACWXY conjugate vaccine, unspecified | Meningococcal ACWXY conjugate vaccine, unspecified | Meningococcal ACWXY conjugate vaccine, unspecified | ||||
VAC1444 | Influenza vaccine, trivalent, VLP, unspecified | ||||||
VAC1008 | |||||||
VAC1359 | |||||||
VAC0464 | |||||||
VAC0682 | |||||||
VAC1226 | Combined hepatitis A and B vaccine, pediatric dose, unspecified | ||||||
VAL328 | COVID-SP-rSnp-XBB | COVID-PS-rSnp-XBB | Covid-SP-rSnp-XBB | ||||
VAC0332 | |||||||
VAC0114 | Live attenuated measles vaccine, unspecified | Live attenuated measles vaccine, unspecified | Live attenuated measles vaccine, unspecified | Live attenuated measles vaccine, unspecified | Live attenuated measles vaccine, unspecified | ||
DIS027 | Frühsommer-Meningoenzephalitis | Tick-borne encephalitis | Εγκεφαλίτιδα από τσιμπούρια | Ērču encefalīts | Kleszczowe zapalenie mózgu | Encefalite transmitida por carrapatos | |
VAC0247 | |||||||
VAC0029 | |||||||
VAC1312 | |||||||
VAC0598 | DTwPHibHepB pentavalent vaccine, unspecified | DTwPHibHepB pentavalent vaccine, unspecified | DTwPHibHepB pentavalent vaccine, unspecified | DTwPHibHepB pentavalent vaccine, unspecified | DTwPHibHepB pentavalent vaccine, unspecified | DTwPHibHepB pentavalent vaccine, unspecified | |
VAC0465 | |||||||
VAC1227 | Recombinant hepatitis B vaccine, pediatric dose, unspecified | ||||||
VAC1445 | Avian influenza vaccine, mRNA | ||||||
VAC0550 | Measles-Rubella vaccine, unspecified | Measles-Rubella vaccine, unspecified | Measles-Rubella vaccine, unspecified | Measles-Rubella vaccine, unspecified | Measles-Rubella vaccine, unspecified | Measles-Rubella vaccine, unspecified | |
VAC0683 | |||||||
VAL329 | Covid-ARNm-S-OMI-XBB.1.5-50 | COVID-mRNA-S-OMI-XBB.1.5-50 | Covid-ARNm-S-OMI-XBB.1.5-50 | Covid-ARNm-S-OMI-XBB.1.5-50 | Covid-ARNm-S-OMI-XBB.1.5-50 | Covid-ARNm-S-OMI-XBB.1.5-50 | Covid-ARNm-S-OMI-XBB.1.5-50 |
VAL414 | DIPH | DIPH | DIPH | DIPH | DIPH | DIPH | DIPH |
VAC1009 | |||||||
VAC0151 | Meningococcal A + C vaccine, unspecified | Meningococcal A + C vaccine, unspecified | Meningococcal A + C vaccine, unspecified | Meningococcal A + C vaccine, unspecified | Meningococcal A + C vaccine, unspecified | Meningococcal A + C vaccine, unspecified | |
VAC0284 | |||||||
VAC0066 | |||||||
VAC0199 | |||||||
VAL192 | PCV-07F | PCV-07F | VPC-07F | PCV-07F | PCV-07F | PCV-07F | PCV-07F |
VAC0948 | |||||||
VAC0815 | Pneumo-Hib, unspecified | Pneumo-Hib, unspecified | Pneumo-Hib, unspecified | Pneumo-Hib, unspecified | Pneumo-Hib, unspecified | Pneumo-Hib, unspecified | |
VAC1131 | 17-valent unconjugated pneumococcal vaccine, unspecified | ||||||
VAC1264 | A(H5) avian influenza vaccine, unspecified | A(H5) avian influenza vaccine, unspecified | A(H5) avian influenza vaccine, unspecified | A(H5) avian influenza vaccine, unspecified | A(H5) avian influenza vaccine, unspecified | A(H5) avian influenza vaccine, unspecified | |
VAC0814 | Pneumococcal conjugate vaccine, serotypes unspecified | Pneumococcal conjugate vaccine, serotypes unspecified | Pneumococcal conjugate vaccine, serotypes unspecified | Pneumococcal conjugate vaccine, serotypes unspecified | Pneumococcal conjugate vaccine, serotypes unspecified | Pneumococcal conjugate vaccine, serotypes unspecified | |
VAC1179 | Cholera and typhoid vaccine, injectable, unspecified | ||||||
VAC1397 | |||||||
VAC1046 | |||||||
VAL419 | BOT | BOT | |||||
VAC0370 | |||||||
VAC0152 | Unconjugated meningococcal vaccine ACWY, unspecified | Unconjugated meningococcal vaccine ACWY, unspecified | Unconjugated meningococcal vaccine ACWY, unspecified | Unconjugated meningococcal vaccine ACWY, unspecified | Unconjugated meningococcal vaccine ACWY, unspecified | Unconjugated meningococcal vaccine ACWY, unspecified | |
VAC0285 | |||||||
VAC0067 | |||||||
VAL193 | PCV-08 | PCV-08 | VPC-08 | PCV-08 | PCV-08 | PCV-08 | PCV-08 |
VAL060 | CHIK-LA | CHIK-LA | CHIK-LA | CHIK-LA | CHIK-LA | CHIK-LA | CHIK-LA |
VAC0816 | |||||||
VAC0949 | |||||||
VAC0900 | |||||||
VAC1132 | COVID-19 bivalent mRNA vaccine, original virus + Omicron BA.4/5 variant, 1.5 micrograms, unspecified | ||||||
VAC1350 | |||||||
VAC1398 | |||||||
VAC1047 | |||||||
VAC1265 | |||||||
VAC0282 | |||||||
VAC0064 | |||||||
VAC0197 | |||||||
VAL190 | PCV-06A | PCV-06A | VPC-06A | PCV-06A | PCV-06A | PCV-06A | PCV-06A |
VAC0728 | |||||||
VAC0812 | Inactivated whole plague vaccine, unspecified | Inactivated whole plague vaccine, unspecified | Inactivated whole plague vaccine, unspecified | Inactivated whole plague vaccine, unspecified | Inactivated whole plague vaccine, unspecified | Inactivated whole plague vaccine, unspecified | |
VAC1044 | COVID-19-Impfstoff, ganzes Virion inaktiviert, nicht spezifiziert | COVID-19 vaccine, whole virion inactivated, unspecified | Εμβόλιο COVID-19, αδρανοποιημένο ολόκληρο ιοσωμάτιο, απροσδιόριστο | Covid-19 vakcīna, viss virions inaktivēts, neprecizēts | Szczepionka przeciwko COVID-19, inaktywowany cały wirion, nieokreślony | Vacina contra a COVID-19, virião inteiro inativado, não especificado | |
VAC0945 | Serogruppe des Meningokokken-Impfstoffs unbekannt, nicht spezifiziert | Meningococcal vaccine serogroup unknown, unspecified | Άγνωστη οροομάδα εμβολίου μηνιγγιτιδοκοκκικού, απροσδιόριστη | Meningokoku vakcīnas serogrupa nav zināma, nav precizēta | Grupa serologiczna szczepionki przeciw meningokokom nieznana, nieokreślona | Sorogrupo da vacina meningocócica desconhecido, não especificado | |
VAC1262 | |||||||
VAC1395 | |||||||
VAC1177 | 3rd generation smallpox vaccine, live vaccinia virus with minimal replication, unspecified | ||||||
VAL417 | COVID-mRNA-S-OMI-BA.2 | Covid-ARNm-S-OMI-BA.2 | |||||
VAC0283 | |||||||
VAC0150 | Meningococcal conjugate vaccine C, unspecified | Meningococcal conjugate vaccine C, unspecified | Meningococcal conjugate vaccine C, unspecified | Meningococcal conjugate vaccine C, unspecified | Meningococcal conjugate vaccine C, unspecified | Meningococcal conjugate vaccine C, unspecified | |
VAC0198 | |||||||
VAC0729 | |||||||
VAL191 | PCV-06B | PCV-06B | VPC-06B | PCV-06B | PCV-06B | PCV-06B | PCV-06B |
VAC0947 | |||||||
VAC1263 | mRNA-Covid-Impfstoff, der das SARS-COV-2-Spike-Protein kodiert, zugelassen | COVID-19 mRNA vaccine encoding the SARS-COV-2 spike protein, authorized | Εμβόλιο mRNA για τον covid που κωδικοποιεί την πρωτεΐνη ακίδας SARS-COV-2, εγκεκριμένο | Autorizēta mRNS Covid vakcīna, kas kodē SARS-COV-2 smaile proteīnu | Zatwierdzona szczepionka mRNA covid, kodująca białko kolczaste SARS-COV-2 | Vacina mRNA covid que codifica a proteína spike SARS-COV-2, autorizada | |
VAC0946 | |||||||
VAC1396 | |||||||
VAC0813 | Pneumococcal unconjugated polysaccharide vaccine, unspecified | Pneumococcal unconjugated polysaccharide vaccine, unspecified | Pneumococcal unconjugated polysaccharide vaccine, unspecified | Pneumococcal unconjugated polysaccharide vaccine, unspecified | Pneumococcal unconjugated polysaccharide vaccine, unspecified | Pneumococcal unconjugated polysaccharide vaccine, unspecified | |
VAC1130 | Trivalent inactivated seasonal influenza vaccine and tetanus toxoid, unspecified | ||||||
VAC1045 | |||||||
VAC1178 | Tetravalent Dengue vaccine, live attenuated chimeric recombinant, unspecified | ||||||
VAL418 | POX | POX | |||||
VAC0240 | |||||||
VAC0373 | |||||||
VAC0155 | Dengue vaccine, unspecified | Dengue vaccine, unspecified | Dengue vaccine, unspecified | Dengue vaccine, unspecified | Dengue vaccine, unspecified | Dengue vaccine, unspecified | |
VAC0022 | |||||||
VAC0288 | |||||||
VAL196 | PCV-11A | PCV-11A | VPC-11A | PCV-11A | PCV-11A | PCV-11A | PCV-11A |
VAC0819 | Inactivated Japanese Encephalitis vaccine, unspecified | Inactivated Japanese Encephalitis vaccine, unspecified | Inactivated Japanese Encephalitis vaccine, unspecified | Inactivated Japanese Encephalitis vaccine, unspecified | Inactivated Japanese Encephalitis vaccine, unspecified | Inactivated Japanese Encephalitis vaccine, unspecified | |
VAL063 | BAT | BAT | BAT | BAT | BAT | BAT | BAT |
VAL281 | Adeno-7 | AD7-LA | Adeno-7 | Adeno-7 | Adeno-7 | Adeno-7 | Adeno-7 |
VAC0904 | Impfstoff gegen Tollwut-Entenembryonen, nicht näher bezeichnet | Rabies duck embryo vaccine, unspecified | Εμβόλιο εμβρύου πάπιας λύσσας, απροσδιόριστο | Trakumsērgas pīļu embrija vakcīna, neprecizēta | Szczepionka przeciwko wściekliźnie zarodków kaczych, nieokreślona | Vacina contra raiva em embrião de pato, não especificada | |
VAC1220 | Meningococcal CY and anti-Haemophilus influenzae type b vaccine, conjugated with tetanus toxoid, unspecified | ||||||
VAC1135 | COVID-19 Plasmid DNA vaccine with non-replicating viral vector, adenovirus encoding the spike protein of SARS-CoV-2, by inhalation, unspecified | ||||||
VAC1268 | |||||||
VAC1002 | |||||||
VAC1353 | |||||||
VAC0591 | |||||||
VAC0241 | |||||||
VAC0023 | |||||||
VAC0374 | |||||||
VAC0156 | HPV Vaccine | HPV Vaccine | HPV Vaccine | HPV Vaccine | HPV Vaccine | HPV Vaccine | |
VAC0289 | |||||||
VAL064 | INF-SUNA4 | Inf-SUNA4 | |||||
VAL282 | Adeno-4 | AD4-LA | Adeno-4 | Adeno-4 | Adeno-4 | Adeno-4 | Adeno-4 |
VAC0905 | Tollwutimpfstoff PHKCV, nicht spezifiziert | Rabies vaccine PHKCV, unspecified | Αντιλυσσικό εμβόλιο PHKCV, απροσδιόριστο | Vakcīna pret trakumsērgu PHKCV, neprecizēta | Szczepionka przeciwko wściekliźnie PHKCV, nieokreślona | Vacina anti-rábica PHKCV, não especificada | |
VAC1003 | |||||||
VAC1136 | 23-valenter konjugierter Pneumokokken-Impfstoff, nicht näher bezeichnet | 23-valent Pneumococcus conjugate vaccine, unspecified | Πνευμονιοκοκκικό 23-δύναμο συζευγμένο εμβόλιο, απροσδιόριστο | Pneimokoku 23-valenta konjugētā vakcīna, neprecizēta | 23-walentna skoniugowana szczepionka przeciw pneumokokom, nieokreślona | Vacina pneumocócica conjugada 23-valente, não especificada | |
VAC1221 | Trivalent vaccine against diphtheria, tetanus and rubella, unspecified | ||||||
VAL197 | PCV-12F | PCV-12F | VPC-12F | PCV-12F | PCV-12F | PCV-12F | PCV-12F |
VAC1354 | |||||||
VAC1269 | |||||||
VAC0592 | |||||||
VAC0371 | |||||||
VAC0153 | Mumps vaccine, unspecified | Mumps vaccine, unspecified | Mumps vaccine, unspecified | Mumps vaccine, unspecified | Mumps vaccine, unspecified | Mumps vaccine, unspecified | |
VAC0020 | |||||||
VAC0286 | |||||||
VAC0068 | |||||||
VAL194 | PCV-09V | PCV-09V | VPC-09V | PCV-09V | PCV-09V | PCV-09V | PCV-09V |
VAL061 | COVID-PS-CpG1018 | COVID-PS-CpG1018 | Covid-SP-CpG1018 | COVID-PS-CpG1018 | COVID-PS-CpG1018 | COVID-PS-CpG1018 | COVID-PS-CpG1018 |
VAC0817 | Inactivated Typhoid vaccine, unspecified | Inactivated Typhoid vaccine, unspecified | Inactivated Typhoid vaccine, unspecified | Inactivated Typhoid vaccine, unspecified | Inactivated Typhoid vaccine, unspecified | Inactivated Typhoid vaccine, unspecified | |
VAC1000 | |||||||
VAC1351 | |||||||
VAC0901 | |||||||
VAC1048 | |||||||
VAC1133 | Meningococcal ACWY polysaccharide conjugate vaccine, unspecified | ||||||
VAC1266 | |||||||
VAC1399 | |||||||
VAC0021 | |||||||
VAC0372 | |||||||
VAC0287 | |||||||
VAC0154 | Malaria vaccine, unspecified | Malaria vaccine, unspecified | Malaria vaccine, unspecified | Malaria vaccine, unspecified | Malaria vaccine, unspecified | Malaria vaccine, unspecified | |
VAC0069 | |||||||
VAL195 | PCV-10A | PCV-10A | VPC-10A | PCV-10A | PCV-10A | PCV-10A | PCV-10A |
VAL062 | O-Chol-rCTB-I | CHOL-SU-rCTB-O | O-Chol-rTCB-I | O-Chol-rCTB-I | O-Chol-rCTB-I | O-Chol-rCTB-I | O-Chol-rCTB-I |
VAC0903 | Tollwutimpfstoff vom Typ Fuenzalida, nicht näher bezeichnet | Rabies vaccine Fuenzalida type, unspecified | Αντιλυσσικό εμβόλιο τύπου Fuenzalida, απροσδιόριστος | Vakcīna pret trakumsērgu Fuenzalida tipa, neprecizēta | Szczepionka przeciwko wściekliźnie typu Fuenzalida, nieokreślona | Vacina anti-rábica tipo Fuenzalida, não especificada | |
VAL280 | BT | BT | BT | BT | BT | BT | BT |
VAC0818 | Typhoid-Paratyphoid vaccine, unspecified | Typhoid-Paratyphoid vaccine, unspecified | Typhoid-Paratyphoid vaccine, unspecified | Typhoid-Paratyphoid vaccine, unspecified | Typhoid-Paratyphoid vaccine, unspecified | Typhoid-Paratyphoid vaccine, unspecified | |
VAC1352 | |||||||
VAC0902 | Tollwutimpfstoff Semple-Typ, nicht spezifiziert | Rabies vaccine Semple type, unspecified | Αντιλυσσικό εμβόλιο Semple τύπου, απροσδιόριστος | Vakcīna pret trakumsērgu Semple tips, neprecizēts | RSzczepionka przeciwko wściekliźnie typu Semple, nieokreślona | Vacina anti-rábica tipo Semple, não especificada | |
VAC1267 | |||||||
VAC1001 | |||||||
VAC1134 | Live attenuated vaccine against Argentine hemorrhagic fever, Junin virus, unspecified | ||||||
VAC1049 | |||||||
VAC0590 |